Characterization and functional analysis of cell-mediated immunity to Leishmania infantum by RODRIGUES, Olívia Roos
  
 
 
 
INSTITUTO DE HIGIENE E MEDICINA TROPICAL 
UNIVERSIDADE NOVA DE LISBOA 
 
 
 
CHARACTERIZATION AND FUNCTIONAL ANALYSIS OF  
CELL-MEDIATED IMMUNITY TO LEISHMANIA INFANTUM 
 
 
ANÁLISE FUNCIONAL DA IMUNIDADE CELULAR  
NA INFECÇÃO POR LEISHMANIA INFANTUM 
 
 
 
 
 
 
OLIVIA ROOS RODRIGUES 
LISBON 
2009 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dissertation in support of Candidature for "Grau de Doutor no Ramo das Ciências 
Biomédicas, Especialidade de Parasitologia" by the Universidade Nova de Lisboa, Instituto 
de Higiene e Medicina Tropical.  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
This work was done at the Unidade de Leishmanioses, Laboratório Associado Centro de 
Malária e Outras Doenças Tropicais, Instituto de Higiene e Medicina Tropical, 
Universidade Nova de Lisboa, under the supervision of Professor Gabriela Santos-Gomes 
from May 2004 to April 2008. The financial support by the Fundação para Ciência e 
Tecnologia was granted with a PhD fellowship SFRH/BD/12250/2003 and research project 
POCI/CVT/55113/2004 of the programme POCI 2010 and FSE, partially funded by the 
European Union Fund FEDER.  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  To my father, as promised.  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                Acknowledgments 
 
 
XIII 
 
ACKNOWLEDGMENTS 
 
 
To Prof. Gabriela Santos-Gomes my supervisor, to whom I will always be grateful, for her 
invaluable teachings, for close guidance, for constant incentive and motivation, for strong support 
and recognition in good and not so good times during these past years, which undoubtly 
contributed to my quest in science.      
 
To Prof. Lenea Campino, Director of the Leishmaniasis Unit for providing the work conditions for 
this study. 
  
To Dr. Sandra Gomes-Pereira, Researcher at the Parasite Disease Group at the Institute for 
Molecular and Cell Biology and Prof. Celso Cunha, Head of the Molecular Biology Unit of IHMT, 
members of my tutorial committee, I convey my uptmost gratitude and sincere appreciation for 
their critical discussions and suggestions, providing crucial guidance during the entire course of 
this work.   
 
To Dr. Marta Soares-Clemente, my sincerest indebtedness for her endless energy, critical and 
constructive suggestions, hard work and dedication in achieving what was set out to do. For those 
long and after-hour work sessions in the laboratory Treging! For all those rhetorical ‗tás feliz?!‘ 
moments, thank you.   
 
Acknowledgments                                                                                                                                 .                                                                                                                                                                                                                                                             
 XIV 
To Dr. Cláudia Marques for her undeniable support and helpful lab discussions, a definite 
contribution to this study.  
 
To Dr. Nuno Rolão for teaching the technical art of Real-time PCR and for his important 
contribution and critical and always helpful discussions related to this work.    
 
To Prof. Virgílio E. do Rosário, the Head of the Malaria Unit, for providing good working 
conditions and logistical support in efficiently bringing this work to good term.  
 
To Prof. Luís Távora Tavira, Coordinator of CMDT-LA for logistics and support for this work and 
its‘ participation in international meetings.    
 
To Dr. Dinora Lopes, Head of the Animal Facility of IHMT for all the extra effort made in 
providing for housing conditions and well-being of the animals used in this study.  
 
To all staff members of IHMT, in special to those of the Units of Molecular Biology, Malaria, 
Mycobacteria, Opportunistic Protozoa/HIV and Other Protozooses, Leptospirosis and Lyme 
Borreliosis, Virology, and from the Administrative Services for having directly or indirectly 
contributed to this work.    
 
                                                                                                                                Acknowledgments 
 
 
XV 
To Dr. Alexandre Salvador, Dr. Simon Monard and Dr. Maria del Cármen Algueró, the ―FACS‖ 
experts, for their time and interest, effort and enthusiasm in this work, and for transmitting their 
―know-how‖ in flow cytometry.  
 
To Prof. Damo Xu and Dr. Haiying Liu from the Department of Immunology and Bacteriology, 
Division of Infection, Immunology and Inflammation, University of Glasgow, UK for so kindly 
accepting me in their laboratory and having provided their expertise on Treg biology and technical 
training of several immunological methods for Treg analysis. 
 
To Prof. Shizou Akira, Head of the Department of Host Defense at the Research Institute for 
Microbial Diseases, Research Center for Emerging Infectious Diseases, University of Osaka, 
Japan, for his immediate collaboration in this work and for developing the TLR-2 knock-out mice 
that were used in this study. 
 
To Prof. Helena Ferronha, Head Researcher of the Department of Cell Biology at the Laboratório 
Nacional de Investigação Veterinária, Lisbon for demonstrated interest, incentive and collaboration 
in this work and for providing access to the laboratory facilities and equipment. 
 
To Prof. Rui Appelberg, Head Researcher of the Laboratory of Microbiology and Immunology of 
Infection Institute for Molecular and Cell Biology, Porto for his interest and incentive in this work 
and for providing full access to the laboratory facilities and equipment and to Dr. M. Salomé 
Gomes for kindly providing access to the TLR-2 knock-out mice, bred and housed at IBMC animal 
facility. 
Acknowledgments                                                                                                                                 .                                                                                                                                                                                                                                                             
 XVI 
To Prof. Hélder Trindade, Director of the Centro de Histocompatibilidade do Sul, Lisbon and Dr. 
Álice Lima, Head of the Laboratory of Flow Cytometry and Cell Sorting for their collaboration in 
kindly granting access to the laboratory facilities and equipment. 
 
 To Dr. Ana Paula Ferreira Martins Head of the Serviço de Anatomia Patológica, Hospital de Santa 
Cruz, Carnaxide and members of staff for technical support in histopatholgy. 
 
To all past and present members that have crossed my path in the Leishmaniasis Unit and my 
special thanks to D. Arminda Barbosa, Sr. João Ramada and José Manuel Cristóvão for all their 
help and support in this work. 
 
To my dearest friends and colleagues: Marta Soares-Clemente, Nuno Rolão, Sofia Cortes, Carina 
Esteves, Mónica Nunes, Rita Moura, Marco Barbosa, Cláudia Marques, Ricardo Rosa, and Maria 
José Capela for all your support, someway or the other, scientifically or otherwise, in this work but 
also most importantly never forgetting our unforgetable TGIFs, as a Unit. 
 
 To all my new Italian and Non-Italian friends who had to put up with me and my thesis, my thesis 
and I, grazie. To my old Friends who know who they are, I thank you. 
 
To my family spread all over the world, to Tessa and Bizkit, to Francisco, to Amanda and above all 
to my Mum and Sis, to whom I don‘t have to say what is always being said.  
 
                                                                                                                                                Summary 
 
 
 
XVII 
SUMMARY 
   
Leishmania infantum is the causative agent of zoonotic visceral leishmaniasis (ZVL), a disease 
frequently characterized by specific impairment of cell-mediated immune responses and 
uncontrolled parasitization. Regulatory T cells (Treg) have been shown to be involved in the direct 
induction of immunosuppresion of effector immune response during chronic Leishmania 
infections. The present study aims firstly to investigate the possible involvement of Treg cells 
during L. infantum infection in a susceptible animal model. Results indicated that CD4
+
CD25
+
 
regulatory T cells are present in L. infantum-infected BALB/c mice and exhibit phenotypic and 
functional characteristics of Treg. The presence of high levels of foxp3 gene expression and surface 
expression of E 7 integrin (CD103) suggest a predisposition for Treg retention within sites of L. 
infantum infection, as is the case of the spleen and draining lymph nodes, consequently influencing 
local immune response and increased susceptibility. However, no evident Th polarization despite 
chronic parasitism in both spleen and liver was observed during L. infantum infection in this model. 
Th1 and Th2 effector immune responses seemed inadequate, perhaps due to Treg expansion. 
Foxp3-expressing-CD4
+
CD25
+
 T cells are indeed capable of producing TGF-  and may contribute 
to immunosuppression and better control of parasite-mediated-immunopathology during infection. 
Surprisingly, IL-10 producing-CD4
+
CD25
-
Foxp3
-
 T cells were also identified as an additional 
source of IL-10 and represent a type 1 regulatory T (Tr1) cell subset that is being induced in vivo 
by L. infantum parasites. These findings suggest that distinct regulatory T cells develop in response 
to L. infantum and may play a possible role in promoting parasite persistence and the establishment 
of chronic infection in this particular experimental model of infection.  Having demonstrated that 
Treg-mediated immunosuppression is evident in L. infantum susceptible infection model, the next 
step would be to verify if in a resistant experimental model of infection, immunosuppresive Treg 
can or cannot be modulated by the parasite. This would represent the development of a parasite 
strategy able to upregulate immunosuppressive cells, dampen effector immune response in their 
favour, and promote expansion, ultimately regulating the regulator. So to elucidate on 
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immunosuppressive Treg function induced by L. infantum parasites and the underlying mechanisms 
involved in the direct host-parasite interactions and immune regulation, the second part of this 
study focuses on the role of TLR-2 on Treg function during L. infantum experimental murine 
infection by investigating the influence of TLR-2 on Treg kinetics, immune response, parasite-
associated pathology and the outcome of L. infantum infection. To achieve this, TLR-2 deficient 
mice (TLR-2
-/-
) and their wild-type C57BL/6 mice (WT) were infected with L. infantum parasites 
and comparative analysis was done to see whether or not the presence or absence of TLR-2 
produces any differential effect on the host parameters related to Treg dynamics and protective 
immunity. Defective TLR-2 signalling had a visible effect on outcome of L. infantum infection. 
Higher rates of parasite multiplication were observed in both spleen and liver of TLR-2
-/-
 knock-out 
mice, despite the ability in forming well-defined and structured liver granulomas. These 
granulomas were apparently ineffective in parasite clearance, when compared to wild-type mice. 
Defective TLR-2 signalling did induce during late infection high retention of memory Treg which 
seemed to be associated to high parasite load and low IFN-  levels. TLR-2 signalling pathway may 
play a role in Treg modulation and consequently in L. infantum pathogenesis. Functional TLR-2 
signalling in WT may be important in providing tight control over FOXP3
+
 committed Treg 
populations, negative Treg regulation and more protective immunity, giving rise to enhanced 
immunity and more effective response against infection. The presence or absence of TLR-2 did not 
seem to influence IL-10 or TGF-  expression, and it did not seem to correlate with CD103
+
 
FOXP3
+
 Treg detected late during infection in TLR-2
-/-
 mice. Detection of high levels of 
suppressive Treg in L. infantum-infected TLR-2 deficient mice was not accompanied by associated 
inductions of immunosuppressive cytokines. The presence of high levels of immunosuppressive 
Treg in infected spleen, in the absence of TLR-2, suggests that this receptor in particular plays an 
important role in regulating the regulators, thus orchestrating effective innate and acquired 
immunity against L. infantum infection.  
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SUMÁRIO 
 
Leishmania infantum é o agente responsável pela leishmaniose visceral zoonótica, uma parasitose 
frequentemente caracterizada por alterações específicas da imunidade celular e parasitismo 
progressivo. Sabe-se actualmente que as células T reguladoras (Treg) são na verdade linfócitos T 
que se encontram directamente envolvidos na indução de mecanismos de imunossupressão da 
resposta imunológica durante infecções crónicas, como por exemplo Leishmania. Deste modo, este 
estudo tem como objectivo analisar o papel das Treg durante a infecção com L. infantum em 
modelo animal susceptível. Os resultados obtidos indicam que os linfócitos T CD4
+
CD25
+
 estão 
presentes em murganhos BALB/c infectados com L. infantum e exibem características fenotípicas e 
funcionais de Treg. A detecção de níveis elevados de expressão do gene foxp3 e do marcador de 
superfície E 7 integrina (CD103) sugere a predisposição para a retenção de Treg nos locais 
preferenciais de infecção por L. infantum, como é o caso do baço e dos gânglios linfáticos, 
influenciando a resposta local e induzindo susceptibilidade. No entanto, apesar de neste modelo de 
infecção se ter observado parasitismo crónico no baço e no fígado não parece ter havido uma 
resposta Th polarizada o que pode estar relacionado com a expansão de Treg.  Linfócitos T 
CD4
+
CD25
+
 que expressam Foxp3 demonstraram ter capacidade de produzir TGF- , contribuindo 
para a imunossupressão e controlo da imunopatologia induzida pelo parasita. Supreendentemente, 
linfócitos T CD4
+
CD25
-
Foxp3
- 
produtores de IL-10 também foram identificados como fonte 
adicional de IL-10, representando uma sub-população de linfócitos T reguladores do tipo 1 (Tr1) 
cuja diferenciação foi induzida pelo parasita. Estes resultados sugerem que diferentes tipos de 
células T reguladoras podem ser estimuladas  durante a  resposta imunológica à infecção por L. 
infantum, contribuindo para a persistência do parasita e o estabelecimento da infecção crónica neste 
modelo experimental. Tendo demonstrado que a imunossupressão mediada por Treg é evidente no 
modelo susceptível de L. infantum, o próximo passo seria verificar se num modelo experimental de 
resistência, a supressão evidenciada pelas Treg seria regulada ou não pelo parasita, representando 
deste modo o desenvolvimento pelo parasita de uma estratégia para promover a expansão de 
células imunossupressivas e a inibição da resposta  efectora  do hospedeiro, isto é regulando os 
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reguladores.  Assim para estudar a função imunossupressora das Treg induzida por L. infantum e os 
mecanismos envolvidos na interacção hospedeiro-parasita e na regulação imunológica, a segunda 
parte deste estudo avalia o papel do receptor TLR-2 na função das Treg durante a infecção 
experimental por L. infantum e analisa a influência deste receptor na cinética das Treg, na resposta 
imunológica e na patologia. Para tal, murganhos mutantes C57BL/6 para o gene TLR-2 (TLR-2
-/-
) e 
os murganhos ―wild-type‖ C57BL/6 foram infectados com L. infantum. A análise comparativa foi 
efectuada de modo a verificar se a presença ou ausência de TLR-2 produz um efeito diferencial nos 
parâmetros do hospedeiro associados à dinâmica das Treg e à imunidade protectora. A ausência de 
sinalização TLR-2 teve um efeito visível no desenrolar da infecção. Elevadas taxas de 
multiplicação do parasita foram observados no baço e fígado dos murganhos TLR-2
-/-
 apesar de se 
ter evidenciado a presença de granulomas hepáticos aparentemente bem estruturados e definidos. 
Estas formas granulatomosas são, aparentemente, ineficazes na eliminação do parasita 
comparativamente aos murganhos ‖wild-type‖. A ausência de sinalização TLR-2 induziu a 
retenção tardia de Treg de memória, associada à elevada carga parasitária e níveis reduzidos de 
IFN-  O TLR-2 poderá desempenhar um papel na regulação das Treg e consequentemente na 
patogénese por L. infantum. Nos murganhos ―wild-type‖, a sinalização via TLR-2 pode ser 
importante no controlo das populações de Treg FOXP3
+ 
, na regulação negativa das Tregs e no 
desenvolvimento de imunidade protectora mais eficaz contra o parasita. A presença ou ausência de 
TLR-2 não influenciou a expressão de IL-10 ou de TGF- e não está relacionado com a detecção 
de Treg CD103
+
 FOXP3
+
 durante a fase tardia da infecção nos murganhos TLR-2
-/-
. Elevados 
níveis de Treg nestes murganhos não foram acompanhados pela indução de citocinas 
imunossupressoras. A presença de níveis elevados de Treg no baço de animais infectados, na 
ausência de TLR-2, sugere que este receptor poderá desempenhar um papel importante na 
regulação dos reguladores, mediando desta forma a imunidade inata e adquirida desenvolvida pelo 
hospedeiro durante a infecção por L. infantum.  
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OBJECTIVES 
 
The main objective of this work is to investigate on whether regulatory T cells (Treg) control 
immune responses to Leishmania infantum and contribute to susceptibility to infection. To further 
study a possible mechanism of host-parasite interaction, toll-like receptor (TLR) - 2 was selected 
and evaluated as the candidate receptor in parasite-induced regulation of Treg and protective 
immunity to infection. In order to achieve this, the following specific objectives were delineated: 
1 – Phenotypic characterization of regulatory T cell populations during L. infantum in vivo 
infection:  
 Identification of Treg populations using specific markers;   
 Kinetics of Treg during in vivo L. infantum infection; 
 Evaluation of Treg and effector immune responses by assessing pro- and  anti-
inflammatory cytokines.  
 
2- Evaluation of the effect of TLR-2 modulation on Treg population during L. infantum in vivo 
infection:  
 Comparison of Treg in vivo cell populations of gene disrupted TLR-2-/- knock-out 
and wild-type mice; 
 Comparison of the evolution of parasite burden;  
 Evaluation of the effect of TLR-2 on Treg kinetics; 
 Evaluation of the effect TLR-2 on effector immune responses. 
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ABBREVIATIONS 
 
Ab - antibody 
Ag - antigen 
AIDS - acquired immunodeficiency syndrome 
AMP - adenosine monophosphate 
AP – acid phosphatase 
APC - allophycocyanin 
APCs - antigen presenting cells 
ATP - adenosine triphosphate 
BMDM - bone marrow derived macrophages 
Bp – base pair 
BSA - bovine serum albumin 
C; G; A; T - cytosine; guanine; adenine; thymine 
Ca
2+
 - calcium ion 
CCR – CC-chemokine receptor  
CD - cluster of differentiation 
cDNA – complementary deoxyribonucleic acid 
CIE – counterimmunoelectrophoresis 
CL – cutaneous leishmaniasis 
cm - centimetre 
CSF - colony stimulating factor 
Ct - cycle threshold 
CTLA – cytotoxic T- lymphocyte antigen  
DAT - direct agglutination test 
DC – dendritic cells 
DCL – diffuse cutaneous leishmaniasis 
DDT - dichloro-diphenyl-trichloroethane 
DLA - dog leukocyte antigen 
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DNA - deoxyribonucleic acid 
dsDNA- double-stranded deoxyribonucleic acid 
DNase – deoxyribonuclease 
dNTP - deoxyribonucleotide triphosphate 
E – efficiency of amplification 
EDTA - ethylenediaminetetraacetic acid 
ELISA - enzyme-linked immunosorbant assay 
FAST – fast agglutination screening test 
FCS - fetal calf serum 
FGT – formol gel test 
FGV- first generation vaccines 
FITC - fluorescein isothiocyanate 
FL - Fluorescence 
FML – fucose mannose ligand 
Foxp3 – forkhead box P3 
FR4- folate receptor 4 
FRET – fluorescence resonance energy transfer 
FSC - forward scatter light 
g - gram 
g - relative centrifugal force 
G – gauge 
GITR – glucocorticoid-induced tumor-necrosis factor receptor family related gene 
GPI – glycosylphosphatidylinositol 
GIPLs – glycoinositol phospholipids 
H3PO4 – phosphoric acid 
HAART – highly active antiretroviral therapy 
HBSS – Hanks‘ balanced salt solution 
HCl – hydrochloric acid 
HIV – human immunodeficiency virus 
HLA - human leucocyte antigens 
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HPRT - hypoxanthine guanine phosphoribosyl transferase 
LeIF – Leishmania elongation initiation factor 
ICT – immunochromatographic test 
IDO – indoleamine 2,3-dioxygenase  
IFA – indirect immunofluorescence antibody 
IFN-  - interferon-gamma 
IgG - immunoglobulin G 
IL - interleukin 
iNOS - inducible nitric oxide synthase  
ip - intraperitoneal   
IPTG - isopropyl-beta-D-thiogalactopyranoside    
KATEX – latex agglutination test 
kb – kilo base 
kDa – kiloDalton 
kDNA – kinetoplast DNA 
KO – knock-out mice  
LACK - Leishmania homolog of receptors for Activated C Kinase 
LDA – limiting dilution assay 
LN – lymph nodes 
LPG – lipophosphoglycan 
LV - liver 
LZ - leishmanization 
M; mM; mM - molar; milimolar; micromolar  
mAb – monoclonal antibody 
MAP – mitogen-activated protein 
MCL – mucocutaneous leishmaniasis 
mg; mg - miligrama; micrograma 
Mg
2+ 
- magnesium ion  
MHC - major histocompatibility complex 
MHC I - major histocompatibility complex class I 
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MHC II - major histocompatibility complex class II 
ml; ml - millilitre; microlitre 
MLEE – multi-locus enzyme electrophoresis 
MPL-SE – monophosphoryl lipid A stable emulsion 
mRNA - messenger ribonucleic acid 
MST – Montenegro skin test 
Mya – millions years ago 
N – Avogadro constant 
NaN3 – sodium azide 
ND – not detectable 
NF-AT – nuclear factor activated T cells 
NF-  nuclear factor kappa-light-chain-enhancer of activated B cells  
NK - natural killer cells 
nm; mm - nanometer; millimeter 
NNN - Novy, Nicolle, MacNeal 
NO - nitric oxide 
Nramp – Natural resistance-associated macrophage protein 
ºC - degree centigrade 
PAGE - polyacrylamide gel electrophoresis 
PAMPs – pathogen-associated molecular patterns 
PBMC – peripheral blood mononuclear cells 
PBS - phosphate buffer saline 
PCD – programmed cell death 
PCR - polymerase chain reaction 
PE – phycoerythrin 
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pg – picograms 
PG – phosphoglycans 
pH - power of hydrogen 
pi – post-infection 
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Rn- fluorescence emission with subtracted background fluorescence signal  
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RPMI - Roswell Park Memorial Institute 
RT - reverse transcription 
SD – standard deviation 
SDS - sodium dodecyl sulfate  
SEM – standard error 
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SGV- second generation vaccines 
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SOCS – suppressor of cytokine signalling  
SP - spleen 
SPF – specific pathogen-free 
spp - species 
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TCR – T-cell receptor 
TGF-  - transforming growth factor - beta 
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3 
1. The genus Leishmania 
  
 
Leishmaniasis is a vector-borne disease caused by a pathogenic protozoan parasite belonging to the 
family Trypanosomatidae, genus Leishmania Ross, 1903. These parasites infect the mononuclear 
phagocytic system of the mammalian host and are transmitted by the bite of a female sand fly of 
the family Psychodidae, genus Phlebotomus Rondari, 1843 or Lutzomyia França, 1924. In man, 
Leishmania spp. can cause a variety of symptoms that range from disfiguring cutaneous and 
mucocutaneous lesions, widespread destruction of mucous membranes, to visceral disease affecting 
amongst others, haematopoietic organs.  
 
2. Biology of Leishmania  
 
2.1. Morphology and life cycle  
 
Leishmania is a unicellular digenetic endoparasite that morphologically alternates between 
intracellular aflagellated amastigotes within the vertebrate host and extracellular flagellated 
promastigotes within the intestinal tract of the phlebotomine sand fly. The amastigote stage is a 
round or ovoid-like organism, 2-6 m in diameter, containing a nucleus, a kinetoplast and an 
internal flagellum. The amastigotes multiply by binary fission within the acidic and hydrolase-rich 
environment of the parasitophorous vacuoles of macrophages. The promastigotes have an 
elongated cell body (about 10-20 m by 2.5-5 m) with a central nucleus, a kinetoplast and a long 
external flagellum that emerges from the anterior part of the cell and confers motility (Figure 1).  
Most Leishmania species (subgenus Leishmania) are suprapylarian parasites: that is, their 
development is restricted to the midgut of the digestive tract of sand flies. Members of the 
subgenus Viannia are peripylarian parasites: they enter the hindgut before migrating forward into 
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the midgut.  Infection initiates when the sand flies feed from an infected host and ingests blood 
containing macrophages infected with amastigotes. The infected blood meal passes to the posterior 
 
                                                               
 
 
 
 
abdominal gut where the infected macrophages are lysed and Leishmania amastigotes released. 
These begin to differentiate into several distinct developmental stages as they migrate anteriorly 
from the posterior hindgut or midgut to the stomodeal valve, which forms a junction with the 
foregut. Within 6–9 days, amastigotes transform into dividing procyclic promastigotes, relatively 
resistant to digestive enzyme activity, which in turn eventually attach to the lining of the midgut 
epithelium, rapidly multiply and differentiate into highly infectious metacyclic promastigotes. Each 
of the intermediate developmental promastigote stages is characterised by morphological and 
Figure 1.  Transmission electron microscopy of Leishmania-infected host cells from hamster skin lesion 
showing amastigote and promastigote forms inside host cell vacuoles. Amastigote with the characteristic 
round shape, a centrally located nucleus, a bar-shaped kinetoplast, and large lipid inclusions. Promastigote 
form with the typical elongated body shape and a free flagellum. Arrowheads: parasite membrane; arrows: 
host parasitophorous vacuole membrane. N nucleus; K kinetoplast; FP: flagellar pocket (adapted from 
Corrêa and Soares, 2006). 
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functional changes aimed at ensuring its‘ survival in the sand fly vector.  Depending on the parasite 
and vector species, there may be additional blood meals during maturation period, but most 
parasites can complete development within the timeframe of a single digestive cycle. The 
metacyclic promastigotes are freely motile and accumulate just behind the stomodeal valve, well 
positioned for egestion from the mouthparts of the sand fly upon uptake of a second blood meal 
and infection of a new host. Some of these promastigotes will survive, invade new cells and 
differentiate once again into amastigotes, hence completing its‘ life cycle. Once inside the skin, the 
promastigotes are phagocytosed by resident tissue macrophages, dendritic cells and neutrophils, 
transformed into amastigotes within the phagolysosome of macrophages. Replication of 
amastigotes can cause host cells to rupture and release parasites capable of invading other  
macrophages (Figure 2).                                                                                                                         
 
2.2. Pathogenecity  
 
Disease progression is dependent on both the species of Leishmania involved and the genetics and 
immune status of the host. Leishmania pathogenesis involves key issues such as promastigote 
differentiation to the mammalian-infective amastigote stage,  parasite responses and adaptations to 
life in host macrophages, genetic differences between major pathogenic species, and the intimate 
interface between the parasite and its‘ host cell (McConville et al., 2007). Parasite virulence factors 
and host mechanisms are inextricably linked to pathogenesis.  
 
2.2.1. Parasite virulence factors 
 
A successful completion of the life cycle of Leishmania parasites in the sand fly requires that they 
survive the digestive enzymes; avoid expulsion from the gut; and at a later stage, migrate anteriorly 
and break free from the midgut epithelium for transmission to the mammalian host. Several 
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molecules are central to vector-parasite interactions during critical stages of the Leishmania life 
cycle.   
 
Figure 2. The Leishmania lifecycle. The promastigote form of Leishmania is transmitted into the skin by 
female phlebotomine sandflies. Once transmitted, the parasites are internalized by macrophages and dendritic 
cells in the dermis where they loose their flagella, transforming into the amastigote form. The amastigotes 
multiply, destroy the host cell and infect other phagocytic cells. The amastigotes disseminate through the 
lymphatic and vascular systems, eventually infiltrating the bone marrow, liver and spleen (reproduced from 
Handman, 2001).  
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Leishmania phosphoglycans share a common phosphorylated galactose-mannose disaccharide 
structure -6Gal( 1-4)Man( 1)-PO4-  and include glycosylphosphatidylinositol (GPI)-anchored 
molecules such as lipophosphoglycans (LPG), secreted extracellular phosphoglycans (PG) and 
secreted glycoproteins as acid phosphatase (AP) and proteophosphoglycans (PPG). Other GPI-
anchored glycoconjugates include the small surface GPI lipids (GIPLs) and the surface protease or 
metalloproteinase gp63 (Yao et al., 2003). 
Proteolytic enzymes secreted by the sand fly to digest the blood meal create a hostile environment 
for the parasites (Sacks et al., 2001; Volf et al., 2001; Ramalho-Ortigão et al 2003). Transitional L. 
major forms transforming from amastigotes to promastigotes in midgut of Phlebotomus papatasi 
are highly sensitive to proteolysis, and up to 50% of parasites can be killed in the first two days 
after blood feeding (Pimenta et al., 1997).  To overcome this, Leishmania parasites have evolved 
specific abilities to modulate the activity of midgut digestive enzymes in their natural or competent 
vector species by inhibiting or delaying the peak of enzymatic activity. Glycoconjugates of 
Leishmania appear to play a part in protecting Leishmania promastigotes from these enzymes.  
Analysis of parasite mutants that are deficient in the synthesis of all PG were shown to be highly 
sensitive to the conditions in the early blood fed midgut (Sacks et al., 2000) although the addition 
of glycoconjugates from a L. major strain enhanced survival in P. papatasi (Schlein et al., 1990). 
These studies give emphasis on the importance of secreted phosphoglycans in protection of 
Leishmania parasites from digestive enzymes.   
Glycoconjugates also seem to be important virulence factors when Leishmania is in the vertebrate 
host. LPG is the largest and most abundant surface glycolipid of promastigotes and forms a dense 
glycocalyx on their surface. It has been implicated as an adhesion molecule that mediates the 
interaction with the midgut epithelium of the sand fly in the subgenus Leishmania, thus preventing 
their loss with the excreted blood meal (Pimenta et al., 1992). LPG variations have also been 
implicated in the specificity of various Leishmania to different Phlebotomus species and thus 
promote vectorial competence to the invertebrate hosts (Pimenta et al., 1994; Sacks et al., 1995; 
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Kamhawi et al., 2000). LPG undergoes several important modifications during the life cycle that 
are characteristic for each Leishmania species. During the acquisition of virulence features in the 
sand fly midgut, LPG elongates, the number of repeating units doubles from about 15 in procyclic 
promastigotes to about 30 in metacyclic forms (Descoteaux et al., 1999). These structural changes 
are required for the detachment of infectious metacyclic promastigotes from the sand fly midgut 
(Sacks et al., 2001). 
LPG has also been implicated in many steps required for establishment of macrophage infections 
apart from its‘ survival in the insect vector (Sacks et al., 2000; Ilg et al., 2001). Studies 
demonstrated that Leishmania phosphoglycans
-/- 
were unable to survive in activated macrophages 
but retained the ability to persist indefinitely in the mammalian host without inducing disease in 
non-activated macrophages (Spath et al., 2003). Later, the same outcome was reported in a model 
of L. major mutant specifically lacking LPG, revealing that the previous findings may be related to 
LPG (Spath et al., 2003). 
By acting as an activator of the complement cascade and binding to serum proteins, LPG facilitates 
promastigote attachment to macrophages and contributes to the ability of metacyclic promastigote 
to resist complement-mediated lysis in the mammalian host (Puentes et al., 1988). This is 
accompanied by an absence of proinflammatory response and no oxidative burst thus enabling 
promastigotes silent entry and easy access to a safe haven, the inside of the macrophage. LPG 
serves as an excellent cover masking direct recognition of parasite molecules by macrophage 
receptors and therefore bypassing macrophage activation. In fact, attachment and internalization of 
L. donovani promastigotes to bone marrow derived - macrophages failed to induce phosphorylation 
of several kinases involved in innate macrophage function such as production of proinflammatory 
cytokines and nitric oxide (NO) (Privé et al., 2000).  Failure to activate macrophages during the 
invasion process may contribute to the successful establishment of Leishmania within the 
mammalian host. 
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Another known function for LPG is related to its‘ ability in manipulating signalling pathways and 
subverting or attenuating normal macrophage function.  To turn off host microbicidal functions, 
Leishmania activates macrophage phosphotyrosine phosphatases and inhibits protein kinase C 
(PKC) activity (Descoteaux et al., 1993; Nandan et al., 2000). Once inside the phagosome of the 
macrophage, Leishmania is now faced with the dangers of subsequent phagosome maturation 
involving interactions with endosomes and lysosomes, vacuoles containing antimicrobial proteins. 
In the case of phagosomes harbouring L. donovani promastigotes, interactions with late endosomes 
and lysosomes are inhibited (Desjardins et al., 1997). Inhibition of phagosome maturation is 
dependent on LPG repeating unit domain since phagosomes harbouring phosphoglycan-defective 
mutants quickly mature (Desjardins et al., 1997). The exact mechanism by which LPG exerts such 
an effect on the phagosome remains unclear; however, the insertion of LPG in cellular membranes 
(Tolson et al., 1990) may alter their fusogenic properties (Miao et al., 1995).  
It is noteworthy to state that the diverse mechanisms used by promastigotes to invade macrophages, 
manipulate innate function and evade and survive host defense mechanisms may not be common to 
all Leishmania species. Different Leishmania species place different emphasis on the importance of 
canonical virulence determinants, including LPG (Turco et al., 2001). Overall, previous studies 
establish a role for LPG in many but not all of the steps previously identified in macrophage 
invasion and survival. In fact new evidence now suggests that LPG is detrimental to long-term 
survival in the vertebrate host, as it is associated with activation of dendritic cells (DC), natural 
killer (NK) cells and NKT cells (Becker et al., 2003; Amprey et al., 2004; Aebischer et al., 2005); 
this is perhaps the reason why it is rapidly downregulated (at least three orders of magnitude) 
(Turco et al., 1991) in amastigotes. Due to its structural characteristics and GPI-anchor, LPG has 
also been identified as a Leishmania ligand capable of activating some ―pathogen-associated 
molecular patterns‖ (PAMPs) recognising receptors, otherwise known as toll-like receptors (TLRs). 
This growing family of receptors are now known to be key players in the detection of pathogens 
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and the induction of anti-microbial immune response. The importance of Leishmania – TLR 
interactions will be discussed in further detail in section 7.3. 
The process of differentiation of metacyclic promastigotes to amastigotes is one of the major 
developmental transitions in the Leishmania life cycle and a key event in establishing infection in 
the mammalian host. In vitro studies suggest that two environmental factors are sufficient to induce 
differentiation of promastigotes to amastigote-like forms (axenic amastigotes). A mild rise in 
temperature (33-37ºC) and a decrease in pH to 5.5 are the conditions that mimic the environment of 
macrophage phagolysosome. In vivo studies show that other factors, such as host serum 
components, may be required for differentiation (Bee et al., 2001). Several works indicate that 
Leishmania in vitro differentiation can be triggered by pharmacological agents that induce protein 
misfolding and promastigote heat shock response (Wiesgigl & Clos, 2001; Barak et al., 2005), by 
mitogen-activated protein (MAP) kinase signalling that are involved in modulating flagellum 
length  (Wiese, 2007) and proteolytic systems involving protein turnover and degradation as key 
processes in autophagy and consequent promastigote-amastigote differentiation (Belesterio et al., 
2007). 
To be able to survive in host macrophages, amastigotes have thought to have acquired (1) amino 
acid permeases that allow them to scavenge host  amino acids from the lumen of phagolysosome 
vacuole in competition with the host transporters (McConville et al., 2007), (2) the capacity of 
endocytosing and degrading host proteins using lysosomal proteinases (Besterio et al., 2007) and 
(3) lack of stage specific changes in mRNA levels and constitutive expression of enzymes involved 
in central carbon metabolism confer selective advantage by allowing these parasites to exploit 
variable nutrient conditions in the mammalian host. 
Leishmania parasites are highly capable of manipulating host response in its favour. Depending on 
parasite stage and species, Leishmania can evade humoral innate defenses, remodel intracellular 
compartments and pathways, and impair macrophage and DC mechanisms (Sacks et al., 2002a; 
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Engwerda et al., 2004; McMahon-Pratt et al., 2004). Parasites interfere with intracellular kinases 
and phosphatases activity, downregulate activating-type signalling pathways, upregulate 
suppressive-type signalling pathways, and affect transcription factors and gene expression (Buates 
et al., 2001; Bertholet et al., 2003; Rodriguez et al., 2004). In turn, macrophage responsiveness and 
secretion of cytokines, surface molecule expression, and generation of leishmanicidal mechanisms 
(reactive oxygen and nitrogen intermediates) are compromised (Bertholet et al., 2003; Engwerda et 
al., 2004; Ray et al., 2000). Parasite effects extend to dendritic cells, which are critical to antigen 
presentation, T-cell co-stimulation, and efficient development of acquired Th1 responses 
(Brandonísio et al., 2004). Effects on dendritic cells include inhibition of migration, maturation and 
activation, and of interleukin (IL-) 12 production (Brandonísio et al., 2004).  More detailed 
immunological aspects of host-parasite interactions will be further discussed in section 7.  
Different species of Leishmania often exhibit strong preference for specific sand fly vectors and 
can cause different types of diseases in the human host. Comparative genome analysis may help 
identify the molecular basis for these differences. To date three completed Leishmania genomes (L. 
major, L. infantum, L. braziliensis) are in the public domain (Ivens et al., 2005; Peacock et al., 
2007) with sequencing of a fourth (L. mexicana) in progress (http://www.genedb.org/). These first 
four species were chosen to represent the main species complexes of the Leishmania subgenus 
together with the best-characterised species of the Viannia subgenus. Importantly, the three 
completed genomes represent species that usually give rise to distinct disease types. Smith (2007), 
details on the remarkable similarity of the three genomes (only ~200 of the ~8300 genes are 
differently distributed) as well as some striking differences. The genes that differ between the three 
species are good candidates for functional analysis to determine their roles in establishment of 
infection. The most divergent, L. braziliensis, possesses 47 genes that are absent from the other two 
species. In comparison, L. infantum has 27 species-specific genes while L. major has only 5. A 
number of the other differentially distributed genes are found in 2 out of the 3 species. Some of 
these species-specific sequences have already been analysed at the molecular level. Examples 
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include the L. infantum A2 gene that encodes an amastigote-specific repeat-containing protein 
previously characterised in L. donovani, the only Leishmania sequence to date that confers a 
change in virulence phenotype when introduced into L. major by genetic transfection (Zhang et al., 
2003); and the HASP and SHERP genes, expressed from a single locus (absent in L. braziliensis) in 
infective stages of L. major and L. infantum, with their protein products localizing in the plasma 
membrane and intracellular membranes, respectively, in these species (Denny et al., 2000; 
Knuepfer et al., 2001).  Despite the well-conserved synteny between the three model species, L. 
braziliensis may have the capacity for more extensive genomic reorganisation, given the putative 
retrotransposons and RNA interference (RNAi – post-transcriptional mechanism for gene 
silencing) machinery very recently found in this species (Peacock et al., 2007). The availability of 
RNAi in L. braziliensis may play a role in the biological differences and different disease outcomes 
observed between the two subgenera. This finding has major practical applications and provides an 
alternative tool to targeted gene replacement for silencing gene expression in these parasites and 
reducing the degree of host pathogenecity.   
 
3. Origin, evolution and taxonomy  
 
It has been differently proposed that the genus Leishmania first appeared either in the ‗Old World‘ 
(Africa, Asia and Europe) (Kerr et al., 2000; Momen et al., 2000) or in the ‗New World‘ (the 
Americas) (Noyes et al., 1997; Stevens et al., 2001). The ‗New World‘ origin is supported by the 
high genetic diversity of neotropical Leishmania species and by combined amino acid, DNA, and 
RNA polymerase-based trees, which root in America. This claim has received support by the 
description of a monoxenic insect flagellate from Costa Rica that branches at the root of the 
Leishmania clade (Yurchenko et al., 2006). In fact, a recent revision of current taxonomy (Lukes et 
al., 2007) proposes that the ancestor of the ‗New World‘ leishmaniasis evolved in South America 
in the Paleocene or Eocene, 46–36 Mya and then migrated via the Bering land bridge to Asia. The 
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Leishmania lineage would have, then, dispersed through Central and/or Southeast Asia during the 
Miocene, 24–14 Mya (Fernandes et al., 1993), where a major diversification gave rise to L. 
aethiopica, L. major, L. gerbilli, L. turanica, L. tropica, and the L. donovani complex (Croan et al., 
1997; Noyes et al., 1997). L. infantum would have then split from the early L. donovani lineage 1 
Mya, and L. donovani soon thereafter invaded India and Africa. Closing the circle, after 500 years 
ago, L. infantum MON-1 European strains were transferred to South America, represented by the 
species formerly designated L. chagasi, considered synonymous with L. infantum (Maurício et al., 
2000). The two main reservoir hosts of the L. donovani complex are humans and canids whose 
historical movements likely would have influenced the distribution of L. donovani and L. infantum. 
Leishmania species must adapt to varied and heterogeneous environments during their life cycle. 
Efficient biological mechanisms are essential for the long-term and short-term survival of the 
parasite. Leishmania parasites basically present a clonal population structure. The great diversity of 
Leishmania species arises from different genetic processes such as asexual multiplication, gene 
amplification, occasional genetic exchanges through interindividual recombination, 
intrachromosomic and intragenic recombination (Victoir et al., 2005). Concerning interindividual 
recombinations, some studies suggest genetic exchange in Leishmania despite the lack of evidence 
of a sexual stage. For example, in the ‗New World‘, hybrids between L. braziliensis and L. 
peruviana, and L. guyanensis and L. braziliensis, have been described (Da-Cruz et al., 1992; Belli 
et al., 1994; Dujardin et al., 1995; Bañuls et al., 1997) and in the ‗Old World‘ hybrids have been 
reported between L. major and L. arabica (Evans et al., 1987; Kelly et al., 1991) and between L. 
infantum and L. donovani (Hide et al., 2006 and 2007) and between L. infantum and L. major 
(Ravel et al., 2006). However, the occurrence of pseudo-recombination events and cross-species 
genetic exchanges is not frequent enough to disturb the propagation of clones stable in space and 
time. It is postulated that the asexual model is enough to ensure parasite fitness in various 
environmental conditions and that sexual recombination is not necessary for the production of a 
large repertoire of genotypes (Ayala et al., 1998; Victoir and Dujardin, 2002). 
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The classification of Leishmania was initially based on ecobiological criteria such as vectors, 
geographical distribution, tropism, antigenic properties and clinical manifestation (Bray, 1974; 
Lumsden, 1974; Pratt and David, 1981; Lainson and Shaw, 1987) - for example, L. guyanensis 
(isolated in Guyana), L. peruviana (isolated in Peru), L. infantum (isolated from a child in Tunisia) 
and L. gerbilli (isolated from gerbils). All members of the genus Leishmania are parasites of 
mammals. The two subgenera, Leishmania and Viannia, are separated on the basis of their location 
in the vector‘s intestine (Lainson and Shaw, 1987). 
However, biochemical and molecular analysis showed that these criteria were often inadequate and 
thus other criteria such as the patterns of polymorphism exhibited by kinetoplast DNA (kDNA) 
markers, proteins or antigens came to be used to classify Leishmania (Kreutzer and Christensen, 
1980; Arnot and Barker, 1981; Pratt and David, 1981; Barker et al., 1986). For epidemiological 
purposes, the most useful taxonomic technique is isoenzyme analysis or multi-locus enzyme 
electrophoresis (MLEE) (Miles et al., 1980; Evans et al., 1984; Rioux et al., 1990). MLEE detects 
different alleles of housekeeping genes by scoring the electrophorectic mobility of enzymes they 
encode. It is still considered the ‗gold standard‘ for Leishmania species identification and genetic 
diversity studies.  
Use of molecular techniques led to the publication of a taxonomic scheme by the World Health 
Organization (WHO, 1990) (Figure 4).  Today 30 Leishmania species are known and 
approximately 20 are pathogenic for humans. These species generally present different 
epidemiological and clinical characteristics related to different genetic and phenotypic profiles. The 
validity of the classification scheme, considered by some workers as too arbitrary, has been 
questioned several times. Debate has centred on L. panamensis, L. peruviana, L. chagasi, L. 
infantum, L. archibaldi, L. garnhami, L. pifanoi, L. venezuelensis and L. forattinii (Bañuls et al., 
1999, 2000; Mauricio et al., 2000, 2001; Cupolillo et al., 2001). L. chagasi is accepted as a 
synonym of L. infantum (see Mauricio et al., 2000) and L. peruviana has been validated as an 
independent species (Bañuls et al., 2000). The other species listed above are still under discussion. 
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In addition, a recent study has shown to have identified a potential new species of Leishmania 
causing VL in Thailand (Sukmee et al., 2008). Through a combination of PCR-RFLP (restriction 
fragment length polymorphism) on the ssrRNA (small subunit ribosomal RNA) and mini-exon 
genes it was shown that the Leishmania spp. found is clearly distinguishable from other members 
of the genus Leishmania. 
 
4. Epidemiology  
 
Leishmaniasis is an important parasitosis, widespread on all the continents except Antartica. 
Human leishmaniasis constitutes a major public health problem and the burden is increasing 
(Desjeux, 2001, 2004). This disease can present different clinical features depending on the 
infecting species of Leishmania and the host‘s immunological status: cutaneous leishmaniasis (CL), 
a disease that can result in unaesthetic stigma if multiple lesions occur; mucocutaneous 
leishmaniasis (MCL; also known as espundia) a mutilating disease; diffuse cutaneous leishmaniasis 
(DCL) a long-lasting disabling disease due to a deficient cellular-mediated immune response; 
visceral leishmaniasis (VL; also known as kala-azar) a disease often fatal if untreated; and post-
kala-azar dermal leishmaniasis (PKDL) a chronic cutaneous disease characterized by a macular, 
maculo-papular or nodular rash that develops  after VL treatment. In 2002, the WHO estimated that 
the number of persons at risk to be around 350 million through 88 countries and the number of new 
cases to be 2 357 000 per year (WHO, 2002). In fact, 2 million new cases (1.5 million for CL and 
500 000 for VL) are considered to occur annually, with an estimated 12 million people presently 
infected worldwide. It is noteworthy to mention that under-reporting is substantial - only around 
600,000 infections are officially reported each year (WHO, 2002). Despite the scarcity of reliable 
data, there is little doubt that the case-load worldwide is considerably higher than official reported 
figures. 
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Figure 4. Taxonomy of Leishmania; underlined species are or have been questioned. (Based on the scheme 
published by the [WHO, 1990] with additions from the literature). 
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Of the 88 leishmaniasis-affected countries, 72 are classed as developing countries, including 13 of 
the least developed countries. Ninety percent of VL cases occur in just five countries — 
Bangladesh, India, Nepal, Sudan and Brazil. Ninety percent of CL cases occur in just seven 
countries — Afghanistan, Algeria, Brazil, Iran, Peru, Saudi Arabia and Syria. VL is of higher 
priority than CL as it is a fatal disease in the absence of treatment (Desjeux, 2004). Anthroponotic 
VL foci are of special concern as they are at the origin of frequent and large-scale tenacious 
epidemics with high case-fatality rates. Malnutrition is a well-known risk factor in the development 
of this form, and epidemics flourish under conditions of famine, complex emergencies and mass 
population movements. In Sudan, for example, a major decade-long epidemic of VL occurred from 
1984 to 1994. Some studies estimate that the disease caused 100 000 deaths in a population of 
around 300 000 in the western upper Nile area of the country (Seaman et al., 1996). Despite the 
huge amount of research conducted on these pathogens in numerous scientific fields since the 
beginning of the last century, recent studies have also shown the reactivation of several other foci- 
in Italy, China, Brazil and Israel (Arias et al., 1996; Gradoni et al., 2003; Guan et al., 2003; 
Nasereddin et al., 2005) — and the emergence of new epidemic foci in Israel and Morocco 
(Jacobson et al., 2003; Al-Jawabreh et al., 2004; Guernaoui et al., 2005; Shani-Adir et al., 2005). 
Nevertheless, leishmaniasis is still considered as a neglected disease and is grossly underestimated, 
mainly due to lack of awareness of its serious impact on health. 
 
5. Leishmaniasis 
 
Leishmaniasis is a typical example of an anthropozoonosis although the majority of infections are 
originally zoonotic. The different epidemiological cycles are (i) a primitive or sylvatic cycle 
(human infection is accidental, transmission occurring in wild animal foci) e.g. L. braziliensis; (ii) a 
secondary or peridomestic cycle (the reservoir is a peridomestic or domestic animal, the parasite 
being transmitted to humans by anthropophilic sand flies), e.g. L. infantum; and (iii) a tertiary, 
strictly anthroponotic cycle, in which the animal reservoir has disappeared (or has not yet been 
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identified) and the sand fly vectors are totally anthroponotic, e.g. L. donovani. Nevertheless, many 
unknown factors remain. For example, the main animal reservoir of L. braziliensis is still unknown 
(Cupolillo et al., 2003). L. tropica was considered to be a strict anthroponosis, but several cases of 
canine infection have been described (Dereure et al., 1991; Banuls, 2007).  
Cutaneous leishmaniasis, which accounts for more than 50% of new cases of leishmaniasis, is 
frequently self-healing in the ‗Old World‘ but, when the lesions are multiple and disabling with 
disfiguring scars, it creates a lifelong aesthetic stigma. It results in formation of skin ulcers at the 
site of the sand fly bite, usually on exposed parts of the body, the face, neck, arms and legs. Its‘ 
most severe form, recidivans leishmaniasis, is very difficult to treat CL, is caused by several 
species of Leishmania: L. major, L. tropica, L. aethiopica, and L. mexicana, but also by L. 
braziliensis, L. panamensis, L. peruviana, L. amazonensis, L. guyanensis, L. naiffi and L. lainson 
(Murray et al., 2005). Dermatropic L. infantum has also proven to cause localized CL (Belazzoug et 
al., 1985).  Time to lesion resolution varies between species and between individuals.  
Diffuse cutaneous leishmaniasis occurs in individuals with defective cell-mediated immune 
response. Its‘ severity is due to disseminated lesions that resemble those of lepromatous leprosy, 
which never heal spontaneously and is subject to relapse after treatment with any of the currently 
available drugs. Because of the devastating consequences to the patient, it is recognized as a special 
public health problem. DCL is caused by L. aethiopica, L. amazonensis and L. mexicana occurs in 
anergic hosts with poor immune responses. This form of disease is restricted to a few foci in 
Ethiopia, Kenya, Venezuela and the Dominican Republic, suggesting an important role for the 
genetics of the parasite as well as the genetics of the host in determining the disease phenotype.  
In mucocutaneous leishmaniasis (―espundia‖) the initial skin lesions cure, but the late development 
of metastatic lesions can lead to extensive destruction of oral-nasal and pharyngeal cavities with 
hideous disfiguring lesions, mutilation of the face and great suffering for life. MCL may also arise 
after inadequate treatment of some Leishmania species, and if untreated can lead to severe 
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deformities or even death. Although mostly related to Leishmania species of the ‗New World‘ such 
as L. braziliensis but also more rarely by L. panamensis and L. guyanensis (Naiff et al., 1988; 
Saraiva et al., 1995; Osorio et al., 1998), MCL has been also reported in the ‗Old World‘ due to L. 
donovani, L. major (Al-Gindan et al., 1983) and, in immmuno-suppressed patients, L. infantum 
(Alvar et al., 1990). 
Visceral leishmaniasis, also known as kala-azar, is the most severe and often fatal syndrome. VL is 
caused by parasites belonging to the L. donovani complex – L. donovani sensu stricto in East 
Africa and the Indian subcontinent and L. infantum in south Europe, North Africa and Latin 
America (Boelaert et al., 2000). There are two types of VL, which differ in their transmission 
characteristics: zoonotic VL is transmitted from animal to vector to human and anthroponotic VL is 
transmitted from human to vector to human. In the former, humans are occasional hosts and 
animals, mainly dogs, are the reservoir of the parasite. Zoonotic VL is found in areas of L. infantum 
transmission whereas anthroponotic VL is found in areas of L. donovani transmission. Following 
an incubation period that generally lasts between 2 and 6 months, VL patients present symptoms 
and signs of persistent systemic infection (including fever, fatigue, weakness, loss of appetite and 
weight loss), parasitic invasion of the blood and reticulo-endothelial system (that is, the general 
phagocytic system), such as enlarged lymph nodes, spleen (splenomegaly) and liver 
(hepatomegaly) and hypergammaglobulinaemia (mainly IgGs from polyclonal B cell activation). 
Fever is usually associated with rigor and chills and can be intermittent. Fatigue and weakness are 
worsened by anaemia, which is caused by the persistent inflammatory state, hypersplenism (the 
peripheral destruction of erythrocytes in the enlarged spleen) and sometimes by bleeding. If left 
untreated, the disease has a high mortality rate mainly due to immunosuppression and secondary 
infections. Some individuals develop PKDL (Zijlstra et al., 2003), which appears within a few 
years of the complete cure of VL. PKDL patients are considered a major source of parasites for 
new infections because of the large number of organisms in the skin accessible to sand fly bites.  
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Human susceptibility to L. infantum is low therefore asymptomatic infections are common in 
healthy populations. Clinical disease is associated with age (infants below 2 years are most 
affected), malnutrition and immunosuppression (e.g. HIV co-infection).  
 
Table 1. Human-infective species of the Leishmania genus. The main species complexes and subgenus are 
shown in bold; the species. * Species that can also be associated with cutaneous leishmaniasis (adapted from 
Smith et al., 2007). 
 
Old World species New World species Disease type 
L. major complex L. mexicana complex Cutaneous 
L. (L.) major L. (L.) mexicana  
L. (L.) tropica L. (L.) amazonensis  
L. (L.) aethiopica L. (L.) pifanoi  
 
L. (L.) venezuelensis 
 
L. (V.) (Viannia) 
subgenus 
 
 L. (V.) braziliensis  
 L. (V.) panamensis  
 L. (V.) guyanensis  
 L. (V.) perviana  
 L. (V.) lansoni  
 L. (V.) braziliensis Mucocutaneous 
L. (L.) aethipoica L. (L.) amazonensis Diffuse cutaneous 
 L. (L.) pifanoi  
L. donovani  
complex 
  
L. (L.) donovani  Visceral 
L. (L.) infantum* L. (L.) chagasi*  
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VL has become a frequent infection in HIV-positive individuals in endemic areas and accelerates 
the onset of AIDS in these patients. Cases of HIV and visceral leishmaniasis co-infection have been 
reported in 35 countries worldwide (Chappuis et al., 2007). Both the cellular and humoral 
responses to L. infantum are diminished in co-infected patients (Moreno et al., 2000), leading to an 
increased parasite load in peripheral blood, lower sensitivity of serological tests, and a higher rate 
of treatment failure (Murray et al., 1999; Deniau et al., 2003). The impact of these co-infections 
was recognised as an alarming problem by international health authorities (Desjeux et al., 1995). 
Cases were reported showing a deadly overlapping between HIV pandemic and the zoonotic entity 
of VL (Gramiccia et al., 2005). In Europe, intravenous drug users have been identified as the main 
population at risk. The demonstration of unusual modes of anthroponotic transmission (i.e. by 
syringe exchange) (Cruz et al., 2002) and the high rate of relapses following antileishmanial 
treatments, were alarming features indicating a trend toward an even higher incidence. Highly 
active antiretroviral therapy (HAART) is used to modify the course of HIV infection. It has also 
been used to treat HIV-positive patients with VL and other infections. HAART appears efficient at 
preventing VL in individuals infected by Leishmania (de la Rosa et al., 2001), as reflected by the 
sharp decrease in the incidence of VL in Europe following the widespread use of HAART 
(Rosenthal et al., 2001; Lopez-Véléz et al., 2003). HAART is used to partially restore immune 
function but its efficacy in preventing VL relapses is disappointingly low (Mira et al., 2004). 
 
6. Control strategies 
 
The main control strategy includes: case finding and treatment, vector control, when feasible and, 
in zoonotic foci, animal reservoir control and vaccine development. It is impossible to devise a 
single control strategy for leishmaniasis control. A strategy combining these three approaches can 
help in eradication of the disease.  
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6.1.   Diagnosis 
 
One of the main challenges in the control of leishmaniasis is the clear need to reinforce screening 
and diagnosis of this disease in the peripheral health structures where patients are treated on the 
basis of clinical suspicion. Diagnostic tools for VL like, for example, invasive methods involving 
spleen, bone marrow and lymph node aspirations, are very difficult to technically implement and 
decentralise. Usually, there are no facilities to perform bone marrow or spleen aspiration in most of 
the district hospitals. Screening and diagnosis in such settings should rely on simple tests. The 
existing tools are based on serological, parasitological and molecular diagnosis. 
In CL, serum antileishmanial antibody can be detected with standardised and sensitive assays 
(Romero et al., 2005) however, in practice (Vega-Lopez et al., 2003) diagnosis is made 
microscopically by identification of amastigotes in Giemsa or Leishman - stained lesion biopsies, 
scrapings, or impression smears. Combination of microscopy and culture increases diagnostic 
sensitivity to more than 85% (Ramirez et al., 2000) and culture (or DNA analysis) allows species 
identification. Detection of parasite DNA in lesion material is usually most sensitive in the 
diagnosis of both cutaneous and mucosal leishmaniasis, (de Oliveira et al., 2003; Faber et al., 2003; 
Vega-Lopez et al., 2003, Weina et al., 2004; Oliveira et al., 2005), but is seldom used as the only 
test producing positive results. Culture and DNA testing are technically difficult laboratory 
techniques that are not currently practical in some developing countries. Serological tests are rarely 
used in CL diagnosis because the number of circulating antibodies against CL-causing parasites 
tends to be low and the sensitivity can be variable.  The specificity can also be variable, especially 
in areas where cross-reacting parasites (e.g., Trypanosoma cruzi) are prevalent (Reithinger & 
Dujardin, 2007). The Montenegro skin test (MST) is occasionally used in CL diagnosis (e.g., in 
epidemiological surveys and vaccine studies) because of its simple use and because of its high 
sensitivity and specificity (Wiegle et al., 1991). The main disadvantages of the MST are that it 
requires culture facilities to produce the MST antigen, that different antigen preparations impact 
test sensitivity, and that the test does not distinguish between past and present infections. 
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Diagnosis of VL is quite complex. Clinical manifestations lack specificity and differential 
diagnosis is important because diseases of other etiologies with a clinical spectrum similar to that 
of the leishmaniasis (e.g., leprosy, skin cancers, and tuberculosis for CL and malaria and 
schistosomiasis for VL) are often present in areas of endemicity. Non-leishmanial tests show that a 
reduction in the number of red and white blood cells and platelets (pancytopenia) was found to be 
highly specific (98%) for VL in suspected clinical patients in Nepal but the sensitivity was low 
(16%) (Boelaert et al., 2004). Marked polyclonal hypergammaglobulinemia (the production of high 
titres of non-specific antibody), a common finding in VL, can be detected by a formol gel test 
(FGT; also called the aldehyde test), which is still used in East Africa and Asia because of its 
simplicity and low cost. However, as the sensitivity of this test is poor (as low as 34%) (Boelaert et 
al., 2004), some experts have recommended its use to be discontinued (Sundar et al., 2003). 
Parasitological diagnosis remains the gold standard in VL diagnosis because of its high specificity 
(Herwaldt et al., 1999). Direct visualisation of amastigotes in clinical specimens in spleen aspirates 
is the classical confirmatory test used in regions where tissue aspiration is feasible and microscopy 
and technical skill are available. Diagnostic sensitivity for splenic, bone marrow, and lymph node 
aspirate smears varies, being higher for spleen (93–99%) than for bone marrow (53–86%) or lymph 
node (53–65%) aspirates (Young et al., 1939, Ho et al., 1948; Siddig et al., 1988; Zijlstra et al., 
1991; Babiker et al., 2007). Serological methods are highly sensitive and being non-invasive they 
are comparatively more suited for diagnosing VL in endemic regions. These methods are either 
based on detection of antibodies (produced against parasite by polyclonal activation of B cells) or 
antigens. Several tests have been developed, but all have two major limitations. First, though serum 
antibody levels decrease after successful treatment (Kumar et al., 2001; Braz et al., 2002), they 
remain detectable up to several years after cure (Hailu et al.,1990; Bern et al., 2005; De Almeida et 
al., 2006). Second, a significant proportion of healthy individuals living in endemic areas with no 
history of VL are positive for anti-leishmanial antibodies owing to asymptomatic infections. 
Antibody-based tests must therefore always be used in combination with a standardized clinical 
case definition for VL diagnosis. Serological tests based on indirect fluorescence antibody (IFA) 
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(Harith et al., 1987), enzyme-linked immunosorbent assay (ELISA) (Kumar et al., 2001) or western 
blot (Santos-Gomes et al., 2000) have shown high diagnostic accuracy in most studies but are 
poorly adapted to field settings. Two serological tests have been specifically developed for field 
use and have been sufficiently validated — the direct agglutination test (DAT) and the rK39-based 
immunochromatographic test (ICT). The DAT is a semi-quantitative test that uses microtitre plates 
in which increasing dilutions of patient‘s serum or blood are mixed with stained killed L. donovani 
promastigotes (Harith et al., 1986; 1987). If specific antibodies are present, agglutination is visible 
after 18 hours with the naked eye. The fast agglutination screening test (FAST) is a simplified 
(single serum dilution at a cut off of 1:800 or 1:1600) and more rapid (2–3 hours) version of the 
DAT, and its diagnostic accuracy seems comparable (Schoone et al., 2001; Hailu et al., 2006), but 
further validation is needed. rK39 is recombinant surface antigen that is highly specific for VL. It is 
a 39-amino acid repeat that is part of a kinesin-related protein in L. chagasi and which is conserved 
within the L. donovani complex (Burns et al., 1993). The test was then developed into an ICT, or 
dipstick, format that was more suitable for field use and is currently the best available diagnostic 
tool for VL for use in remote areas. Antigen-based immunodiagnostic tests are found to be more 
specific than antibody based methods as they avoid cross-reactivity and can distinguish active from 
past infections and are also more useful in immunosuppressed patients. A latex agglutination test 
(KATEX) detecting a heat-stable, low-molecular-weight carbohydrate antigen in the urine of VL 
patients has also shown promising initial results (Attar et al., 2001; Sarkari et al., 2002). In the 
particular case of zoonotic canine leishmaniasis, infected dogs that apparently are asymptomatic 
are also infectious and constitute an important reservoir for transmission. Specific and more 
sensitive tools are needed to distinguish asymptomatic from symptomatic dogs. A very recent study 
by Rajasekariah (2008) has developed a canine ELISA assay based on a cocktail of exo-antigens 
prepared from three species (L. infantum, L. donovani, and L. major).  
Although different molecular methods have successively been evaluated for leishmaniasis 
diagnosis (e.g., pulsed-field gel electrophoresis and multilocus enzyme electrophoresis) (Jaffe et 
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al., 1987), PCR-based assays currently constitute the main molecular diagnostic approach of 
researchers and health professionals. It is a definite breakthrough in the diagnosis and prognosis of 
VL as a non invasive method with excellent sensitivity and specificity. Polymerase chain reaction 
(PCR) identification is also currently used to identify different Leishmania species, diagnosis and 
control canine leishmaniasis (de Andrade et al., 2006; Gomes et al., 2007).  A variety of nucleic 
acid detection methods targeting both DNA and RNA have been developed. Different DNA 
sequences in the genome of Leishmania like ITS region, gp63 locus, telomeric sequence, sequence 
targeting rRNA genes and 18SrRNA, ssUrRNA and both conserved and variable regions of kDNA 
minicircles have been documented in diagnosis and prognosis of VL (Salotra et al., 2001; 
Wortmann et al., 2001; Cortes et al., 2006).  PCR formats range from simplified PCR methods for 
use in laboratory settings with minimal equipment, PCR-enzyme-linked immunosorbent assay 
(ELISA), a ―reverse hybridization‖ method based on the capture of PCR amplicons by specific 
probes immobilized in ELISA microtiter wells and colorimetric visualization (Martin-Sanchez et 
al., 2002; De Donker et al., 2005) to more sophisticated, rapid and high-throughput methods in 
which Leishmania PCR products are analyzed during their amplification (real-time PCR) after 
staining with SYBR-green I dye or hybridization with fluorogenic probes (e.g., TaqMan or 
fluorescence resonance energy transfer [FRET]) (Rolão et al., 2004). In leishmaniasis diagnosis, 
PCR applications is particularly advantageous when parasite load is low (e.g. in blood and 
conjunctiva) (Cruz et al., 2002; Strauss-Ayali et al., 2004), in HIV-coinfection (Bossolasco et al., 
2005; De Doncker et al., 2005), in the quantification of tissue parasite load and monitorization of 
disease progression and outcome (Mary et al., 2004), in evaluating the viability of parasites (van 
der Meide et al., 2005) when assessing the efficacy of drug therapies and predicting treatment 
outcomes and in the confirmation of clinical cure in VL (Maurya et al., 2005). In these cases, RNA 
should be preferred to DNA as an amplification target because the latter is still detected for a long 
time (estimated at 24 h) after parasite death (Quispe-Tintaya et al., 2005). 
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6.2.   Reservoir and vector control 
 
In the case of human reservoirs, serological diagnosis at the infection stage, if followed by a 
prompt treatment, will prevent the evolution to overt disease and reduce morbidity and mortality 
(Singh et al., 2006). In zoonotic VL, dogs are the main reservoir of L. infantum. Despite evidence 
from experimental studies showing a decreased incidence of VL in both dogs and children 
following serological screening of dogs and culling of sero-positive animals (Ashford et al., 1998; 
Palatnik-de-Sousa et al., 2001), the efficiency and acceptability of this control strategy is 
increasingly being debated (Tesh et al., 1995; Reithinger et al., 2002; Alvar et al., 2004). Culling of 
infected dogs is not considered an acceptable measure, both for ethical, socio-economical reasons 
and the low impact of this measure in situations of permanent transmission, such as Brazil (Moreira 
et al., 2004). Treating infected dogs is also not an effective control strategy as relapses are frequent 
and dogs can regain infectivity weeks after treatment, despite being clinically cured (Alvar et al., 
1994; João et al., 2006). Moreover, the widespread veterinary use of VL drugs might lead to 
resistance in parasites. A new control approach is the use of deltamethrine-treated collars (Scalibor 
ProtectorBand, Intervet International BV) which reduced the risk of infection in dogs (by 54%) and 
children (by 43%) in a study conducted in Iran (Gavangi et al., 2002). Vaccination of dogs would 
nevertheless be the best strategy if an efficacious vaccine can be developed. 
Sand flies are susceptible to the same insecticides as Anopheles mosquitoes, the malaria vector. 
Following the large scale antimalarial insecticide dichloro-diphenyl-trichloroethane (DDT)  
spraying campaigns that was implemented in the 1950s VL almost completely disappeared from 
the Indian subcontinent (Kaul et al., 1994). Unfortunately, the disease quickly re-emerged when 
these spraying campaigns were discontinued. The use of insecticide-impregnated bednets (ITNs), 
as an alternative to residual-insecticide house spraying, could concomitantly prevent VL and other 
vector-borne diseases, such as malaria. However there is limited evidence that bednets provide 
protection against VL (Chappuis, 2007). Case-control studies conducted in Bangladesh and Nepal 
showed that sleeping under a non-impregnated bednet during the warm months was a protective 
                                                                                                                                           Introduction 
 
 
 
27 
factor against VL (Bern et al., 2005). Despite low usage, the mass distribution of ITNs in Sudan 
was accompanied by a 27% reduction in the incidence of VL in an observational study (Ritmeijer 
et al., 2007).  
 
6.3. Treatment and vaccines 
 
Several drugs are available for treating leishmaniasis. Pentavalent antimonial compounds, such as 
the lead molecule megalumine antimonate (glucantime ) and sodium stibogluconate, are the drugs 
used in first line chemotherapy. Pentavalent antimony is a prodrug that is reduced by glutathione to 
active trivalent species catalyzed by thiol-dependent-reductase (Franco et al., 1995). This trivalent 
is toxic to both amastigotes, and promastigotes. Potential targets that are inhibited by pentavalent 
antimonials are enzymes in glycolosis that are essential for adenosine triphosphate (ATP) levels in 
Leishmania and purine transporters and DNA topoisomerases, all essential for nucleoside 
metabolism (Berman et al., 1987; Lucumi et al., 1998; Demicheli et al., 2002). Antimonials are 
toxic drugs with frequent, sometimes life-threatening, adverse side effects, including cardiac 
arrhythmia and acute pancreatitis. The emergence of resistance against antimonials led to the use of 
other compounds such amphotericin B, pentamidine, paromomycin and allopurinol, considered to 
be second-line drugs. Pentamidine acts on the pathogen genome by hampering replication and 
transcription at the mitochondrial level, while Amphotericin B, an antifungal macrolide polyene, 
binds selectively to Leishmania cell membrane sterols, forming barrel shaped transmembrane pores 
and induces changes in membrane permeability through uncontrolled loss of ions. This leads to 
cellular dysfunction and eventually cell lysis (Brajtburg et al., 1985). However, it can also cause 
life-threatening adverse side effects such as hypokalemia (low potassium levels in the blood), 
nephrotoxicity and first-dose anaphylaxis. Its‘ lipid formulations that involve either phospholipids 
or detergents, referred to as ―liposomes‖ and ―mixed micelles‖ have been developed as drug 
delivery systems to minimize side effects. Other anti-fungals like ketoconazole, fluconazole and 
Introduction                                                                                                                                           . 
 
28 
terbinafine are found less effective. Amphotericin B is currently the most effective antileishmanial 
drug that induces the highest cure rates and has been recommended as first line drug in India, being 
more widely used now for treatment of VL. Paromomycin, an antibiotic, also exhibits good 
antileishmanial activity and acts primarily by impairing the macromolecular synthesis and altering 
the membrane properties of Leishmania (den Boer et al., 2006). Allopurinol inhibits the enzyme 
adenylosuccinate synthetase, which mediates the conversion of inosonic acid to adenosine 
monophosphate. Allopurinol hydrolyzes to allopurinol ribosides, an analogue of inosine, gets 
incorporated instead of ATP into leishmanial RNA, and there it interferes in the normal protein 
synthesis (Marr et al., 1977).  
Current treatments against leishmaniasis are usually unsatisfactory due to some limitations 
including the route of administration of the drugs, their unaffordable cost and toxicity (Guerin et 
al., 2002; Croft et al., 2003; Singh et al., 2004). Efforts have been made to develop new 
leishmanicidal drugs and to find new strategies of drug design (Singh et al., 2004). Of interest for 
medicinal chemists is the pharmacological observation that certain molecules with anticancer 
activity and their derivatives might be also useful as antiprotozoal agents. It has been hypothesized 
that the cytotoxicity displayed by different antitumor drugs against protozoan parasites may be 
related to the fact that these parasites and cancer cells share diverse biochemical similarities which 
affect to DNA metabolism, protein kinases pathways, glucose catabolism enzymes, and polyamines 
metabolism (Klinkert et al., 2006). In addition, the growth of tripanosomatids parasites in their host 
and that of cancer cells show at least two common features that are (i) their mutual capacity for 
rapid cell division and (ii) some immune evasion and defense strategies. Leishmania parasites 
exhibit a molecular mechanism of programmed cell death (PCD) which shares some similarities 
with the apoptosis mechanism of cell suicide of multicellular organisms. Such mechanisms of PCD 
include proteins with caspase-like activity, cytochrome C release and DNA fragmentation. 
Therefore, the killing efficacy of some anticancer drugs against Leishmania may be due to the 
induction of programmed cell death in this protozoan parasite. Probably, the most promising drug 
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found is the antitumor compound miltefosine. Miltefosine is an alkylphosphocholine that is known 
to be toxic to both Leishmania promastigotes and amastigotes (Croft et al., 1987; Escobar et al. 
2002). This drug has good gastrointestinal tract absorption and has the advantage of having more 
potent action when administered orally than when injected intravenously since it can cause 
erythrocyte lysis. Several proposed mechanisms for the mode of action of miltefosine include 
damage to the flagellar membrane (Santa-Rita et al., 2000), perturbation of alkyl-phospholipid 
metabolism and GPI-anchor biosynthesis (Lux et al., 1996), interference with ether-lipid 
remodelling through the inhibition of alkyl-lyso-phosphatidylcholine specific acyltransferase (Lux 
et al., 2000) and inhibition of the de novo synthesis of phosphatidylcholine (Lira et al., 2001). 
Miltefosine currently underwent Phase IV trial for the treatment of Indian VL and the final cure 
was 82% by intention to treat and 95% by per protocol analysis, with only 3 deaths out of 1,132 
patients (Bhattacharya et al., 2007). However, Miltefosine is a teratogenic drug and its use is 
therefore strictly forbidden in pregnant women or in women who could become pregnant within 
two months of treatment. Non-adherence to the recommended regimen could lead to widespread 
parasite resistance and the increasing use of this drug in canine leishmaniasis in Europe might also 
increase the development of miltefosine resistance in L. infantum. 
Leishmaniasis in general, but particularly CL, is probably one of the few parasitic diseases that are 
most likely to be controlled by vaccines (Khamesipour et al., 2006). The leishmanial life cycle is 
relatively uncomplicated and recovery from primary infection usually renders the host resistant to 
subsequent infections which only makes a successful vaccine even more feasible. Extensive 
evidence from animal models indicates solid protection can be achieved by immunisation using 
parasite-specific proteins, DNA or genetically attenuated parasites (Kedzierski et al., 2006; 
Khamesipour et al., 2006).   In general, the leishmaniasis vaccines in development can be divided 
into three categories: (i) Live Leishmania; including new genetically modified constructs; (ii) First 
generation vaccines (FGV) consisting fractions of the parasite or whole killed Leishmania with or 
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without adjuvants; and (iii) Second generation vaccines (SGV) including all defined vaccines, i.e., 
recombinant proteins, DNA vaccines and combinations thereof. 
‗Leishmanization‘ (LZ), which simulates live infection by inoculation of live virulent L. major 
promastigotes, has been used as a vaccine for protection against CL (Senekji et al., 1941; 
Greenblatt et al., 1980). However, problems associated with LZ such as loss of parasite infectivity 
as a result of continuous sub-culturing, cases of immunosuppression in HIV-endemic areas and 
reduced responsiveness and chronic disease have lead to its discontinued use (Nadim et al., 1983). 
Until know this kind of vaccination is the only one that confers consistently high protection against 
LC. Therefore, a new interest has emerged in developing vaccines that use live parasites. New live 
vaccination strategies using mutant parasites, such as knock-out parasites lacking essential survival 
genes (Cruz et al., 1990; Alexander et al., 1998; Veras et al., 1999; Papadopoulou et al., 2002) or 
suicidal cassettes - Leishmania parasites genetically modified to commit suicide in response to 
external signals for self-destruction (Davoudi et al., 2005), are currently being tested. None of these 
constructs has reached clinical development, however this approach provides possibilities for 
induction of protection with a self-limiting infection, possibly without any associated pathology. At 
present there is only one prophylactic live vaccine in use. It is a mixture of live virulent L. major 
mixed with killed parasites that is being carried out in Uzbekistan (Sergiev et al., 1992; Gafurov et 
al., 1999).  
Several SGV candidate DNA-derived proteins are currently under evaluation (Kedzierski et al., 
2006) but the only one that has been engineered and assessed in human trials (Reed and Campos-
Neto, 2003; Coler and Reed, 2005) is Leish-111f, a polyprotein antigen composed of three antigens 
expressed in both promastigotes and amastigotes across the Leishmania genus; Leishmania 
elongation initiation factor (LeIF), L. major stress-inducible protein (LmSTI1), and thiol-specific 
antioxidant (TSA), fused in tandem. This vaccine when combined with monophosphoryl lipid A-
stable emulsion (MPL-SE) as adjuvant  induces a potent Th1-type immune response and protects 
mice and non-human primates against CL (Campos-Neto et al., 2001, Coler et al., 2002, Skeiky et 
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al., 2002) and recently mice and hamsters against VL (Coler et al., 2007).  However, Leish-111f 
failed to protect against canine leishmaniasis in a recent Phase III vaccine trial, where 95% showed 
evidence of L. infantum infection (Gradoni et al., 2005). The Leish-111f-MPL-SE product is the 
first defined vaccine for leishmaniasis in human clinical trials and has completed Phase I and II 
safety and immunogenicity testing in normal, healthy human subjects (Coler et al., 2007). Most of 
the recombinant derived proteins have also been tested as DNA vaccines (Kedzierski 2006) and are 
recommendable since they are usually highly immunogenic and elicit both humoral and cellular 
immune responses. Gp63 and LACK are the most extensively studied DNA vaccines against CL 
and VL but no development for use in humans have so far been reported.  
Despite all efforts, no vaccine against any form of human leishmaniasis has yet been available. One 
major factor contributing against the development of a Leishmania vaccine is the lack of a 
conceived market for human leishmaniasis vaccines. In the absence of industrial interests, many 
candidate vaccines have remained as fine publications (Khamesipour, 2006). However, strong 
protective effects against canine leishmaniasis have been achieved with a vaccine developed in 
Brazil, a fucose manose ligand (FML)-Quillaja saponin formulation, capable of inducing in 
naturally exposed vaccinated dogs 92 and 95% protection to up to 3.5 years (Palatnik et al., 1994; 
Borja-Cabrera et al., 2002).  
Other factors such as virulence, genetic differences between Leishmania species as well as host 
genetic factors controlling host protective immunity against different Leishmania also contribute to 
the problem and difficulties facing the design of a pan-Leishmania vaccine. An ideal anti-
leishmanial vaccine would need to possess several attributes that include; (1) safety; (2) 
affordability to populations in need; (3) induction of CD4
+
Th1 and CD8
+
 T cell responses and 
long-term immunological memory; (4) effectiveness against both CL and VL; (5) stability and (6) 
effectiveness as a prophylactic.   
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7. Host – Parasite interactions 
 
Cure in all forms of leishmaniasis is affected through cellular immune response capable of 
activating host macrophages to eliminate the parasite. Although leishmanial infections induce 
strong humoral responses, antibodies appear to play no role in protection and in fact are associated 
with non-healing forms of leishmaniasis. Not only do organisms of this genus have the ability to 
withstand, inhibit or circumvent the microbicidal activity of host macrophages, but under the 
appropriate circumstances, they can subvert the induction of both innate and adaptive immune 
responses.  
Early classical experiments established that T-cell-deficient mice rapidly succumb to disease 
following inoculation with any one of several species of Leishmania, and that transfer of normal T 
cells confers resistance to the animals (Holaday et al., 1991). The CD4
+
 subset of T cells is crucial 
for resistance, whereas CD8
+
 T cells seem to participate more in the generation of immune memory 
than as effector cells involved in parasite elimination (Muller et al., 1991; Uzonna et al., 2004; 
Scott et al., 2005). It is universally accepted that the nature of the T-cell response is one of the 
crucial factors controlling experimental and human leishmaniasis (Tripathi et al., 2007). 
Engagement of pathogen recognition receptors, namely toll-like receptors, on the surface of host 
immune cells with Leishmania surface molecules has also gained significant importance in the 
development of innate immunity (Becker et al., 2003; de Veer et al., 2003; de Trez et al., 2004; 
Flandin et al., 2006; Whitacker et al., 2008). TLR signalling may also directly or indirectly regulate 
the immunosuppressive function of regulatory T cells (Liu et al., 2006; Sutmuller et al., 2006; Liu 
and Zhao, 2007) in immune responses and subsequently stimulate adaptive immunity thus 
influencing disease outcome.  
Taking into consideration the main focus of the present dissertation, special attention will be given 
only on CD4
+
 T cell-mediated response during acquired immunity to Leishmania. 
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7.1. Acquired immune responses against Leishmania  
 
7.1.1. Th1 and Th2 responses 
 
In human and experimental leishmaniasis, immunity is predominantly mediated by T lymphocytes. 
T cells play a major role in generating specific and memory T-cell responses to intracellular 
parasitic infections. T helper (Th) 1 and Th2 cells can be distinguished by the cytokines they 
secrete: Th1 cells secrete activators of cell-mediated immunity such as gamma-interferon (IFN- , 
while Th2 cells secrete cytokines such as interleukin (IL)-4, which promote antibody responses 
(Mosmann and Coffman, 1989). Cytokines can form a complex network of synergistic and 
antagonistic interactions, which not only induce but also control immune responses. The control of 
leishmanial infection is mediated by a Th1 type immune response, and experimental studies in 
murine models of CL (L. major) have established a clear-cut dichotomy between Th1-mediated 
protection and Th2-mediated disease susceptibility (Locksley et al., 1987; Heinzel et al., 1989; 
Scott et al., 1998; Sacks & Noben-Trauth, 2002). Resolution of infection is mediated by Th1 cells 
that produce IFN- . IFN-  induces the production of nitric oxide (NO) in phagocytic cells that 
harbour L. major (principally macrophages), which leads to destruction of the parasite (Green et al., 
1990; Liew et al., 1990). T-cell differentiation from naïve T cells (Th0) to either to Th1- or Th2-
type effector cells depends chiefly on the priming during differentiation. IL-12 induces Th1 cells 
(regulated by transcription factor T-bet), to produce IFN-  and tumor necrosis factor-alpha (TNF-
). IL-4 induces Th2 cells (regulated by GATA-3) to produce IL-4, IL-13 and IL-10. Infection with 
L. major in animal models resembles self-limiting CL in humans (Scott et al., 1998). Upon 
infection with L. major, mice of the resistant phenotype clearly develop a dominant Th1 phenotype 
of immune response to the parasite antigens. By contrast, susceptible BALB/c mice develop a 
typical Th2 response. Targeted disruption of the IFN-  gene in resistant C57BL/6 mice causes these 
animals to become highly susceptible to L. major (Wang et al., 1994). However, the identification 
of the precise role of type 2 responses remains more elusive, and characterization of Th2 cytokine 
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functions is an area of continuing speculation and investigation. Studies on the role of IL-4, has 
provided some contradictory observations (Alexander et al., 1999). The apparent resolution of 
infection with L. major in BALB/c mice treated at the time of infection with an anti-IL-4 
monoclonal antibody (Sadick et al., 1990; Chatelain et al., 1992) or in IL-4-deficient BALB/c mice 
(Kopf et al., 1996; Mohrs et al., 1999) helped to establish the view that early production of IL-4 
drives the polarized Th2 response that is responsible for suppressing Th1-cell development and 
inhibiting the high-level secretion of IFN-γ. Early IL-4 response is shown to be confined largely to 
an oligoclonal population of CD4
+
 T cells with a Vβ4Vα8 T-cell receptor (TCR) that recognize the 
Leishmania antigen LACK (Leishmania homologue of receptors for activated C kinase) (Launois et 
al., 1997). It has been proposed that LACK-specific Vβ4Vα8 CD4+ T cells represent a unique 
lineage in BALB/c mice that are biased to produce IL-4 because their TCR has relatively low 
affinity for peptide/MHC (Malherbe et al., 2000). Despite the strong evidence for a disease-
exacerbating role for IL-4, Scott, (1996) demonstrated that early IL-4 production does not 
necessarily predict susceptibility to L. major infection. In fact, (Noben-Trauth et al., 1996) found 
that IL-4-deficient BALB/c mice remained susceptible to L. major infection.  These apparent 
differences may arise, in part, due to different parasite strains or species being examined or 
different tissue sites (footpad, ear or base of the tail) being infected. Also redundancy in IL-4 
function via the compensatory activity of other cytokines such as IL-13, which shares many of the 
properties of IL-4, may obscure otherwise significant activity. Most importantly, early IL-4 
production by LACK-reactive CD4
+
 T cells has been observed in both susceptible and resistant L. 
major-infected mice (Reiner et al., 1993; Julia et al., 1999;  Stetson et al., 2002), Resistant mice can 
also display an early, albeit transient, IL-4 response following L. major infection (Scott et al., 
1996). So the critical defect in BALB/c mice seems to be in their inability to redirect the early IL-4 
response along a normal Th1 differentiation pathway during infection. This indicates that the 
ability to redirect early Th2 response is the more probable determinant of resistance in the mouse 
model (Sacks and Noben-Trauth, 2002). A predominant Th2 response is not the underlying 
determinant of susceptibility in these animals.  
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The fact that IL-4
-/-
 deficient mice developed progressive disease following infection with L. major, 
suggests that although IL-4 and IL-13 biological activity is lacking, these mice could be, under 
some circumstances, fully susceptible (Noben-Trauth et al., 1999). Consequently, it is possible that 
mechanisms or cytokines other than IL-4 and IL-13 can promote susceptibility to infection. The 
fact that the lesion size and number of parasites are reduced in these mice treated with anti-IL-10 
antibodies (Ab) (Noben-Trauth et al., 2003) indicate that IL-10 could also play a role in 
susceptibility to infection with L. major (Sacks et al., 2004). IL-10
-/-
 deficient BALB/c mice were 
more resistant to L. major than wild type mice (Kane and Mosser, 2001). Interestingly, it has been 
shown that IL-10 released by CD4
+
 T cells is also implicated in the persistence of Leishmania in 
healed lesions of resistant C57BL/6 mice since complete elimination of parasites occurred in these 
mice only when the IL-10 signalling pathway was abrogated with anti-IL-10R Ab (Belkaid et al., 
2001). So the principal function of IL-10 is to limit the magnitude of an immune response, and it 
does so by inhibiting APC function, blocking cytokine and chemokine secretion, and inhibiting the 
induction of activities initiated by other cytokines, notably macrophage activation by IFN- Moore 
et al., 2001). These clinical and experimental studies indicate that unfavourable infection outcomes 
are not related to Th2 dominance or a Th1 response defect per se but to concomitant expression of 
IL-10 that renders macrophages poorly responsive to activation signals. 
The Th1/Th2 paradigm is important in determining disease outcome in murine CL. However, this 
dichotomy is not as influential during murine L. donovani and L. chagasi visceral disease, in which 
curative type 1 response is instead suppressed by IL-10 and transforming growth factor-  (TGF-
without Th2 cytokine production (Wilson et al., 2005). Leishmania chagasi directly affects its 
local environment by activating latent TGF- , and both L. donovani and L. chagasi suppress host 
macrophage responses to IFN-  (McMahon-Pratt and Alexander, 2004). Protective immunity 
against L. donovani is dependent on IL-12-driven type 1 response and IFN-  production. A disease-
promoting role for IL-4 and the Th2 response in VL, however, is more difficult to identify. For 
example, the differential production of Th1 and Th2 cytokines does not control the rate of cure of 
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murine VL (Bogdan et al., 1993). No constant association between Th1 responses and resistance to 
disease with predominance of cells that produce IFN- has been identified in human VL (Khalil et 
al., 2005). The levels of IFN-  and IL-4 are elevated during active disease and decline significantly 
after cure. The lack of IFN-  production by peripheral blood mononuclear cells (PBMC) seems to 
predict progression of the infection into fulminant VL (Carvalho et al., 1985, 1989; Bacellar et al., 
1991). However, it is likely that several mechanisms may participate in the inability of 
lymphocytes from VL patients to produce IFN- , one important point is related to the imbalance of 
cytokines produced in response to Leishmania antigens, i.e. high production of IL-4 and IL-10 and 
low IL-2 and IFN-  production (Khalil et al., 2005). Although lymphocytes from patients with VL 
have a strong expression of mRNA for IL-4 and sera have high IL-4 levels, there is no evidence 
that IL-4 is involved in the down-regulation of the Th1 type of response in human leishmaniasis 
(Alexander et al., 2000; Wilson et al., 2005). It has been shown that in vitro addition of mAb 
against IL-4 did not restore the lymphocyte proliferative response or IFN-  production in L. 
chagasi-stimulated PBMC from VL patients. IL-4 also did not suppress lymphocyte proliferative 
response or IFN- production in subjects cured of leishmaniasis (Ribeiro-de-Jesus et al., 1998). 
Thus, the prominent role of IL-4 as the leading Th2 cytokine in murine CL was not consistently 
seen in human VL. 
Initially IL-10 was categorized as a Th2 cytokine (Hsieh et al., 1992) but with the newly discovered 
suppressor population of T cells, its Th2 candidature has been diluted out. Patients with VL have 
increased expression of mRNA for IL-10 in bone marrow and lymph node cells and high levels of 
IL-10 in L. chagasi-stimulated PBMC supernatants (D‘Oliveira et al., 1997). The fact that IL-10 
abrogates the effect of IL-12 in inducing IFN-  production in L. chagasi-stimulated PBMCs of VL 
patients strongly suggests that IL-10 is a major immunosuppressive cytokine which is directly 
involved in the progression of Leishmania infection to visceral disease (Bacellar et al., 1996). 
Moreover, the addition of monoclonal antibodies to anti-IL-10 restores the lymphocyte 
proliferative response and IFN-  production in PBMC from VL patients (Hailu et al., 2005). 
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Individuals with acute visceral leishmaniasis caused by L. donovani simultaneously express IL-10 
and IFN-  transcripts, and IL-10 decreases after resolution of disease (Ghalib et al., 1993; Karp et 
al., 1993). 
In recent studies, (Anderson et al., 2007; Jankovic et al., 2007), it was demonstrated that infection-
driven IFN- -producing Th1 cells are a crucial source of IL-10. IL-10 production by antigen-
specific Th1 cells was necessary and sufficient to suppress immunity to a non-healing form of L. 
major in conventionally resistant mice, and, in Toxoplasma gondii-infected mice, the cells were 
required as a protective feedback mechanism to prevent lethal inflammation. The production of IL-
10 by antigen-specific Th1 cells is a normal stage in their differentiation programme which is 
reached after full activation. Because splenic CD25
-
 T cells from VL patients have elevated 
expression of both IFN- and IL-10, it is possible that at least some are IL-10–IFN-  double 
producers, activated in a strong inflammatory setting as a mechanism of feedback control (O‘ Garra 
et al., 2007). 
 
7.2. Immunosuppression 
 
Many pathogens have evolved mechanisms to manipulate the immunoregulatory network of the 
host to their advantage, thereby generating conditions that ensure their survival for an extended 
period of time. A common strategy used by microorganisms to extend their survival involves the 
induction of regulatory responses that are normally associated with the termination of effector 
immune responses of the host. Although it has long been recognized that T cells with suppressive 
or anergic activity are generated in vivo during infection (Mahanty et al., 1996), it has only recently 
emerged that specialized subsets of regulatory T cells (Treg) also contribute to this regulatory 
network.  
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Several types of regulatory T cells have been described (Shevach et al., 2006) on the basis of their 
origin, generation and mechanism of action, with two main subsets identified: naturally occurring 
CD4
+
CD25
+
 regulatory T cells (referred to here as natural Treg or nTreg cells), which mainly 
develop in the thymus and regulate self-reactive T cells in the periphery, and inducible regulatory T 
cells (iTreg cells), which develop in the periphery from conventional CD4
+
 T cells after exposure 
to signals such as regulatory cytokines, immunosuppressive drugs or antigen-presenting cells 
(APCs) conditioned by microbial products (O‘Garra et al., 2004). According to Belkaid, (2007), 
nTreg are those cells that belong to the population of regulatory T cells that is present in the host 
before pathogen exposure, and iTreg as those that acquire regulatory function in the context of a 
given infection. Inducible regulatory T-cell populations include T regulatory 1 (Tr1) cells, which 
secrete IL-10 and T helper 3 (Th3) cells, which secrete TGF-β. 
 
7.2.1. Naturally occurring Treg 
 
Naturally occurring CD4
+
CD25
+
 regulatory T cells, that represent 5–10% of peripheral CD4+ T 
cells in naïve mice, constitutively express surface CD25, the α-subunit of the IL-2 receptor, before 
activation (Sakaguchi et al., 1995) These cells also express cytotoxic T-lymphocyte antigen 4 
(CTLA-4) (Read et al., 2000), glucocorticoid-induced tumor-necrosis factor receptor family-related 
gene (GITR) (Shimizu et al., 2002), OX40 (McHugh et al., 2002), CD39 and CD73 (Deaglio et al., 
2007) and high levels of folate receptor 4 (FR4) (Yamaguchi et al., 2007). However, none of these 
markers are specific for nTreg cells, as they can also be expressed by activated T cells. The recent 
discovery of the expression of the X chromosome–encoded forkhead helix-winged transcription 
factor family member, forkhead box P3 (FOXP3) (Brunkow et al., 2001; Hori et al., 2002; Fontenot 
et al., 2003, Khattri et al., 2003), that is known to be crucial for the development and function of 
nTreg, is the most definitive signature of nTreg cells in mice (Shevach et al., 2006). However, its 
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expression in humans can also be transiently upregulated by activated non-Treg cells (Gavin et al., 
2006).  
Foxp3 expression can be induced de novo by conventional CD4
+
 T cells which only renders the 
distinction between nTreg and iTreg cells less obvious. Very recent studies have given emphasis on 
epigenetic regulation of permanent expression of Foxp3 in truly committed Treg (Floess et al., 
2007).  Activated conventional CD4
+
 T cells and TGF- -treated cells displayed no Foxp3 DNA 
demethylation despite expression of Foxp3, whereas subsets of stable Treg, even upon extended in 
vitro expansion, remained demethylated (Baron et al., 2000). The unique Foxp3 promoter 
methylation profile in Treg suggests that a demethylated pattern is a prerequisite for stable Foxp3 
expression and suppressive phenotype (Janson et al., 2008).  
Treg cells require activation via T cell receptor (TCR) to exert regulatory function and their 
suppressive activity is related to their ability to inhibit IL-2 production via a mechanism requiring 
direct cell-contact (Thornton and Shevach, 2000). nTreg form long-lasting interactions with 
dendritic cells (DC) and impair their ability to subsequently activate effector T cells. Thus nTreg 
cells may inhibit T-cell responses indirectly by modulating the function of APC (Tang et al., 2006). 
CTLA-4-expressing nTreg cells induce the expression by APCs of the enzyme indoleamine 2,3-
dioxygenase (IDO), which degrades tryptophan, and lack of this essential amino acid has been 
shown to inhibit T-cell activation and promote T-cell apoptosis (Fallarino et al., 2003). Controversy 
still exists regarding the molecular mechanisms underlying Treg in vivo and in vitro function, 
although several studies have suggested the involvement of TGF- 1 (Nakamura et al., 2004) and 
IL-10 (Asseman et al., 1999; Annacker et al., 2001) in Treg suppressive activity in vivo. More 
recently, adenosine and cyclic AMP have also been shown to contribute to Treg-cell suppressive 
activity (Bopp et al., 2007; Deaglio et al., 2007). However, the mechanisms of suppression by Treg 
cells are still largely unclear.  
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The main function of nTreg is to preserve immune homeostasis in the host by controlling excessive 
immune responses and the extent of immune-mediated pathology. This is of particular importance 
when maintaining self-tolerance and minimizing immunopathology normally associated to the 
onset of autoimmune diseases (Sakaguchi et al., 1995). One consequence of such control during 
infectious diseases is enhanced pathogen survival. Several persistent pathogens are known to 
establish chronic infections by engaging CD4
+
CD25
+
 regulatory T cells and taking advantage of 
their immunosuppressive function (Belkaid et al., 2002; McKee and Pearce, 2004; Campanelli et 
al., 2006; Vigário et al., 2007). In L. major infection of genetically resistant mouse strain, nTreg 
cells favour parasite survival and expansion. These cells accumulate at sites of infection and locally 
control the expression of Th1 effector mechanisms through IL-10-dependent and IL-10 
independent mechanisms, and this prevents efficient elimination of the parasite (Belkaid et al., 
2002; Yurchenko et al., 2006). In this model of infection, parasite persistence, as a result of 
immune suppression by nTreg cells, is necessary for the maintenance of protective immunity 
against the parasite. However, when the regulatory control is too excessive, the pathogen replicates 
without restraint and may compromise the survival of the host. For example, in humans infected 
with Plasmodium falciparum, a causative agent of human malaria, the removal of nTreg cells 
enhances in vitro proliferation of PBMCs and their production of IFN-γ in response to malaria 
antigens (Walther et al., 2005). In L. major infection of susceptible mice, nTreg were shown to 
suppress both Th1 and Th2 cells (Aseffa et al., 2002; Xu et al., 2003) by both IL-10/TGF-  – 
dependent and independent mechanisms (Liu et al., 2003). Also a role for Treg cells in restraining 
pathogenic responses during non-healing L. amanzonensis infection was observed (Ji et al., 2002). 
Evidence from infection with different protozoan parasites suggests that nTreg cells recognize 
microbial antigens (Belkaid et al., 2002, Hesse et al., 2004, Hisaeda et al., 2005). In murine 
leishmaniasis, nTreg cells that accumulate at the site of infection can recognize parasite-derived 
antigens (Suffia et al., 2006). In addition, far from being anergic, as in vitro experiments had 
suggested (Thorthon et al., 2000), nTreg cells proliferate vigorously when they encounter their 
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cognate microbial antigens (Suffia et al., 2006). Notably, these cells are restricted to the site of 
infection and depend on antigen for their maintenance. Such compartmentalization provides a 
potential explanation to the concept of concomitant immunity, in which the host is immune to re-
infection at a secondary site while maintaining a local chronic infection (Mendez et al., 2004). 
One mechanism by which microorganisms might manipulate regulatory T-cell function is by 
creating an environment that favours the retention of regulatory cells at sites of infection. Integrin 
αEβ7 (also known as CD103 or ITGAE), the expression of which is positively modulated by TGF-
β, has been shown to favour natural Treg-cell retention at sites infected by the parasite L. major 
(Suffia et al., 2005). In the same model of infection, CC-chemokine receptor 5 (CCR5) expression 
by nTreg cells was shown to be required for their migration to the infected sites (Yurchenko et al., 
2006).   
 
7.2.2. Induced Treg - Tr1/ IL-10 producing Treg 
 
The mechanisms underlying the failure to control the growth and systemic spread of Leishmania 
parasites in human and murine visceral leishmaniasis are not well understood. Although the 
absence of antigen-specific Th1 response in the PBMC from VL patients is thought to be causally 
related to disease progression, the finding that these patients also express elevated IFN-  mRNA in 
lesional tissue, as well as elevated serum levels of proinflammatory cytokines, suggests that their 
immunological defect cannot be explained simply by immune tolerance or Th2 polarization. As a 
possible homeostatic mechanism to control persistent infection-induced inflammation, elevated 
levels of the regulatory cytokine IL-10 have been reported repeatedly in clinical studies of VL. 
Elevated production of IL-10 is frequently found in human VL (L. donovani) (Caldas et al., 2005). 
Based on experimental models, IL-10-deficient or anti-IL10 receptor treated mice display enhanced 
resistance and leishmanicidal activity against L. donovani (Murphy et al., 2001; Murray et al., 
2005). However, the extensive data generated fail to support a major role for nTreg in human VL.  
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It cannot be out ruled that CD4
+
CD25
+
Foxp3
+
 Treg contribute to immune suppression during the 
earliest stages of infection (Nylén et al., 2007), however, extensive analyses of blood and splenic 
aspirates from Indian VL patients still do not support a major role for nTreg during overt disease. 
nTreg were not elevated in the blood and did not accumulate at the site of infection (spleen) in 
active VL cases; no changes in frequencies were observed with treatment. Moreover, antigen-
specific IFN-  responses were not rescued by depleting the PBMCs of CD25
+
 cells (Nylén et al., 
2007a). In contrast, a more recent study, demonstrated a probable immunosuppressive role for 
CD4
+
CD25
+
 regulatory T cells, during active VL, and post-treatment with amphotericin B, during 
reactivation in PKDL patients (Saha et al., 2007).   
Recent studies now point out to the existence of an important source of IL-10-producing T cell 
subset, CD4
+
CD25
-
Foxp3
-
 T cells, which seem to be the main cells involved in IL-10-mediated 
immune suppression in human (Nylén et al., 2007) and in murine VL (L. donovani) (Stäger et al., 
2006).  Treg cells that develop in peripheral lymphoid tissues, which are frequently FOXP3 
-
 have 
been termed adaptive or induced Treg (iTreg). Within this particular category of Treg, there are the 
so called antigen-specific CD4
+
 T cells or Tr1 cells, known to produce large amounts of IL-10. Tr1 
are involved in the down-regulation of immune responses via IL-10 and suppressing naïve and 
memory Th1 or 2 responses (Mills and McGuirck, 2004). High levels of splenic IL-10 mRNA was 
found primarily in the CD25
-
FoxP3 mRNA
low
 T cells, which accumulate in the spleen of VL 
patients. Thus, parasite-driven adaptive regulatory/Tr1 cells (Roncarolo et al., 2001) appear to be 
more important than nTreg cells in the suppression of anti-Leishmania immunity in VL. 
 
7.2.3. Th3 immune response 
 
Th3 cells are a regulatory T-cell subset, that was originally thought to be involved in oral tolerance, 
and that primarily secretes TGF- (Chen et al., 1994; Fakaura et al., 1996) Because TGF-β1 
knock-out (KO) mice exhibited severe multi-organ inflammations, TGF-β1 has been thought to be 
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an important immune regulatory cytokine. This cytokine provides help for IgA induction and has 
suppressive properties for both Th1 and Th2 cells. TGF-β1 was suggested to be involved in the 
regulatory function of CD4
+
CD25
+
 regulatory T cells (Annunziato et al., 2002; O‘Garra et al., 
2004), though the molecular mechanism of TGF-β1 induction in such regulatory-type T cells 
remains to be elucidated. As the expression of CD25 and Foxp3 is induced in T cells under 
experimental conditions (in the presence of IL-4, IL-10 and TGF- ), Th3 cells are also referred as 
iTreg that are generated from naïve T cells and that expand upon encounter with antigen 
(McGuirck and Mills, 2002). Th3 cells can be distinguished from Th2 cells by cytokine profiles; 
Th3 cells produce much more TGF-β1 and IL-10 and less IL-4 than Th2 cells (Chen et al., 1994; 
Seder et al., 1998). Suppressor of cytokine signalling (SOCS3) - deficient CD4
+
 T cells infected 
with L. major were shown to produce more TGF-β1 and IL-10 and are thought to be more likely to 
exhibit a Th3-like phenotype (Kinjyo et al., 2006). 
 
7.2.4. Th17 response 
 
Another subset of CD4
+
T cells that produce IL-17, Th17 cells, and to a lesser extent, TNF and IL-
6, has been identified as a highly pro-inflammatory lineage and induces severe autoimmunity (Cua 
et al., 2003; Langrish et al., 2005). Whereas IL-23 serves to expand previously differentiated Th17 
cell populations (Langrish et al., 2005), IL-6 and TGF-β induce the differentiation of Th17 cells 
from naive precursors (Veldhoen et al., 2006; Mangan et al., 2006). It has pleiotropic activities, one 
of which is to coordinate tissue inflammation by inducing the expression of pro-inflammatory 
cytokines (such as IL-6 and TNF), chemokines (such as KC, MCP-1 and MIP-2) and matrix 
metalloproteases, which mediate tissue infiltration and tissue destruction (Kolls et al., 2004).  IL-17 
is also involved in the proliferation, maturation and chemotaxis of neutrophils (Fossiez et al., 
1996). Of particular interest is recent data suggesting a dichotomy between Foxp3
+
Treg cells and 
Th17 cells. T cells exposed to TGF-β upregulate Foxp3 and become iTreg cells; however, when 
cultured with TGF-β and IL-6, naїve T cells generate Th17 cells with highly pathogenic activities 
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(Betelli et al., 2006). Therefore, during the steady state, when the immune system is not activated, 
TGF-β favours the generation of iTreg cells, which suppress inflammation and prevent the 
development of autoimmunity. However, after infection, IL-6 produced by the innate system 
inhibits the generation of iTreg and, together with TGF-β, induces the differentiation of Th17 cells. 
These results suggest that Th17 and iTreg cells may arise from the same precursor in distinct 
cytokine milieus. 
 
Figure 5. Summary of the nature of regulatory T cells and the mechanism of suppression that depends on the 
strength and stage of the pathological process. During an acute infection, polyclonal natural Treg cells may 
contribute to the control of the inflammatory process. During chronic infections with sustained Th1 or Th2 
cell responses, several regulatory processes may contribute to immune regulation. Natural Treg cells, 
expressing CTLA-4, could produce cytokines, such as IL-10 or TGF-β, to prevent tissue damage; those that 
accumulate at the site of infection may be enriched in pathogen-specific Treg cells. Tr1 cells can be induced 
because of the effect (deactivation and induction of cytokine production) of pathogens on APCs or chronic 
exposure to microbial antigen. FOXP3
– 
T cells could be converted into FOXP3
+
 regulatory T cells at sites 
enriched in TGF-β, such as the skin or the gut. During infections that induce a sustained Th1-cell response, 
Th1 cells themselves may also contribute to the limitation of immune responses and tissue damage through 
the release of IL-10 (adapted from Belkaid et al., 2007).   
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IL-6 and probably other pro-inflammatory cytokines may act as ‗pivots‘, determining whether an 
immune response is dominated by protective Treg cells or highly pro-inflammatory Th17 effector 
T cells (Betelli et al., 2007). Currently, there is limited information on the role of IL-17 in 
Leishmania infection. Given the chronic inflammation and neutrophil/macrophage migration 
during Leishmania infection, it is logical to speculate that IL-17 may play a role in leishmaniasis. 
Xin, (2007) observed that L. amazonensis-infected DCs preferentially induce CD4
+ 
T cells with an 
IFN-
low
 IL-10
high
 IL-17
high
 phenotype although the specific condition that induces IL-17 expression 
remained unclear. 
 
7.3. Immunoregulation  
 
Pathogens can favour regulatory T cell function. Because nTreg cells generate favourable 
conditions for the persistence of microorganisms, it is conceivable that the induction, maintenance 
and function of natural Treg cells could also be manipulated by microorganisms. In addition to the 
TCR recognition of specific antigens, nTreg cells can also respond to microbial products 
independent of TCR signals. New evidence has demonstrated that Treg cells can also sense 
pathogens directly through Toll-like receptors (TLR) and, consequently, modify their behaviour 
(Sutmuller et al., 2006). TLR signalling may directly or indirectly regulate the immunosuppressive 
function of CD4
+
CD25
+
 Treg cells in immune responses and shift the balance between CD4
+
 Th 
cells (effector T cells) and Treg cells, and subsequently influence the outcome of the immune 
response (Liu and Zhao, 2007). 
The family of TLRs is a major class of receptors (Lemaitre et al., 1996; Medzhitov et al., 1997) that 
recognize pathogen-associated molecular patterns (PAMPs). These molecules, found in bacteria, 
viruses, fungi and protozoa, present highly conserved molecular structures. Signalling pathways 
activated by TLRs result either in the activation of the transcription nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-κB), with subsequent production of pro-inflammatory 
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cytokines, chemokines, antimicrobial peptides and additional defense molecules, or in the 
activation of mitogen-activated protein kinases p38 and JNK (Kawai et al., 2006). Between the 
activation of TLR and the release of NF-κB, there is an important step that is mediated by adaptor 
molecules. MyD88 is the most common adaptor molecule for the activation of NF-κB and is 
present in most TLR.  
The first study evaluating TLRs and the MyD88 dependent pathway in Leishmania infection was 
undertaken by Hawn, (2002). This study evaluated experimental L. major infection and cytokine 
expression from macrophages in MyD88
-/-
 deficient mice. MyD88
-/- 
C57BL/6 mice were highly 
susceptible to L. major and developed non-protective Th2 response (Debus et al., 2003; Muraille et 
al., 2003). Other studies showed that the activation of NF-κB in macrophage cell lines by the 
parasite derived molecule LPG was mediated by TLR-2 (de Veer et al., 2003). Becker, (2003) had 
similar results in vitro using NK cells, suggesting that three molecules of LPG aggregate with one 
molecule of TLR-2. In VL, NK cells are associated with a good prognosis and TLR9 was also 
shown to be required for their activation as it is essential for the production of IL-12 by DCs 
(Schleicher et al., 2007). Ribeiro-Gomes, (2007) recently determined the role of neutrophils 
elastase. This enzyme produced by neutrophils induces the leishmanicidal activity of macrophages 
through TLR4 activation.  
It is commonly accepted that TLR-mediated recognition of specific structures of invading 
pathogens initiates innate as well as adaptive immune responses via DCs or other APCs. However, 
emerging evidence of TLR expression on T cells (Kabelitz et al., 2006), including nTreg cells 
(Caramalho et al., 2003) suggests the potential involvement of TLR signalling in adaptive immune 
regulation. Consistent with a direct role for TLRs, human nTreg cells express TLR-5 at levels that 
are comparable to APCs, and co-stimulation with the TLR-5 ligand flagellin increases their 
suppressive capacity and enhances their expression of Foxp3 (Crellin et al., 2005). This feature 
could offer certain pathogens an opportunity to enhance immunosuppression. Although some 
ligand interactions with TLRs have been proposed to increase nTreg-cell suppressive capacity, 
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others have been shown to limit their function (Sutmuller et al., 2006). For example, TLR2 
signalling temporarily abrogates the suppressive phenotype of nTreg cells and decreases their 
Foxp3 expression (Sutmuller et al., 2006a), Following removal of the TLR-2 trigger, the in vitro-
expanded Treg cells fully regained their phenotype and suppressive capabilities. Thus, TLR ligands 
have the capacity to act directly on Treg cells through TLR and, ultimately, modulate the immune 
response (Liu et al., 2006).  
Recently, Peng, (2005) have shown that human Treg cells express high levels of TLR-8, and that 
the TLR-8 triggering of Treg cells also prevents their suppressive phenotype. It is not known 
exactly how the TLR triggering of Treg cells modulates their suppressive effects, and whether the 
triggering of different TLRs occurs through the same pathway or has the same effect on Treg-cell 
function (Sutmuller et al., 2006). One explanation could be the up-regulation or down-regulation of 
Foxp3 expression following the different TLR stimulations (Crellin et al., 2005; Liu et al., 2006), 
but how TLR-signalling affects Foxp3 expression is still unclear. Experimental data support the 
idea that TLR-2 signalling on murine Treg cells might function as a strong co-stimulatory trigger. 
This would force Treg cells into the proliferative pathway, which might be paralleled by the 
reversal of their suppressive capabilities (Sutmuller et al., 2006a). It is tempting to hypothesize that 
Leishmania-derived TLR-2 ligands could help to expand Treg cells and abrogate suppression 
during the acute phase of the infection. During late chronic phases of infection, accompanied by 
decreases in the presence of TLR2 ligands, Treg-cell suppressive activity would be expected to 
increase again in order to prevent immune-mediated pathology and enable long-term parasite 
persistence.   
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1. Phenotypic characterization of regulatory T cell populations 
during L. infantum in vivo infection 
 
The first part of the study involved direct identification of typical regulatory T cell populations 
through the use and detection of several known cell surface molecules. To confirm their presence 
and behaviour within the host infected with L. infantum parasites, host cells were isolated, 
phenotypically characterized and followed-up in terms of cell dynamics and cytokine response 
during the course of in vivo infection.  
 
1.1. Experimental design 
 
Treg cell frequency and phenotype was studied in pooled lymph node (LN) and spleen (SP) cells 
isolated from susceptible mice infected with L. infantum.  Samples were collected from lymph 
nodes and spleen for isolation of total leukocytes, single-cell separation, cytokine in vitro assays 
and gene expression as well as parasite detection in spleen and liver (LIV), the main target organs 
of L. infantum. The experiments were repeated three times. 
 
1.2. Animals and parasites 
 
1.2.1. Mice 
 
Six- to eight-week-old male BALB/c mice (Mus musculus), specific pathogen-free (SPF), were 
purchased from the Instituto Gulbenkian de Ciência and maintained at Instituto de Higiene e 
Medicina Tropical (IHMT) animal facilities. Standard commercial feed (Harlan Ibérica, Spain) and 
water were provided ad libitum.  Upon arrival the mice were divided into two groups, control and 
infected. Animals were infected via intraperitoneal (i.p.) route with a parasite suspension of 
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virulent L. infantum promastigotes. Five to seven animals were sacrificed for each studied time 
point. The experiments were conducted according to EU requirements (86/609/CEE), recognized 
by the Portuguese law (DR DL129/92 and Portaria 1005/92). 
 
1.2.2. Parasites 
 
The L. infantum MON-1 (MHOM/PT/89/IMT151) strain was maintained by regular passage 
through BALB/c mice and amastigotes were isolated from infected spleens. After in vitro 
transformation, virulent promastigotes were collected from spleen homogenates after two weeks of 
culture at +24ºC in a solid phase composed of NNN (Novy, McNeal, Nicolle) growth medium 
(Santos-Gomes and Abranches, 1996) plus Schneider‘s insect liquid medium (Sigma, USA), with 
L-glutamine, 100 U.ml
-1 
penicillin, 100 g.ml
-1
 streptomycin and supplemented with 10% foetal 
calf serum (FCS) (Invitrogen, USA), previously inactivated for 30‘at +56ºC.  
In order to obtain a high number of promastigotes, primary isolated parasites were expanded in 
Schneider 10% FCS. Stationary phase parasites with less than five subculture passages were used 
for mice inoculation. Promastigotes were harvested by centrifugation (1800 g, 15‘, 4ºC) and 
washed once with phosphate buffered saline (PBS) (Cambrex, USA). Parasites were subsequently 
counted in Neubauer hemocytometer and resuspended in the appropriate volume of PBS.  Infection 
was performed i.p with 5x10
6
 promastigotes in a final volume of 100 l per mouse.  
 
1.2.3. Antigen preparation 
 
Promastigote lysate for use in cell stimulation assays was prepared from stationary phase 
promastigotes. Parasites were harvested by centrifugation (1800 g, 15‘, +4ºC) and washed twice 
with isotonic PBS / 2 mM EDTA (Sigma). The supernatant was discarded and pellet resuspended 
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in 500 ml of distilled water. The promastigotes were disrupted by repeated freeze thawing cycles -
70ºC and room temperature . Cell debris was spun down (15 000 g, 15‘ +4ºC) and the protein 
content of the supernatant was determined by spectrophotometry (Gene Quant II; Pharmacia 
Biotek, Sweden). The lysate was stored in aliquots at -70ºC until use.   
 
1.3. Sample collection 
 
Animals were sacrificed by cervical dislocation at days 2, 7, 14, 28 and 56 days post-infection (pi). 
The organs were aseptically dissected from animals and maintained at +4ºC in RPMI 1640 (Gibco-
Brl, USA) containing 2 mM L-glutamine, 2 mM sodium pyruvate, 25 mM Hepes, 5x10
-2 
mM -
mercaptoethanol, 100 U.ml
-1 
penicillin, 100 g.ml
-1
 streptomycin and 10% FCS. Cervical 
superficial, illiary, axillary, brachial, inguinal, superior mesenteric and popliteal LN were extracted 
together with whole spleen and liver. Individual portions of the spleen and liver of each animal was 
separated and maintained in Schneider‘s 10% FCS for parasite detection. LN and the remaining 
spleen samples were processed and pooled according to infected and non-infected animal group in 
order to further achieve optimal lymphocyte concentration for use in follow-up immunological 
assays. 
 
1.4. Parasite detection 
 
Parasite burden in the spleen and liver was determined by limiting dilution assay (LDA) (Rodrigues 
et al., 2009). This method estimates the number of viable parasites within an infected organ by 
using geometrical dilutions of homogenized organ and detecting live viable promastigotes through 
light microscopy. After, aseptic collection, spleen and liver were weighed and homogenized 
individually in a known volume of Schneider 10% FCS (1.5 ml and 3.5 ml, respectively). The 
homogenized organ suspensions were diluted 1:2 for spleen and 1:30 for liver, and an initial 
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suspension volume of 200 l was placed into the first four wells (quadruplicates of each sample) 
and four-fold serial dilutions (50 l suspension + 150 l medium) of the infected tissues were 
distributed in 96-multiwell plates (Nunc, Germany). After 10-15 days at +24ºC, a sample of each 
well was examined by light microscopy and defined as positive or negative depending on the 
presence or absence of promastigotes in the well. The final titre was set as the highest dilution for 
which the well contained at least one parasite and the number of parasites per gram of 
homogenized organ was calculated as follows: (Reciprocal titer of the last positive well per total 
volume of homogenized organ x dilution factor) divided by the weight (gram) of the homogenized 
organ. The viable parasitic load (VPL) was expressed as the number of Leishmania per gram of 
homogenized organ: 
 
VPL= (4)
last positive titre
 x volume of homogenized organ / 0.2 (ml)  x dilution factor                              
                                                      weight of homogenized organ (g) 
 
1.5. Phenotypic characterization of regulatory T cells 
 
The identification of regulatory T cell subsets and the analysis of cell dynamics during L. infantum 
infection were carried out using a technology called flow cytometry. Immunophenotyping is one of 
the largest clinical and research applications of flow cytometry. Usually, immune cells such as 
lymphocytes are the main cells under study where the primary measurements are of fluorochrom-
conjugated antibodies bound to cellular receptors. A complex system of receptor identification has 
been developed within immunology using specific monoclonal antibodies (Ab) able to recognize 
surface cell markers, which are referred to as Cluster of Differentiation (CD) antigens of which at 
the time of writing and for human cells there are 320 such classifications. By conjugating 
fluorescent molecules to antibodies that recognize specific receptors, a population of cells binding 
that antibody and therefore that fluorescent molecule can be identified and level of expression 
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quantified by flow cytometry.  
 
1.5.1. Isolation of total leukocytes 
 
After collection, LN were placed in ice-cold RPMI 10% FCS. Fatty tissues in suspension were 
discarded and LN transferred to cold medium and gently macerated with a syringe knob through a 
sterilized plastic strainer onto a Petri dish. The released cell suspension was aspirated and gently 
resuspended several times through sterilized nylon mesh (Cadisch, UK).  The suspension was 
washed three times, by centrifuging (10‘, 300 g, +4ºC) until no cloudy supernatant (fatty 
aggregates) were visible and resuspended in RPMI 10% FCS for cell separation. Cell numbers and 
viability were assessed by Trypan blue (Sigma) exclusion. 
Spleens were firstly disrupted through a stainless steel sieve in cold Hanks balanced salt solution 
(HBSS) (Sigma) 10% FCS. After one centrifugation (10‘, 300 g, +4ºC), the pellet was resuspended 
in incomplete RPMI and gently layered onto Ficoll gradient density solution (Biochrom AG, UK) 
(2 ml of homogenized organ per 4 ml of separating solution). The mixed suspension was then 
centrifuged (20‘, 925 g, +20ºC). Differential migration during centrifugation results in the 
formation of layers containing different cell types. The bottom layer contains erythrocytes which 
are aggregated by the Ficoll and, therefore, sediment completely through the Ficoll. The layer 
immediately above the erythrocyte layer contains mostly granulocytes which at the osmotic 
pressure of the Ficoll solution attain a density great enough to migrate through it. Because of their 
lower density, the lymphocytes are found at the interface between the plasma and the Ficoll with 
other slowly sedimenting particles (platelets and monocytes). The lymphocytes were then 
recovered from the interface and subjected to three washing steps (5‘, 300 g, +4ºC) with 
incomplete HBSS to remove any contaminating platelets, plasma proteins and excess Ficoll. Cell 
numbers and viability were assessed by Trypan blue exclusion. 
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1.5.2. Flow cytometry - basic concepts 
 
The essential principle of flow cytometry is that single particles or cells suspended within a stream 
of liquid are interrogated individually in a very short time as they pass at high speed through a light 
source focused at a very small region defined as the interrogation point. The optical signals 
generated are mostly spectral bands of light in the visible spectrum, which represent the detection 
of various chemical or biological components, mostly fluorescence. Flow cytometry is defined by 
the measurement of multiple physical and chemical characteristics of particles or cells. By 
analyzing single particles/cells in flow, it is possible to separate them into populations based upon a 
group of variables that can be measured on each particle/cell. These populations can be separated 
electronically and identified using multivariate data analysis techniques.  
The most common detection system in flow cytometry uses fluorescent molecules that are attached 
by one means or another to the particle of interest. If the particle is a cell, such as a white blood 
cell, for example, the fluorescent probe might be membrane bound, cytoplasmic, or attached to 
nuclear material. Monoclonal or polyclonal antibodies that recognize specific receptors on cells are 
commonly used for this purpose. By conjugating fluorescent molecules to these antibodies, it is 
possible to monitor both the location and number of these conjugated antibodies as they bind to cell 
receptors (Figure 6).   
                                                     
 
 
Figure 6. Fluorophore-labeled antibody binding to specific molecule on the cell surface or inside the cell. 
Intensity of fluorescence detected depends on the number of specific receptors for each fluorophore-labeled 
antibody (http://www.invitrogen.com/site/us/en/home/support/Tutorials.html).  
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Basically flow cytometry studies cell properties in terms of light scattering and fluorescence. 
Forward scatter (FSC), or low-angle light scatter, is the amount of light that is refracted or scattered 
in the forward direction as the laser light source strikes the cell (Figure 7).  The light is then 
quantified by a detector that converts intensity into voltage and the latter into a numerical value. 
The magnitude of the voltage pulse recorded for each cell is proportional to the cell size.  
 
 
 
 
 
Figure 7. Forward scatter (FSC) of light generated at forward low angle as the cell passes through the laser is 
proportional to cell size. 
 
 
 
 
 
 
Figure 8. Side scatter (SSC) light generated at large angles as the cell passes through the laser  is proportional 
to granularity and internal structural complexity of the cell. 
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Light scattering at larger angles for example to the side is caused by granularity and structural 
complexity inside the cell. This side-scattered light (SSC) is collected at a separate detector, usually 
located 90º from the laser‘s path. The signals collected by the FSC and SSC detectors can be 
plotted individually on a one-dimensional histogram or two-dimensional histogram that‘s gives 
information on both cell size and internal cell complexity (Figure 8).  
Fluorescence is the third parameter used to study cellular characteristics. When laser light of the 
right wavelength strikes the fluorophore-labeled antibodies that have been used to mark a cell 
population, a fluorescent signal is emitted and detected along the same path as the side scatter 
signal. Fluorescence data is collected in generally the same way as FSC and SSC data. Multiple 
fluorescence parameters can be used simultaneously in order to be able to detect multiple 
characteristics within a single cell population. The analysis of fluorescence data in addition to that 
generated by FSC and SSC, is what is defined in flow cytometry as multiparametric analysis. 
 
Figure 9. Fluorescence signals (FL) generated as the cells labeled with fluorophore-antibodes passes through 
the laser.   
 
As mentioned above, data collected can be graphically represented by histograms or dot plots. 
Histograms present only one-dimensional data and show the number of cells or events according to 
cell distribution to the parameter of choice. A dot plot presents two-dimensional data where two 
Detector FL/SSC 
Laser 
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parameters can be studied at once in a single cell population. Each dot on the dot plot represents a 
cell, and each cell has been associated with all of the scatter and fluorescence data collected at the 
time it passed through the interrogation point. By directing the analysis software to consider only a 
certain population of interest, a region or gate can be drawn around different populations and 
selected for restricted analysis, excluding all cells outside the gate (Figure 10).  
Data analysis on a two parameter dot plot allows the distinction of four populations. Dividing the 
dot plot into four quadrants, cells with positive fluorescence for both parameters are double 
positive and appear in the upper right quadrant. Cells positive for only one of the parameters appear 
either in the upper left or lower right quadrants and double negative cells in the lower left quadrant 
(Figure 11).     
 
 
 
 
 
 
 
 
 
 
Figure 10. A dot plot representing two-dimensional data, forward and side scatter, is able to 
distinguish several cells subsets within in a single cell population.  
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Figure 11. A two parameter dot plot orange and green fluorescences and the distinction of four different sub-
populations. 
 
If the fluorescence emission profiles for each different individual fluorophore used in an assay 
overlap, it becomes very difficult to identify which fluorophore is the real emitter of fluorescence 
for the cell population of interest. To achieve this, it is necessary to perform spectral compensation 
whereby a percentage of signal from one detector is subtracted from the other in order to correct for 
spectral overlap. Depending on the instrument and software used, compensation is set in the 
instrument hardware before the sample is run or within the software after data collection.   
  
1.5.3. Cell preparation and surface staining 
 
 
CD4
+
 T pre-enriched cell fractions were centrifuged (5‘, 300 g, +4ºC) and re-suspended with PBS, 
2% FCS, 0.01% NaN3 at 10
6
 cells ml
−1
. Aliquots of 5x10
5
 cells were incubated in the dark (30‘, 
+4ºC) with 20 l of the following fluorochrom-conjugated anti-mouse Ab: Ab FITC-labeled anti-
CD3 (clone 145-2C11), PerCp-labeled anti-CD4 (clone RM4-5), PE-labeled anti-CD25 (clone 
PC61.5), FITC-labeled anti-CD103 (clone M290), FITC-labeled anti-CD45RB (clone 16A), FITC-
labeled anti-GITR/TNFRSF18 (clone 108619), (BD Pharmingen, USA). The antibodies used were 
titrated for optimal performance and concentration where a set of serial antibody dilutions (1:2) is 
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used for a constant volume and number of cells. As the cells are stained with increasingly diluted 
concentrations of antibody, the intensity of fluorescence decreases. The ratio of the mean 
fluorescence of the positive cells by the negative cells was calculated and defined as the signal-to-
noise ratio (S/N) and plotted as a function of the dilution to produce an inverted parabolic shaped 
curve whose zenith is the ideal titre. For discrete populations this concentration produces the best 
distinction between positive and negative cells.  For heterogeneous populations, the titre is 
determined as the titre point where saturation has occurred. Optimal dilutions are shown in Table 2. 
 
Table 2.  Fluorophore-labeled antibodies used for immunophenotyping of cell populations.  
Anti-mouse Final
monoclonal Antigen Specificity concentration Dilution
antibody ( g.ml
-1
) (v:v)
Anti - CD3 - FITC T-cell receptor-associated CD3 Mature T cells 5 1:100
complex
Anti – CD4 - PerCP L3T4 differentiation antigen MHC class II-restricted T cells 0.5 1:400
including Th cells and Treg
Anti – CD25 - PE IL-2 receptor  chain, p55 Early T cell activation 1 1:200
Anti – CD103 - FITC α chain of αIELβ7 integrin Peripheral T cell interaction with 1 1:100
epithelia
Anti – CD45RB -FITC Exon B-dependent epitope of  Activation of  naïve cells into  1.25 1:400
CD45 glycoprotein memory cells express low levels
Anti – GITR - FITC TNFRSF18 glycoprotein Activated T, B cells, co-stimulatory 2.5 1:20
receptor on Treg  
 
To characterize regulatory T cell populations, various T cell subsets were detected with 3-color 
combinations of fluorochrom-conjugated Ab directed towards antigens of interest as follows: 
- CD4-PerCP / CD25-PE / CD3-FITC 
- CD4-PerCP / CD25-PE / CD45RB-FITC 
- CD4-PerCP / CD25-PE / CD103-FITC 
- CD4-PerCP / CD25-PE / GITR-FITC 
Materials and Methods                                                                                                                          . 
 62 
Cells were washed with PBS and then fixed (20‘, +4ºC) with 2% paraformaldehyde in the dark 
(20‘, +4ºC), then washed again and resuspended in 200 l of  PBS, 2% FCS, 0.01% NaN3  and kept 
in dark at +4ºC until analyzed by flow cytometry. Compensation was set for every different 
combination of fluorophores used in each assay. Data acquisition was performed on a 
FACSCalibur flow cytometer and analyzed using BD FACSDiva Software (BD Biosciences, 
USA). 
 
1.6. Cytokine in vitro assay of CD4+CD25+ and CD4+CD25- T cells  
 
CD4
+
CD25
+
 and CD4
+
CD25
-
 T cell populations were isolated by magnetic cell separation and  
cultured in RPMI 10% FCS. 10
5
 cells per 150 l per well were cultured in U-bottom 96-well plates 
and incubated (72h, 5% CO2)  under different conditions, 50 l of: (1) complete medium; (2) equal 
numbers of antigen-presenting cells (APC); (3) soluble crude Leishmania antigen (Ag); (4) APC 
and Ag (10 g.ml
-1
); (5) APC and soluble anti-CD3  Ab (1 g.ml
-1
) (BD Biosciences) and (6) 
APC, anti-CD3  and Ag, and (7) L. infantum infected APC and anti-CD3  at a ratio of 1 
lymphocyte per 1 APC.  
 
1.6.1. CD4+CD25+ and CD4+CD25- T cell isolation 
 
CD4
+
 T cells were subsequently pre-enriched from pooled lymphocytes from spleen and LN. Total 
CD4
+
 T cells were purified by using the CD4
+
 T Cell Isolation Kit (Miltenyi Biotec, Germany). 
Mouse CD4
+ 
T cells were isolated by depletion of non-CD4
+
 T cells (negative selection). Non-
CD4
+
 T cells were magnetically labeled with a cocktail of biotin-conjugated monoclonal antibodies 
(Ab), as primary labeling reagent, and anti-biotin monoclonal Ab conjugated to microbeads, as 
secondary labeling reagent. The magnetically labeled non-CD4
+
 T cells were depleted by retaining 
them on the MACS® column (Miltenyi Biotec) in the magnetic field of a MACS Separator 
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(Miltenyi Biotec), while the unlabeled CD4
+
 T cells passed through the column.  
Briefly, the lymphocyte suspensions were resuspended in ice cold degassed PBS buffer, pH 7.2, 
containing no Ca
2+
 or Mg
2+
, supplemented with 0.5% bovine serum albumin (Boehringer 
Mannheim, Germany) and 2 mM EDTA and passed through pre-separation filters with 30 μm 
nylon mesh to remove cell aggregates. Cells were centrifuged (10‘, 300 g, +4ºC), the supernatant 
completely pipetted off and the pellet resuspended in 40 μl buffer per 107 total cells. 10 μl of 
biotin-antibody cocktail was added per 10
7
 total cells and left to incubate (25‘, +4ºC) in the dark. 
30 μl of PBS 0.5% BSA, EDTA buffer and 10 ml of anti-biotin microbeads cocktail per 107 total 
cells were then added and cells left to incubate (25‘, +4ºC). Cells were washed by adding 10-20 X 
labeling volume of buffer and centrifuged (10‘, 300 g, +4ºC). The pellet was then resuspended in 
500 μl buffer per 108 cells and passed through the LS+ column in the magnetic field of the MACS 
separator. The effluent, the negative unlabeled fraction representing the enriched CD4
+
 T cells, was 
collected and then used for flow cytometry analysis and further CD4
+
CD25
+
 and CD4
+
CD25
-
 T cell 
separation. Cells retained in the column, the magnetically labelled (non-CD4
+
 T cell) fraction were 
eluted by removing the column from the magnetic field of the MACS separator. Cell purity which 
was determined by flow cytometry was > 95% for separated CD4
+
 T cell populations. 
The CD4
+
 T cell-enriched fraction was centrifuged (10‘, 300 g, +4ºC), the supernatant discarded 
and the pellet resuspended in 100 μl PBS 0.5% BSA, EDTA buffer per 107 total cells. Cells were 
stained with 20 μl of phycoerythrin (PE) -anti-CD25 Ab (BD Pharmingen) per 107 total cells and 
left to incubate 15‘, +4ºC on ice and in the dark and then washed with 2 ml buffer per 107 total cells 
and centrifuged (10‘, 300 g, +4ºC). The pellet resuspended in 100 μl buffer per 107 total cells. 10 μl 
of anti-PE-microbeads (Miltenyi Biotec) per 10
7
 total cells was added and the cells left to incubate 
(15‘, +4ºC). The pellet was then resuspended in 500 μl buffer per 108 cells and passed through the 
MS
+
 column in magnetic field of the MACS separator. The effluent, the negative unlabeled fraction 
representing the enriched CD4
+
CD25
-
 T cells, was collected. Cells retained in the column, the 
magnetically labelled (CD4
+
CD25
+
 T cell) fraction were eluted.  Cell purities which were 
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determined by flow cytometry were approximately ~ 80% and 96% for CD4
+
CD25
+
 and 
CD4
+
CD25
-
 subsets, respectively. CD4
+
CD25
+
 and CD4
+
CD25
-
 subsets were then used for in vitro 
cytokine assaying and gene expression analysis.  
 
1.6.2. APC Preparation  
 
APC were obtained from spleen and LN of syngeneic naïve mice. Non-CD4
+
 T cell fractions, 
containing CD4
 
negative T cells and CD4
 
negative non-T cells including antigen-presenting cells 
such as dendritic cells, macrophages and B cells (Xu et al., 2003) were obtained through positive 
selection using the CD4
+
 T cell isolation kit (see section 1.6.1.). APC were treated with 1 mg.ml
-1
 
of mitomycin C (Sigma) and incubated (~120‘, +37ºC, 5% CO2). Mitomycin C inhibits DNA 
synthesis and consequently unable cells to proliferate but they can still function as APC and induce 
T cell proliferation.  APC were then washed three times with RPMI 10% FCS before culture.  
 
1.6.3. Detection of in vitro cytokine production 
 
Cytokines were determined in supernatants collected from co-cultures of CD4
+
 T cells subsets. 
IFN-  and IL-4 levels by effector CD4
+
CD25
-
 T cells and IL-10 and TGF-  by regulatory 
CD4
+
CD25
+
 T cells were determined by enzyme–linked immunosorbant assay (ELISA). The 
sandwich ELISA or double antibody technique begins with an antibody bound to a solid phase 
support. An unknown amount of the antigen from a sample to be measured is added to the well. At 
the same time, serial dilutions of known amounts of purified recombinant antigen are added so as 
to construct a standard curve. An enzyme conjugate is then added to the well with bound antigen-
antibody or immune complexes. A substrate is added to the enzyme conjugate which is bound to 
the immune complex. In the presence of the enzyme conjugate bound to the immune complex, the 
substrate is converted into a detectable signal that will show as a positive test or color change.  
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ELISA assays for all cytokines were performed using ELISA sets (BD Biosciences). Briefly, 100 
μl per well of diluted capture monoclonal Ab were added to a 96-well plate and incubated 
(overnight, +4°C). Unbound Ab was aspirated and the wells washed 3X with PBS 0.05% Tween-20 
(Sigma-Aldrich, USA). To avoid non-specific binding, the reaction was blocked with 200 μl per 
well of assay diluent (PBS, FCS, 10%, pH 7), incubated (1h) and later aspirated and washed once 
again three times. 100 μl of standard recombinant protein or of the sample to be measured were 
then added to each well and incubated (2h) and later aspirated and washed five times. 100 μl of 
working detector, containing the detection biotinylated monoclonal Ab and streptavidin-
horseradish peroxidase conjugate (SAv-HRP) was added to each well and left to incubate (60‘), 
aspirated and washed seven times (30‘‘- 1‘ soaks).  The substrate solution (100 μl, 
tetramethylbenzidine) was added to each well, and the plate was left to incubate (30‘) in the dark. 
Finally 50 μl of the stop solution (1 M H3PO4) was distributed to each well and the absorbance read 
at 450 nm within 30‘ on a microplate ELISA reader (Titer Multiskan Plus MK II; Labsystems, 
USA). The limit of detection of the recombinant cytokines are listed in Table 3. 
 
Table 3.  Concentrations of recombinant proteins used for standard dilutions of each cytokine detected by 
ELISA. 
Cytokine 
 
Limit of Detection 
(pg.ml
-1
) 
 
IFN  2000   – 31.3 
IL-4 500   – 7.8 
IL-10 2000   – 31.3 
TGF-  4000 – 62.5 
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1.7.   Gene expression analysis of Treg selective marker – Foxp3 
 
Expression of the transcription factor Foxp3 (forkhead box P3) has been implicated as a key 
element for CD4
+
CD25
+ 
T regulatory cell function in mice (Hori et al., 2003). In order to determine 
whether foxp3 gene expression is confined or not to CD4
+
CD25
+
 T cells with a regulatory 
phenotype during L. infantum infection, CD4
+
CD25
+
 and CD25
-
 cell fractions were analyzed ex 
vivo for foxp3 mRNA expression. 
 
1.7.1.   RNA extraction and reverse transcriptase reaction 
 
Total RNA was extracted from separated CD4
+
CD25
+
 and CD25
- 
cell populations by using the 
RNeasy Mini kit (Qiagen, Germany) according to the manufacturer‘s recommendations. This 
method combines the selective binding properties of a silica-based membrane with the speed of 
microspin technology. A specialized high-salt buffer system allows up to 100 μg of RNA longer 
than 200 bases to bind to the RNeasy silica membrane. Biological samples are first lysed and 
homogenized in the presence of a highly denaturing guanidine-thiocyanate–containing buffer, 
which immediately inactivates RNases to ensure purification of intact RNA. A DNase treatment 
follows to ensure removal of any DNA contamination. Ethanol is added to provide appropriate 
binding conditions, and the sample is then applied to an RNeasy Mini spin column, where the total 
RNA binds to the membrane and contaminants are efficiently washed away. High-quality RNA is 
then eluted in 40 μl water.  
RNA samples were then denatured for 5‘ at  +65ºC before being reverse transcribed into cDNA 
using 200U M-MLV RT (Promega), at +37ºC for 60‘ in the presence of 3 mM 5X M-MLV RT 
buffer (250 mM Tris-HCl, pH 8.3, 375 mM KCl and 15 mM MgCl2) (Promega, USA), 10 mM 
BSA (Boehringer Mannheim), 0.5 mM dNTPs (Life technologies, Gibco Brl), 40U rRNAsin 
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ribonuclease inhibitor and 0.1 g of Oligo (dT)15 (Promega) per 1 g of RNA. The samples were 
then heated 5‘ at +95ºC for RT inactivation cooled and stored at -20ºC. 
 
1.7.2.   Molecular cloning of foxp3  
 
In order to obtain large quantities of stock foxp3 for absolute quantitation of target DNA, foxp3 
gene was cloned using PCR fragments generated by a selected pair of primers, into a pGEM-T 
Easy Vector cloning system (Promega). The recombinant plasmid containing the sequence of 
interest was used to transform E. coli competent cells, extracted and purified for construction of 
standard curves and quantification of foxp3 mRNA expression by real-time PCR.  
 
1.7.2.1.   PCR of foxp3 gene 
 
The foxp3 primer sequences were described by Zelenay, (2005) and PCR conditions further 
adapted and optimized (Table 4). For the PCR reaction, a final concentration of 0.3 M was used 
for sense and anti-sense primers, 1.5 M of MgCl2, (Bioline, Germany), 0.2 mM of dNTPs 
(Bioline) and 0.04 U. l
-1
of Taq polymerase (Bioline) with A-tailing activity that optimizes cloning 
efficiency.  PCR amplification of foxp3 used the following conditions: initial denaturation for 4‘ at 
+94ºC, followed by a total of 35 cycles (thermal profile for each cycle: 30‘‘at +94ºC, 30‘‘ at 
+61ºC, 30‘‘ at +72ºC).  
Correction for inefficiencies in RNA input of reverse transcriptase reaction was performed by 
normalization to a ―housekeeping gene‖. An ideal ―housekeeping‖ gene should be expressed at a 
constant level among different tissues of an organism, at all stages of development, and should not 
be affected by the experimental treatment itself. A commonly used endogenous control gene was 
selected for this purpose; hypoxanthine guanine phosphoribosyl transferase (HPRT). The sense 
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and anti-sense primer sequences (Table 4) were designed on Primer Express software (Perkin-
Elmer/Applied Biosystems) (Rosa et al., 2005; Rodrigues et al., 2006). For the PCR reaction, a 
final concentration of 0.4 M was used for sense and anti-sense primers, 2.5 M of MgCl2, 0.25 
mM of dNTPs and 0.01 U. l
-1
of Taq DNA polymerase. PCR amplification of hprt used the 
following conditions: initial denaturation for 5‘ at 94ºC, followed by a total of 30 cycles (thermal 
profile for each cycle: 20‘‘at +94ºC, 30‘‘ at +59ºC, 30‘ at +72ºC). 
 
Table 4. Primer sense and anti-sense sequences for housekeeping genes hypoxanthine guanine 
phosphoribiosyl transferase (HPRT) and Foxp3.  
 
Target genes Nucleotide Sequences 
 
 
Size of PCR product  
(nº base pairs) 
 
HPRT – Sense primer 5’- GCTCGAGATGTCATGAAGGAGAT - 3’ 
91 
HPRT – Anti-sense primer 5’- CCAGCAGGTCAGCAAAGAACT - 3’ 
FOXP3 – Sense primer 5’- TTCATGCATCAGCTCTCCACT – 3’ 
100 
FOXP3– Anti-sense primer 5’- AAGGTGGTGGGAGGCTGA - 3’ 
 
1.7.2.2.   Transformation of E. coli with recombinant plasmid DNA 
 
Recombinant plasmid DNA was obtained by cloning PCR products of target genes in the pGEM -
T Easy Vector cloning system (Promega). Linearized pGEM -T Easy vector contains 3‘ terminal 
thymidine nucleotides to both ends. These single 3‘-T overhangs promote the ligation with PCR 
fragments through binding to the 3´-A overhangs added previously by the Taq DNA polymerase 
during PCR reaction. The insert:vector  ratio was optimized to 9:1 and the amount of insert needed 
for the ligation reaction calculated according to the following formula: 
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ng insert = ng vector x  kb size of insert  x  insert : vector molar ratio  
kb size of vector 
Briefly, for every standard reaction, 5 l of 2X Ligation buffer, T4 DNA Ligase, 1 l of pGEM -T 
Easy vector, 1 l of T4 Ligase (3 Weiss units/ l) were added to the appropriate volume of PCR 
product insert (corresponding to the quantity calculated above) to obtain a final volume of 10 l per 
reaction and incubated overnight at +4ºC.  
E. coli JM109 efficiency competent cells were transformed by adding 50 l of bacterial suspension 
to 2 l of the ligation reaction and incubated for 20‘ on ice. Cells were heat-shocked for 45‘‘-50‘‘ 
at exactly 42ºC and immediately returned to ice for 2‘. Highly enriched medium (950 l SOC) 
(Promega) was added to the ligation reaction transformations and incubated 90‘, at +37ºC with 
shaking (150 rotations per minute). 100 l of each transformation culture was plated overnight at 
+37ºC onto duplicate Luria broth (Lennox, Scharlau Microbiology, Spain) containing 100 g.ml
-1
 
amplicillin (Sigma), 0.5 mM  isopropyl-beta-D-thiogalactopyranoside (IPTG) (Sigma) and 80 
g.ml
-1
  5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-Gal) (Sigma) for colour screening 
and further selection of recombinant clones containing the PCR product.  These colonies are in 
most cases white as a consequence of the interruption of the coding sequence of -galactosidase 
gene when the PCR product is correctly cloned in-frame with the lacZ gene within the cloning 
region of the pGEM -T Easy vector.     
 
1.7.2.3.   Plasmid DNA extraction and restriction analysis 
 
Plasmid DNA was extracted from bacteria by using the High Pure Plasmid Purification kit (Roche 
Applied Science, Switzerland) according to the manufacturer‘s recommendations. Alkaline lysis 
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releases plasmid DNA from bacteria and RNases removes all RNA in the lysate. Then, in the 
presence of a chaotropic salt (guanidine HCl), plasmid DNA binds selectively to glass fiber fleece 
in a special centrifuge tube. The DNA remains bound while a series of rapid ―wash-and-spin‖ steps 
remove contaminating bacterial components. Finally, low salt elution removes the DNA from the 
glass fiber fleece.  
In order to confirm the presence of the target sequence within the purified recombinant DNA 
plasmids, the latter were subject to restriction analysis by using restriction enzymes that cuts at 
specific sites of the pGEM -T Easy vector generating a known number of fragments with specific 
expected sizes. Recombinant plasmid DNA (4 l) was incubated 120‘ in a water bath +37ºC with 1 
l of Nci I  (MB Fermentas, Germany), 1 l of 10X Tango
TM 
buffer and 4 l of distilled water. The 
restriction fragments obtained (10 l) were run 90‘, 120 mV on a 1% agarose gel stained with 
ethidium bromide (EtOH) to confirm for the presence of insert within the plasmid nucleotide 
sequence. Normal PCR reaction, using conditions described in section 1.7.2.1., was also carried out 
for foxp3 and hrpt using recombinant plasmid DNA as PCR template for mouse genes. PCR bands 
reconfirming presence of PCR product in question were run on a 3% agarose gel for 90‘ at 120 
mV.  
 
1.7.3.   Real-time PCR assay 
 
A reliable quantification of cytokine gene expression is a valuable technique for analyzing 
immune responses. The study of cytokine profiles can help to clarify functional properties of 
immune cells and inflamed tissues both for research and for clinical diagnosis. Real-time PCR 
offers a powerful tool for the quantitation of target nucleic acids (Holland et al., 1991, Higuchi et 
al., 1992). Being a very high throughput technique that is both accurate and sensitive enough, real-
time PCR can be performed on very small samples with low levels of gene expression. It monitors 
the progress of the PCR as it occurs (i.e., in real time) and reactions are characterized by the point 
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in time during cycling when amplification of a target is first detected rather than when the amount 
of target accumulates after a fixed number of cycles (e.g. end-point PCR assay).  
Figure 13. shows a graphical display of fluorescence signal versus cycle number. In the initial 
cycles of PCR, there is no significant change in fluorescence signal. This predefined range of PCR 
cycles is called the ―baseline‖. A baseline subtracted amplification plot is generated by calculating 
a mathematical trend using fluorescence values (Rn) corresponding to the baseline cycles of 
amplification. Then, an algorithm searches for the point on the amplification plot at which the 
delta Rn value crosses the threshold, the level set above the baseline and sufficiently low to be in 
the exponential growth region of the amplification curve. The fractional cycle at which the 
fluorescence passes the threshold is defined as CT. 
One of the applications of this technology is quantitative real-time PCR using SYBR Green - a 
highly specific, double-stranded DNA (dsDNA) binding dye used to detect PCR product as it 
accumulates during PCR cycles. This method enables simple and rapid measurement of PCR 
product accumulation during the exponential reaction phase combining amplification and 
detection in one single step. It also obviates the need for expensive hybridization probes. SYBR 
Green dye binds to all dsDNA, the result is an increase in fluorescence intensity proportional to 
the amount of PCR product produced. 
The advantages of the SYBR Green dye is that it can be used to monitor the amplification of any 
dsDNA sequence, no probe is required, which reduces assay setup and running costs and due to 
multiple dye binding the fluorescent signals produced are much stronger which increases 
sensitivity. SYBR Green dye provides a convenient and cost effective technique to screen a large 
number of samples and targets. The primary disadvantage is that it may generate false positive 
signals; i.e., because the SYBR Green dye binds to any dsDNA, it can also bind to non-specific 
dsDNA sequences. To circumvent this, RNA samples were pre-treated, prior to cDNA synthesis, 
with DNase to eliminate any contaminating DNA. DNA melting curves of post-PCR of product 
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were analyzed individually for non-specific amplification with distinct melting profiles curves to 
those of the target product and for the formation of primer-dimers.  dUTP replacement of dTTP in 
SYBR Green PCR Master mixes and enzyme treatment with AmpErase UNG, that eliminates 
dUTP, prevents re-amplification of PCR carry-over products in SYBR Green assays.  
 
Figure 13. PCR amplification plot. Fluorescence emission is measured continuously during the PCR reaction 
and Rn (increase in fluorescence emission, from which the background fluorescence signal is subtracted) is 
plotted against cycle number. The standard deviation is determined from the data points collected from the 
base line of the amplification plot. The threshold cycle (Ct) is the cycle at which the fluorescence exceeds a 
chosen threshold limit (usually 10 times the standard deviation of the base line) (adapted from:    
http://www3.appliedbiosystems.com/cms/groups/mcb_marketing/documents/generaldocuments/cms_04144
0.pdf).  
 
In this study, absolute quantification was performed to determine levels of gene expression. 
Absolute quantification determines the input copy number of the template of interest by relating the 
PCR signal to a standard curve. In order to measure the cytokine copy number in unknown 
samples, the measurement to a standard curve of known cytokine copy numbers is used as 
comparison. The basis for measurement is a standard curve with known quantities of plasmid 
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cytokine DNA generated as described in section 1.7.2.2.  The corresponding copy numbers were 
calculated according to the following equation (Hein et al., 2001):  
Copy number = 9.1 x 10
11
 [ g of plasmid standard/size (plasmid + insert) in kb]  
The DNA content of each sample was determined using a standard curve obtained by processing, in 
parallel, samples containing fixed DNA concentrations. Determination of DNA concentrations was 
performed by spectrophotometry, and molar concentrations were determined using the following 
formula: 1 µg of 1,000 bp DNA = 1.52 pmol = 1.52 x 10
–12 
mol x N molecules (where N stands for 
Avogadro's number or 6.023 x 10
23
 molecules / mol). Serial dilutions from the resulting clones 
were used as standard curves, each containing a known amount of input copy number. Final results 
were expressed as the copy number of each cytokine per 1000 copies of hprt. 
Amplification was carried out in a total volume of 20 l, containing 2 l of cDNA sample or 
plasmid DNA standards, 10 l of 2X SYBR
 
Green I dye PCR Master Mix (Applied Biosystems, 
USA) and foxp3 primers (0.2 M). PCR amplification was performed in the ABI GeneAmp 5700 
(Perkin-Elmer/Applied Biosystems), in duplicate wells, using the following conditions for foxp3: 
15‘ at 95ºC for AmpliTaq Gold activation, followed by a total of 45 cycles (thermal profile for 
each cycle: 15‘‘ at +95ºC, 20‘‘ at +61ºC, 10‘‘ at +72ºC) and for hprt (0.3 M): 10‘ at +95ºC 
followed by 40 cycles (15‘‘at +95ºC, 1‘ at +60ºC). 
PCR amplification efficiency is the rate at which a PCR amplicon is generated and is expressed as 
a percentage value. If a particular PCR amplicon doubles in quantity during the geometric phase of 
its PCR amplification then the PCR assay has 100% efficiency. The slope of the standard curve is 
used to estimate the PCR amplification efficiency of a real-time PCR reaction. A real-time PCR 
standard curve is graphically represented as a semi-log regression line plot of CT value vs. log of 
input nucleic acid (Figure 14). A standard curve slope of –3.32 indicates a PCR reaction with 
100% efficiency. A calculation for estimating the efficiency (E) of a real-time PCR assay is: 
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E = (10 
–1/slope
 –1) × 100 
 
(A) 
 
 
(B) 
       
 
Figure 14. Quantitative analysis of gene expression by real-time PCR. (A) Amplification plots of standard 
curves from titration of recombinant plasmid DNA ranging from 1.5x10
8
 to 9.4x10
4
 copies of each target 
gene. (B) Amount of plasmid DNA used for the determination of gene expression was plotted against the 
mean Ct value. 
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Efficiencies of amplification for hprt and foxp3, were 93.1% and 97.8% respectively. Intra-assay 
coefficient of variation of copy numbers ranged from 0.12% – 1.64% for hprt and 0.12 – 2.02% 
for foxp3. Inter-assay coefficient of variation ranged from 1.8 – 5.6% for hprt, 1.2 – 3.5% for 
foxp3. 
 
1.8.    Gene expression analysis of Toll-like receptor-2 on CD4+CD25+ T cell subsets 
 
In order to detect the expression of Toll-like receptor-2 by CD4
+
CD25
+
 T cell subsets, real-time 
PCR was performed and samples evaluated for tlr2 mRNA expression. Gene expression analysis 
and molecular cloning of tlr2 was done using the same procedures as previously described for 
foxp3 in section 1.7.  
  
1.8.1.   PCR of tlr2 gene 
 
The tlr2 primer sequences were described by Sutmuller, (2006) and PCR conditions further 
adapted and optimized (Table 5). For the PCR reaction, a final concentration of 0.2 M was used 
for sense and anti-sense primers, 1.5 M of MgCl2, 0.2 mM of dNTPs and 0.04 U. l
-1
of Taq 
polymerase. PCR amplification of tlr2 used the following conditions: initial desnaturation for 5‘ at 
+94ºC, followed by a total of 30 cycles (thermal profile for each cycle: 20‘‘at +94ºC, 30‘‘ at 
+60ºC, 30‘‘ at +72ºC).  
 
1.8.2.   Real-time PCR assay 
 
Amplification was carried out in a total volume of 20 l, containing 2 l of cDNA sample or 
plasmid DNA standards, 10 l of 2X SYBR
 
Green dye PCR Master Mix and tlr2 primers (0.2 
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M). PCR amplification was performed in duplicate wells, using the following conditions for tlr2: 
10‘ at 95ºC for AmpliTaq Gold activation, followed by a total of 40 cycles (thermal profile for 
each cycle: 15‘‘ at +95ºC, 1‘ at +60ºC). Efficiencies of amplification for tlr2 were 99.4% and 
intra-assay and inter-assay coefficients of variation ranged from and 0.21 - 2.11% and 0.4 – 6.9%  
respectively. 
 
Table 5. Primer sense and anti-sense sequences for TLR-2.  
Target genes Nucleotide Sequences 
 
Size of PCR product of 
amplification 
  (nº base pairs) 
TLR2 – Sense primer 5’- AACCTCAGACAAAGCGTCAAATC - 3’ 
65 
TLR2 – Anti-sense primer 5’- ACCAAGATCCAGAAGAGCCAAA - 3’ 
 
 
2.   Evaluation of the effect of TLR-2 modulation on Treg populations 
during L. infantum in vivo infection 
 
The second part of the study involved the evaluation of the role of the pathogen pattern recognition 
receptor TLR2 on the modulation of regulatory T cells during in vivo L. infantum infection and its‘ 
effect on protective immune response and consequent control of infection. To investigate this, gene 
disrupted TLR2
-/-
 knock-out mice were infected with L. infantum parasites and compared to wild-
type mice regarding Treg kinetics, cytokine response, liver histopathology and evolution of parasite 
burden.  
 
2.1.   Experimental design 
 
Treg cell frequency and phenotype were separately studied in spleen cells, lymph node cells, and in 
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liver and spleen tissues isolated from L. infantum infected - TLR2
-/-
 knock-out mice on a C57BL/6 
genetic background and compared to C57BL/6 wild type (WT) mice. Parasite detection was carried 
out in spleen and liver organs. Two independent experiments were performed. 
 
2.2. Animals and parasites 
 
TLR2
-/-
 knock-out male mice, 12 to 14-week-old, obtained from S. Akira, University of Osaka, 
Japan, were bred in the IBMC animal facility and maintained at IHMT animal house. C57BL/6 
littermate mice were purchased at IBMC. Upon arrival, each mice strain was divided into two 
groups, control and infected. Sterilized commercial feed (SAFE Scientific animal food & 
engineering) and water were provided ad libitum and animals kept in HEPA filtered sterilized 
cages with weekly replacements.  Animals were infected via intravenous (i.v.) route with a parasite 
suspension of 10
7
 virulent L. infantum promastigotes prepared as described in section 1.2.2. All 
experiments were conducted according to EU requirements (86/609/CEE), recognized by the 
Portuguese law (DR DL129/92 and Portaria 1005/92).   
 
2.3.   Sample collection 
 
Four animals per each group were sacrificed by cervical dislocation at days 7 and 28 days pi. The 
organs were aseptically dissected from each individual animal and maintained at +4ºC in RPMI 
10% FCS. Cervical superficial, illiary, axillary, brachial, inguinal, superior mesenteric and 
popliteal LN were extracted together with whole spleen and liver. Portions of the spleen and liver 
tissues of each individual animal was separated and maintained either in Schneider‘s 10% FCS for 
parasite detection, in RNA stabilizing solution (Qiagen) for RNA extraction and in 3.7% buffered 
formaldehyde for histopathology. Samples were processed for use in follow-up immunological 
assays. 
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2.4. Parasite detection 
 
Parasite burden in the spleen and liver for each individual animal was determined by LDA as 
previously described in section 1.4. 
 
2.5. Phenotypic characterization 
 
Spleen cells of each animal were stained with the same surface markers as described in section 
1.5.3. although cells underwent intracellular staining for the FOXP3 proteins and prior fixation. 
 
 2.5.1. Isolation of total leukocytes 
 
Total leukocytes were isolated from LN and spleen from each individual animal according to 
section 1.5.1..  
 
2.5.2. Cell surface markers and intracellular staining of FOXP3 
 
For FOXP3 intracellular staining, the APC anti-mouse/rat FOXP3 Staining Set was used according 
to manufacturer‘s recommendations (eBioscience, USA). Briefly, 106 cells were re-suspended with 
PBS, 2% FCS, 0.01% NaN3. Aliquots of 10
6
 cells were incubated in the dark (20‘, +4ºC) with 20 l 
of the following fluorochrom-conjugated anti-mouse Ab: Ab FITC-labeled anti-CD3, PerCp-
labeled anti-CD4, PE-labeled anti-CD25, FITC-labeled anti-CD103, FITC-labeled anti-CD45RB, 
FITC-labeled anti-GITR/TNFRSF18. Cell were washed once in PBS, 2% FCS, 0.01% NaN3 by 
centrifuging (370 g, 5‘, +4ºC) and fixed in 250 l Fix/Perm solution (eBioscience) for FOXP3 
intranuclear staining for overnight at +4ºC. The cells were washed twice and resuspended in 250 l 
of Permeabilization buffer (eBioscience), blocked (to avoid non-specific antibody binding) with 50 
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l rat serum diluted 1:50 in 1X Permeabilization buffer for 30‘.  Without washing after blocking 
step, allophycocyanin (APC)-labeled conjugated anti-mouse/rat FOXP3 FJK-16s was used for 
staining. This antibody has specificity for FORKHEAD BOX P3 or SCURFIN, a 4955 kDa protein 
and member of the forkhead/winged helix family of transcriptional regulators and that was 
identified as the gene defective in ‗scurfy‘ (sf) mice. The Ab was diluted (1:100) in 1X 
Permeabilization buffer and 30 l added to suspension. The cell suspension were then incubated for 
30‗ at +4°C in the dark.  After washing twice in 250 l of 1X Permeabilization buffer, cells were 
resuspended in PBS, 2% FCS, 0.01% NaN3 and analyzed by flow cytometry.  
To characterize regulatory T cell populations, various T cell subsets were detected with 4-color 
combinations of fluorochrom-conjugated antibodies directed towards antigens of interest as 
follows: 
- CD4-PerCP / CD25-PE / CD3-FITC / FOXP3-APC 
- CD4-PerCP / CD25-PE / CD45RB-FITC / FOXP3-APC 
- CD4-PerCP / CD25-PE / CD103-FITC / FOXP3-APC 
- CD4-PerCP / CD25-PE / GITR-FITC / FOXP3-APC 
Compensation was set for every different combination of fluorophores used in each assay. Data 
acquisition was performed on a FACSCalibur flow cytometer and analyzed using BD FACSDiva 
Software.  
 
2.6. Detection of cytokine transcripts 
 
Immediate RNA stabilization of harvested LN and spleen cells, spleen and liver tissues was 
performed by immersing overnight at +4ºC in RNA later and frozen at -80ºC for further analysis 
of cytokines gene expression (IFN- , IL-4, IL-10 and TGF-  profiles. Gene expression analysis 
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and molecular cloning of cytokines were done using the same procedures as previously described 
in section 1.7. The sense and anti-sense primer sequences were designed on Primer Express 
software (Table 6). For the PCR reaction, a final concentration of 0.4 M was used for sense and 
anti-sense primers, 2.5 M of MgCl2, 0.25 mM of dNTPs and 0.01 U. l
-1
of Taq DNA polymerase. 
PCR amplification of IFN- , IL-4, IL-10 and TGF-  used the following conditions: initial 
denaturation for 5‘ at 94ºC, followed by a total of 30 cycles (thermal profile for each cycle: 20‘‘at 
+94ºC, 30‘‘ at +59ºC, 30‘‘ at +72ºC) (Rosa et al., 2005; Rodrigues et al., 2006). 
Real-time PCR assay was carried out using the same procedure as described for hprt in 1.7.3.. 
Efficiencies of amplification for IFN- , IL-4, IL-10, TGF-  were 99 %, 94 %, ~100 % and 98.6 % 
respectively. Intra-assay coefficient of variation ranged from 0.04 to 2.17 % for IFN- , 0.04 to 
1.79 %  for IL-4, 0.06  – 2.69 % for IL-10 and 0.04  – 5.94 % for TGF- Inter-assay coefficient of 
variation ranged from 0.4 to 1.33 % for IFN- , 0.15 to 1.49 % for IL-4, 1.7 – 6.5 % for IL-10 and 
1.0 – 4.5 % for TGF-
. 
Table 6. Primer sense and anti-sense sequences for cytokines IFN, IL-4, IL-10 and TGF- . 
Target genes Nucleotide Sequences 
 
 
Size of PCR product  
(nº base pairs) 
 
IFN-  – Sense primer 5’- CAATGAACGCTACACACTGCATC - 3’ 
72 
IFN-   – Anti-sense primer 5’- CGTGGCAGTAACAGCCAGAA  - 3’ 
IL-4 – Sense primer 5’- GACGCCATGCACGGAGAT – 3’ 
81 
IL-4 – Anti-sense primer 5’- GCCCTACAGACGAGCTCACTCT - 3’ 
IL-10 – Sense primer 5’- CAAGGCAGCCTTGCAGAAA  - 3’ 
71 
IL-10 – Anti-sense primer 5’- CAGTAAGAGCAGGCAGCATAGC - 3’ 
TGF-  – Sense primer 5’- CACCTGCAAGACCATCGACAT - 3’ 
71 
TGF-  – Anti-sense primer 5’- ACAGGATCTGGCCACGGAT  - 3’ 
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2.7.   Histopathology 
 
The host tissue response in terms of immunopathology was assessed by analyzing the 
granulomatous response in the liver. Liver inflammation was evaluated by estimating the total 
number of infiltrating cells per square millimeter and the granuloma size in histological liver tissue 
sections.  
For tissue processing, the livers were removed, cut into small pieces, and immersed in fixative, 3.7 
– 4 % formaldehyde. The volume of fixative versus the volume of tissues was 10:1.  Dehydration 
was performed with increasing concentration of graded ethanol up to absolute alcohol. After 
dehydration, tissue specimens were cleared with xylene and embedded in paraffin. Tissue sections, 
5 to 6 m in thickness was prepared from the tissue blocks and mounted on standard glass slides.  
 
2.8.   H&E staining  
 
The distribution of inflammatory cell infiltrates were examined in slides of paraffin-embedded 
livers stained with hematoxylin and eosin. Glass slides with the tissue sections were immersed 10‘ 
in xylene to deparaffinated and hydrated in decreasing concentrations of graded ethanol (100%, 
96%, 70%), placed under running tap water for 2‘ and immersed in filtered Harris‘ hematoxilin 
(Sigma) for 10‘. Slides were then placed again under running tap water, 1% HCl (Sigma) added for 
a few seconds and washed with water for 10 min. Slides were then immersed in 1% Eosin Y (w/v) 
(Sigma) and washed. Dehydration was performed with increasing concentration of graded ethanol 
up to absolute alcohol. Slides were incubated 5‘, +65ºC, dried and mounted with resin embedding 
agent – Entellan (Sigma) and observed using light microscopy for granuloma formation. Size and 
number were expressed as the number of infiltrating cells per area (cm
2
). 
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3.   Statistical analysis 
 
The non-parametric Mann–Whitney U test was used to compare variables of two independent 
samples from infected and non-infected mice, TLR2
-/-
 and WT mice, in relation to all parameters 
studied and to compare the same variables between different time points. Results are represented as 
mean values  standard error (SEM) or mean values  standard deviation (SD) according to 
samples in each study.  Differences were considered significant with a 5% significance level 
(p<0.05). Statistical analysis was performed with the SPSS 13.0 for Windows software (SPSS 
Inc.).   
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1. Phenotypic characterization of regulatory T cell populations 
during L. infantum in vivo infection 
 
1.1.   Parasite detection 
 
Parasite burden in the spleen and liver was evaluated during the course of infection. Viable 
Leishmania parasites that were detected in the spleen at two days pi, showed a considerable 
increase in number at 28 days pi and a reduction at 56 days pi. Except for day 7 pi, the spleen 
showed higher levels of parasitism than liver. In the latter, parasites were only detected 7 days pi. 
Parasite load in liver showed some variations in number, with increases at 28 days pi and a slight 
decrease at 56 days pi (Figure 15). Follow-up studies beyond the experimental period defined, 
revealed the presence of high levels of viable parasites in the spleen after 112 days pi.   
 
 
 
 
 
 
 
 
Figure 15. Evolution of parasite burden in spleen and liver of BALB/c mice infected with L. infantum 
promastigotes. Parasite load was determined at 2, 7, 14, 28 and 56 days post-infection (pi) by limiting 
dilution assay. Results are expressed as the number of parasites x 10
3 
per gram (g) of homogenized organ.  
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1.2.   Phenotypic characterization of regulatory T cells 
 
The frequencies of expression of various Treg markers on the surface of freshly isolated and pooled 
leukocytes from spleen and lymph nodes of L. infantum – infected and control BALB/c mice were 
analyzed in order to identify potential subsets of Treg cells induced in response to the parasite 
(Figure 16).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16. Typical FSC/SSC plot of the population of isolated total CD4+ T cells from BALB/c mice. P1 represents the 
subpopulation of viable lymphocytes gated on for further immunophenotyping (A). Total number of cells characterized 
on the basis of size and granularity and structural complex is shown in B and C. Non-stained samples were used as 
negative controls for FL1, FL2 and FL3 (D-F) in comparison to samples positive for each fluorescence detector (G-I). 
(A) (B) (C) 
(D) (E) (F) 
(G) (H) (I) 
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Data was collected and analyzed on a two parameter dot-plot in order to measure the percentage of 
cells positive for each fluorophore-labeled antibody used. Shown below are four representative dot 
plots for CD4
+
CD25
+
 and CD25
-
 cells, CD4
+
CD25
+
GITR
+
 and CD4
+
CD25
+
CD103
+
, 
CD4
+
CD45RB
low
  and CD45RB
high
 T cells (Figure 17).  
  
  
 
 
 
 
 
 
 
 
Figure 17. Representative plots of CD4
+
 T cells for CD25, GITR, CD103 and CD45RB markers.   
 
After 7 days of infection with L. infantum, a transient expansion of CD3
+
CD4
+
CD25
+
 (p=0.010, 
Figure 18A), CD4
+
CD25
+
GITR
+
 (p=0.017, Figure 18B), and CD4
+
CD25
+
CD103
+
 (p=0.010, Figure 
18C) T cells was detected. Cell frequencies returned to steady state levels at 14 days pi. 
CD4
+
CD25
+
GITR
+
 and CD103
+
 T cells again showed increases at 28 days pi (p=0.027) (Figure 
18B, C) and CD3
+
CD4
+
CD25
+
, CD4
+
CD25
+
GITR
+
 and CD4
+
CD25
+
CD103
+
 T cells at 56 days pi 
(p=0.002) (Figure 18A, B and C). CD3
+
CD4
+
CD25
-
 effector T cells of infected animals maintained 
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lower than non-infected animals throughout the infection period being significantly reduced at 7 
(p=0.027) and 56 days pi (p=0.002) (Figure 18D). These results indicate that CD4
+
CD25
+
 T cell 
subsets that also express GITR and CD103 are induced and readily expand in response to L. 
infantum in vivo infection and are in fact recruited to the sites of parasite infection.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18. Dynamics of CD4
+
CD25
+
 and CD25
- 
T cell populations during L. infantum infection. Frequency 
of pooled draining lymph nodes and spleen cells from BALB/c mice at 2, 7, 14, 28 and 56 days pi. Cells were 
analyzed for surface expression of CD3, CD4, CD25, GITR, CD103, CD45RB (A-H). Representative plots 
of cells from naïve and day 56 infected BALB/c mice show staining and percentage for CD25 gated on CD4
+
 
T cells, for GITR and CD103 of CD4
+
CD25
+
 gated cells (I).  Results are mean values  SD. *(p<0.05) 
indicates statistically significant differences in comparison to naïve cells (day 0). 
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Cell frequencies of CD45RB
low 
between infected vs. naïve cells within the CD4
+
 showed slight 
variations throughout the period of study (Figure 18F). CD45RB
low
  frequency within the 
CD4
+
CD25
+ 
(Figure 18G) and CD4
+
CD25
-
 (Figure 18H) fractions were also analyzed in this study, 
as well as, CD103
+ 
numbers within the CD4
+
CD25
-
 fraction however, no significant differences 
were found. 
 
The expression of foxp3 was used as a discriminatory intra-cellular marker for regulatory T cells. 
Therefore, the expression of foxp3 was analyzed ex vivo in cells isolated from spleen and LN, that 
were magnetically separated into CD4
+
CD25
+ 
and CD25
- 
defined subsets.  
 
Increased gene expression levels of transcription factor foxp3 by CD4
+
CD25
+
 T cells, was observed 
at days 2 (p=0.029), 7 (p=0.029) and 28 pi (p=0.016) in L. infantum-infected mice compared to 
naïve mice, confirming the presence of cells with regulatory phenotype (Figure 19A). In fact, foxp3 
expression by CD4
+
CD25
+
 T cells reached higher levels at 7 and 28 days pi coincidently with 
higher frequencies of CD4
+
CD25
+
GITR
+
 and CD103
+
. foxp3 levels by CD4
+
CD25
-
 effector cells of 
infected mice were low throughout the experimental period, with statistical significance at 14 
(p=0.010) and 28 (p=0.012) (Figure 19B) days pi.  
 
These data show clearly that foxp3 is selectively expressed in the CD4
+
CD25
+
 T cell fraction with 
enhanced expression in cells from infected animals.  
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Figure 19. Expression of foxp3 mRNA by CD4
+
CD25
+
 (A) and CD25
-
 (B) cell fractions from pooled 
draining lymph nodes and spleen cells of L. infantum-infected (■) and naïve (□) BALB/c mice at 2, 7, 14, 28 
and 56 days pi. Results are analyzed by real-time PCR and data are mean values  SEM and expressed as 
number of copies x 10
3
/1000 copies of housekeeping gene HPRT. *(p<0.05) indicates statistically significant 
differences in comparison to naïve cells (CON).  
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1.3.   Detection of in vitro cytokine production 
 
1.3.1.   CD4+CD25+ T cell subset 
 
After providing evidence that CD4
+
CD25
+ 
T cells express foxp3, their functional activity was 
characterized with regard to production of Treg-associated cytokines such as IL-10 and TGF-
In vitro cytokine production was evaluated in the separated CD4
+
CD25
+
 fractions isolated from 
pooled spleen and LN cells. Significant results presented correspond to the following conditions of 
stimulation: cells with medium; cells with APC and anti-CD3  and cells with APC, anti-CD3  and 
antigen. CD4
+
CD25
+ 
T cells showed increased IL-10 production when stimulated with APC and 
anti-CD3  at days 14 (p=0.013) and 56 pi (p=0.029) (Figure 20A). Stimulation with Leishmania 
antigen increased production of this cytokine at 2 and 14 day pi, however significant differences 
were not observed. No significant differences were observed with other stimulatory conditions 
mentioned in section 1.6 of Material and Methods. 
 
TGF-  concentrations produced by CD4
+
CD25
+
 T cells were found to be significantly increased 
when in the presence of APC and anti-CD3  at 28 (p=0.007) and 56 (p=0.034) days pi and also 
when additionally stimulated with antigen earlier at day 7 pi (p=0.048) and later at 28 and 56 days 
pi (p=0.005) (Figure 20B).   
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Figure 20. In vitro production of IL-10 and TGF-  by CD4+CD25+ T cells fractions (A, B), purified from 
pooled draining lymph nodes and spleen cells of L. infantum-infected and naïve BALB/c mice, and cultured 
in vitro alone (□), in the presence of mitomycin C-treated antigen presenting cells (APC) at a ratio of 1 
lymphocyte per 1 APC activated with soluble anti-CD3  (■) or with Leishmania antigen (■) were evaluated. 
Cytokines were quantified by ELISA in culture supernatant after three days of activation. Results are mean 
values  SEM expressed in pg..ml
-1
. *(p<0.05) indicates statistically significant differences in comparison to 
naïve cells (day 0). ND, not detectable.  
(A) 
(B) 
0
50
100
150
200
0 2 7 14 28 56
Days post-infection 
IL
-1
0
 (
p
g
 m
l-
1
)
CD25+
CD25+  APC + CD3e
CD25+  APC+ CD3e + Ag
    *
   ND    ND   ND
     *
0
600
1200
1800
0 2 7 14 28 56
Days post-infection 
T
G
F
-
 (
p
g
 m
l-
1
)
    * *
    *
 * *
                                                                                                                                                   Results 
 
 
93 
1.3.2.   CD4+CD25- T cell subset 
 
Th1 and Th2 cytokines were also evaluated in effector T cell populations in order to determine the 
type of immune response induced with disease outcome. Although effector cells produced IFN-
no significant differences were found when comparing to naïve cells, either alone, in the 
presence of APC and soluble anti-CD3  or in the presence of APC and soluble anti-CD3  and 
antigen (Figure 21A). 
Concentrations of IL-4 produced by CD4
+
CD25
-
 effector T cells from infected animals maintained 
reduced in comparison to naïve cells until day 28 pi (Figure 21B). An early specific inhibition of 
IL-4 was observed at day 7 pi when stimulated with antigen in the presence of APC and anti-CD3  
(p=0.019). Effector cells were only able to produce significant levels of IL-4 at day 56 pi when 
stimulated with antigen (p=0.030) and with APC and anti-CD3  (p=0.033).  
Interestingly, CD4
+
CD25
-
 effector T cells produced large quantities of IL-10, without additional 
stimulation soon after 2 (p=0.001) and 7 days pi (p=0.027) and also when stimulated with APC and 
anti-CD3  at 2 (p=0.032), 7 and 56 days (pday 7 and 56 0.001) of infection (Figure 22) In presence of 
Leishmania antigen, effector cells responded with even higher levels of IL-10 at day 7 pi 
(p 0.001), reaching peak values at 56 days pi (p 0.001). However, inhibition of IL-10 production 
occurred at days 14 (p=0.037) and 28 pi, in non-stimulated cells, (p=0.024), in cells stimulated with 
APC (p=0.032) and anti-CD3  (p=0.018) and with antigen at day 28 pi (p=0.006).   
Th1 and Th2 responses to L. infantum infection do not seem to really contribute to infection control 
or disease progression since IFN-  and IL-4 were produced in reduced quantities to be biologically 
significant and affect parasite evolution. On the other hand, Treg-associated cytokine secreting 
cells, such as TGF- producing CD4
+
CD25
+
 T cells and IL-10-producing CD4
+
CD25
-
 T cells are 
actively induced in response to infection.  
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Figure 21. In vitro production of IFN-  and IL-4 by CD4
+
CD25
-
 T cell fractions (A, B), purified from pooled 
draining lymph nodes and spleen cells of L. infantum-infected and naïve BALB/c mice, and cultured in vitro 
alone (□), in the presence of mitomycin C-treated antigen presenting cells (APC) at a ratio of 1 lymphocyte 
per 1 APC activated with soluble anti-CD3  (■) or with Leishmania antigen (■) were evaluated. Cytokines 
were quantified by ELISA in culture supernatant after three days of activation. Results are mean values  
SEM expressed in pgml
-1
. *(p<0.05) indicates statistically significant differences in comparison to naïve cells 
(day 0). ND,  not detectable.  
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Figure 22. In vitro production of IL-10 by CD4
+
CD25
-
 T cell fractions, purified from pooled draining lymph 
nodes and spleen cells of L. infantum-infected and naïve BALB/c mice, and cultured in vitro alone (□), in the 
presence of mitomycin C-treated antigen presenting cells (APC) at a ratio of 1 lymphocyte per 1 APC 
activated with soluble anti-CD3  (■) or with Leishmania antigen (■) were evaluated. Cytokines were 
quantified by ELISA in culture supernatant after three days of activation. Results are mean values  SEM 
expressed in pg.ml
-1
. *(p<0.05) indicates statistically significant differences in comparison to naïve cells (day 
0). ND, not detectable.  
 
1.4.   Gene expression analysis of tlr2 
 
To test whether the CD25
+
 T cell fraction isolated expressed TLR-2 and to compare levels of 
induction during Leishmania infection, murine TLR-2 gene expression was monitored by real-time 
PCR. 
CD4
+
CD25
+
 T cells isolated and separated from spleen and LN cells did indeed express detectable 
levels of murine TLR-2 (Figure 23). In response to L. infantum infection TLR-2 expression was  
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Figure 23. Expression of tlr2  mRNA by CD4
+
CD25
+
 cell fractions from pooled draining lymph nodes and 
spleen cells of L. infantum-infected BALB/c mice at 2, 7, 14, 28 and 56 days pi. Results were analyzed by 
real-time PCR and data are mean values  SEM expressed as number of copies x 10000 copies of 
housekeeping gene HPRT.  
 
increased in relation to non-infected animals at days 2 and 14 pi and reduced at days 7, 28 and 56 
pi, although these differences were not statistically significant.  
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2.   Evaluation of the effect of TLR-2 modulation on Treg populations 
during L. infantum in vivo infection 
 
 
2.1.   Parasite detection 
 
The number of parasites was detected in spleen and liver of TLR-2 deficient (TLR2-/-) and wild-
type C57Bl/6 (WT) mice by limiting dilution assay.   
 
 
 
 
 
 
 
 
 
 
Figure 24. Determination of parasite burden in spleen and liver of TLR-2
-/-
 and WT mice on a C57Bl/6 
background infected with L. infantum promastigotes. Parasite load was determined at 7 and 28 days post-
infection (pi) by limiting dilution assay. Results are expressed as the number of parasites per gram (g) of 
homogenized organ. (p<0.05) and ‡ (p<0.05) indicate statistically significant differences when comparing 
TLR-2
-/-
 vs WT mice and days 7 vs. 28 pi, respectively.  
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TLR-2
-/-
 mice showed pronounced parasite expansion and seemed to be more susceptible than WT 
mice to L. infantum (Figure 24). 
Higher rates of parasite multiplication, at both time points were observed in spleen and liver of     
TLR-2
-/-
 mice, showing evidence of non-healing infection. Significant high values were observed 
on day 28 pi in the spleen (p=0.003) and in the liver (p<0.001).  The liver showed higher rates of 
parasitization than spleen regardless of type of mice or observational time point. Increases in 
parasite burden with infection time was found significant in both spleen and liver of TLR-2
-/-
 mice 
(p=0.002) but only in liver of WT mice (p=0.001). 
 
2.2.   Phenotypic characterization of regulatory T cells 
 
To evaluate the influence of the TLR-2 gene in parasite-induced regulation of Treg and protective 
immunity to L. infantum infection in mice with resistant phenotype, in vivo Treg subpopulations 
were phenotypically characterized in both gene disrupted TLR-2
-/- 
knock-out and WT mice.   
In contrast to the first part of this study, FOXP3 protein expression was evaluated in the same T 
cell subsets by flow cytometry, through intracellular detection of FOXP3 nuclear transcription 
factor together with other Treg surface markers (Figure 25).  
 
 
 
 
 
Figure 25. A typical dot plot of the population of CD3+CD4+CD25+FOXP3+ T cells from C57Bl/6 mice.  
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Non-infected TLR-2
-/- 
mice showed reduced numbers of CD3
+
CD4
+
CD25
+
FOXP3
+
 T cells in 
relation to their WT counterparts although no significant differences were observed (Figure 26). 
However, when looking specifically to other Treg markers, such as CD4
+
CD25
+
GITR
+
FOXP3
+
 T 
cells, the number of cells in infected TLR-2
-/- 
mice were significantly reduced (p=0.008) when 
compared to WT mice during the initial phase of infection (day 7 pi) (Figure 26B).  But in WT 
mice, CD4
+
CD25
+
GITR
+
FOXP3
+
 T cells actually decreased significantly with infection (p day 28 vs. 
day 0=0.026; p day 28 vs. day 7=0.024).   
In WT mice, CD4
+
CD25
+
CD103
+
FOXP3
+
 T cells also decreased upon initial infection (pday 7 vs. day 
0=0.006) but recovered cell numbers (pday 28 vs. day 7=0.016) (Figure 26C). In TLR-2
-/- 
mice, 
significant increases in CD4
+
CD25
+
CD103
+
FOXP3
+
 T cells were detected after 28 days pi (pday 28 vs. 
day 0=0.001;  pday 28 vs. day 7=0.003). Also, L. infantum induced significantly higher levels of CD103
+ 
Treg in TLR-2
-/- 
mice than in WT at both times pi (pday 7 vs. day 0 =0.006; p day 28 vs. day 7=0.008).  The 
same was observed at day 28 pi for Treg with memory phenotype CD4
+
CD25
+
CD45RB
low
FOXP3
+
 
T cells when comparing with cells from non-infected TLR-2
-/- 
and day 7 pi (p =0.006) and when 
comparing both type of mice  (p=0.004) (Figure 26D). 
So the results indicate that in WT mice reductions of GITR
+
 and CD103
+ 
FOXP3
+ 
Treg occur with 
L. infantum infection while gene disrupted TLR-2
-/-
 mice show clear induction of CD103
+ 
CD45RB
low
 memory Treg with late infection. This may imply that WT mice are perhaps more 
capable of surmounting a more robust effector response against the parasite since the presence of 
immunosuppressive Treg seems hampered. The absence of TLR-2 seems to favour Treg 
accumulation and retention in infected spleen which is confirmed in TLR-2
-/-
 mice. So TLR-2 
could play a role in regulating Treg since in WT mice retention is not evident.   
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Figure 26. Characterization of Treg cell populations during L. infantum infection. Frequency of cells isolated 
from spleen of WT and TLR-2
-/- 
on a C57BL/6 background at days 7 and 28 pi. Cells were analyzed for 
surface and intracellular expression of CD3, CD4, CD25, GITR, CD103, CD45RB and FOXP3 (A-D). 
Results are mean values  SEM, representative of two independent experiments. * (p<0.05), ‡ (p<0.05) and 
(p<0.05) indicate statistically significant differences when comparing samples from control (day 0) vs. 
infected animals, days 7 vs. 28 pi and TLR-2
-/-
 vs. WT mice, respectively. 
 
Several effector T cell subsets were also analyzed. Significant increases in CD3
+
CD4
+
CD25
-
FOXP3
-
 T cells from both TLR-2
-/- 
and WT mice were only seen in response to late infection 
(pTLR2-/- day 28 vs. day 0=0.006; pWT day 28 vs. day 0=0.047) (Figure 27A). So different mouse genotype does 
not seem to have different outcomes in the number of splenic effector cells induced with infection.   
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It is now generally accepted that CD4
+
FOXP3
+
 T cells with low amounts of CD25 or even lacking 
CD25 expression show potent suppressive capacity (Lehmann et al., 2002; Fontenot et al., 2005). 
For this reason, FOXP3
+
 cells within the CD25
-
 and CD103
+
 cell fraction has also been analyzed. 
Similarly to GITR
+ 
Treg (Figure 26B), TLR-2
-/- 
showed lower number of CD4
+
CD25
-
FOXP3
+
 T 
cells when compared to WT mice (p=0.001) (Figure 27B). In WT mice, these cells decreased at 
day 28 pi (p day 28 vs. day 0=0.033; p day 28 vs. day 7=0.009). On the other hand, CD4
+
CD25
-
CD103
+
FOXP3
+
 T cells of WT mice behaved in the same fashion as regulatory 
CD4
+
CD25
+
CD103
+
FOXP3
+ 
T cells, having decreased numbers (p day 28 vs. day 0=0.008) and 
significantly lower than TLR-2
-/-
 mice (p=0.038) (Figure 27C). 
WT mice weren‘t initially able to induce effective effector response upon L. infantum infection 
even though there were reduced Treg numbers in these mice. C57BL/6 mice experimentally 
infected with VL strains are known to be initially susceptible to infection, showing rapid increases 
in liver parasite burden until 4 weeks of infection. After reaching a plateau, the number of parasites 
decline and the mice develop self-curing phenotype and low levels of chronic infection (Murray et 
al., 2001). In fact, increased effector response was only observed later during infection 
(CD3
+
CD4
+
CD25
-
FOXP3
-
).  
Even though, TLR-2
-/- 
mice showed more Treg retention, this did not seem to affect effector T cell 
response against L. infantum. So, immunosuppression is not evident, regarding influence on 
effector response, in the absence of TLR-2. Other mechanisms may be involved in eliciting effector 
response and by-passing the action of immunosuppressive Treg.  
Regarding FOXP3
+
 populations within the CD25 negative subset, again in TLR-2
-/- 
mice, the 
numbers are not increased in relation to WT. However, in WT mice this FOXP3
+
 population and 
the CD103
+
FOXP3
+
 population within the CD25 negative cell fraction do still decrease with 
infection as expected, the latter being more reduced in relation to TLR-2
-/- 
as well.   
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Figure 27. Characterization of CD25 negative CD4
+
 populations during L. infantum infection. Frequency of 
cells isolated from spleen of WT and TLR-2
-/- 
on a C57BL/6 background at days 7 and 28 pi. Cells were 
analyzed for surface and intracellular expression of CD3, CD4, CD25, CD103 and FOXP3 (A-C). Results are 
mean values  SEM representative of two independent experiments. * (p<0.05), ‡ (p<0.05) and (p<0.05) 
indicate statistically significant differences when comparing samples from control (day 0) vs. infected 
animals, days 7 vs. 28 pi and TLR-2
-/-
 vs. WT mice, respectively. 
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2.3.   Detection of cytokine transcripts 
 
In order to evaluate whether the absence of TLR-2 affects protective immune response and 
consequent outcome of L. infantum infection, cytokine response was analyzed at each observational 
time point as well as in both TLR-2
-/- 
and WT mice and in separate cell and tissue samples so as to 
study the influence of this gene on specific organ response.  
 
2.3.1.   IFN-  
  
The spleen, a peripheral lymphoid organ, is regarded as one of the centers of activity of the 
reticuloendothelial system which is part of the immune system, consisting of phagocytic cells 
located in reticular connective tissue, primarily monocytes and macrophages. The spleen is also the 
organ where B cells that migrate from the bone marrow mature and where mature T lymphocytes 
circulate and differentiate into effector and memory lymphocytes upon exposure to antigen. Taking 
all this into consideration, it is also important to evaluate total splenic tissue response and not just 
single-cell response.  
An initial IFN-  response to L. infantum infection was transiently elicited in TLR-2
-/- 
mice by total 
mononuclear cells isolated from the spleen at day 7 pi (p=0.048) (Figure 28A). Total lymph node 
cells from WT mice showed an early Th1 response with significant expression of IFN- in relation 
to control (p=0.003). However, during the course of infection this ability was significantly lost 
(p=0.001) (Figure 28B).  TLR-2
-/- 
mice were less capable of expressing IFN- at day 7 pi (p=0.043) 
in comparison to WT, maintaining at day 28 pi, low expression levels (p=0.003; p=0.001). When 
looking at total spleen tissue, the same response occurs later showing increased but late expression 
of IFN-  at day 28 pi  (p day 28 vs. day 0=0.013) when compared to non-infected mice and to day 7  pi (p 
day 7 vs. day 28=0.020) and also in relation to TLR-2
-/- 
mice (p=0.019) (Figure 28C). Liver tissue of both 
types of mice did not respond with significant variations in IFN- expression (Figure 28D).  
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Results show that spleen cells of TLR-2
-/- 
mice initially produced weak IFN- response to infection 
and showed significantly lower levels during early infection in LN and later in total spleen tissue 
than WT mice.  
(A) (B) 
 
 
 
 
      (C)                                                                              (D) 
 
 
 
 
 
 
Figure 28.Ex vixo mRNA expression of  IFN-  by isolated mononuclear spleen (SP) cells (A), total SP tissue 
(B), isolated lymph node cells (LN) (C) and liver (LIV) tissue (D) from L. infantum-infected wild-type (WT) 
and TLR-2
-/-
 knock-out mice (TLR2-/-). Results were analyzed by real-time PCR and data are mean values  
SEM representative of two independent experiments and expressed as the number of copies per 1000 copies 
of housekeeping gene HPRT. * (p<0.05), ‡ (p<0.05) and (p<0.05) indicate statistically significant 
differences when comparing samples from control (day 0) vs. infected animals, days 7 vs. 28 pi and TLR-2
-/-
 
vs. WT mice, respectively. 
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This associated to increases observed in effector T cell populations late during infection in WT 
mice might explain better control of parasite load in WT mice. In addition, GITR
+
 Treg were also 
found to be low in number later during infection. However, in LN an early IFN- response was 
more evident in WT mice, indicating differential organ response perhaps due to other circulating 
immune cells also capable of producing this cytokine (e.g. CD8
+
 T cells, NK cells). 
Overall, Th1 response mediated by IFN- was not strong or clearly evident in TLR-2
-/- 
mice, 
perhaps a reflection of the presence of high levels of accumulating Treg. 
 
2.3.2.   IL-4 
 
 
In spleen cells of TLR-2
-/- 
mice, IL-4 was found reduced after day 28 pi (p day 28 vs. day 0=0.005; pday 28 
vs. day 7 =0.001) and significantly less in relation to WT mice (p=0.001) (Figure 29A). In addition, in 
spleen tissue IL-4 response also increased significantly in WT mice early upon infection (pday 7 vs. day 
0=0.001) but then decreased (pday 28 vs. day 7 =0.001) with the course of infection (Figure 29C). The 
same occurred in TLR-2
-/- 
mice (p day 7 vs day 0=0.002) where it was significantly higher than WT mice 
(p=0.046). At day 28 pi a decrease in IL-4 expression was detected in TLR-2
-/- 
mice (p day 28 vs. day 7 
=0.021). 
 
 Similar pattern was observed by LN cells, having increased significantly IL-4 expression in WT 
mice at day 7 pi (p day 7 vs. day 0 =0.010) and then decreased later (p day 28 vs. day 0=0.012; p day 28 vs. day 7 
<0.001) (Figure 29B). Again this was seen in TLR-2
-/- 
mice (p day 7 vs. day 0<0.001) but in contrast to 
WT mice, IL-4 maintained elevated in relation to control at day 28 pi (p day 28 vs. day 0 =0.001) and was 
significantly higher than WT (p<0.001). 
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 In liver, high levels of IL-4 expression was only detected at day 28 pi in TLR-2
-/- 
mice (p day 28 vs. day 
0 =0.027) (Figure 29D). 
 
The results from spleen tissue and LN give evidence of an early IL-4 burst which occurs in both 
types of mice but is more accentuated in spleen tissue of TLR2
-/-
 mice. After 28 days of infection, 
IL-4 expression subsides substantially in spleen of TLR2
-/-
 mice. This strong IL-4 inhibition late 
during infection in TLR2
-/-
 mice is interesting since one would expect susceptible mice to have 
high levels of Th2 cytokines. 
 
The fact that Treg levels considerably increase later during infection of these mice, may suggest 
that Treg in spleen may be mediating Th2 response, by inhibiting local IL-4 response as infection 
progresses. However, when considering other organs like LN and liver, a different pattern can be 
seen. IL-4 actually remains relatively higher in TLR-2
-/-
 mice in relation to WT mice. So, 
differential organ IL-4 response may influence the outcome of immune response to L. infantum 
infection.  
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 (A)                                                                            (B) 
 
 
 
 
 
(C)                                                                              (D) 
 
 
 
 
 
 
Figure 29.Ex vixo mRNA expression of  IL-4 by isolated mononuclear spleen (SP) cells (A), total SP tissue 
(B), isolated lymph node cells (LN) (C) and liver (LIV) tissue (D) from L. infantum-infected wild-type (WT) 
and TLR-2
-/-
 knock-out mice (TLR2-/-) Results were analyzed by real-time PCR and data are mean values  
SEM representative of two independent experiments and expressed as the number of copies per 1000 copies 
of housekeeping gene HPRT. * (p<0.05), ‡ (p<0.05) and (p<0.05) indicate statistically significant 
differences when comparing samples from control (day 0) vs. infected animals, days 7 vs. 28 pi and TLR-2
-/-
 
vs. WT mice, respectively. 
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2.3.3.    IL-10 
 
In WT mice, IL-10 expression gradually increased with infection time at day 7 pi (p=0.012) and 28 
pi (p day 7 vs. day 0<0.001; p day 28 vs. day 7<0.001) in SP cells (Figure 30A). TLR-2
-/- 
mice behaved 
similarly with increases at day 28 pi (p day 28 vs. day 0=0.002; p day 28 vs. day 7 =0.004). However, total 
spleen tissue showed low IL-10 levels and no significant variations (Figure 30C).  
LN cells from TLR-2
-/- 
mice presented increased values at day 28 pi (p day 28 vs. day 7<0.001) (Figure 
30B). In liver although IL-10 values were lower than other organs, an early transient decrease was 
observed in WT mice (p day 7 vs. day 0 =0.007), followed by increasing levels at day 28 pi (p day 28 vs. day 
0=0.046; p day 28 vs. day 7<0.001) (Figure 30D). On the other hand, TLR-2
-/- 
mice also increased IL-10 
values after one month of infection (p day 28 vs. day 0=0.027; p day 28 vs. day 7<0.001). However, no 
differences between both types of animals were seen regarding IL-10. 
In general, IL-10 expression is mainly observed during late infection, regardless of mice type, 
although in LN this is only evident in TLR-2
-/- 
mice. Late IL-10 expression could be contributing to 
higher parasite multiplication rates observed in the liver when comparing to spleen. Spleen cells of 
WT mice showed some ability to express IL-10 earlier upon infection although in the liver, 
inhibition was observed in comparison to controls. This could indicate that liver shows some 
evidence of initial control of infection since the source of immunosuppressive IL-10 seems to be 
inhibited. This may be related to lower CD103
+
 Treg retention that was detected at the same time 
point, hence less immunosuppression, better effector response and lower parasite load in relation to 
TLR-2
-/- 
mice. But the absence of TLR-2 and high Treg retention detected does not seem to 
correlate with IL-10 expression.     
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(A)                                                                               (B) 
 
 
 
 
 
(C)                                                                               (D) 
 
 
 
 
 
Figure 30. Ex vixo mRNA expression of  IL-10 by isolated mononuclear spleen (SP) cells (A), total SP tissue 
(B), isolated lymph node cells (LN) (C) and liver (LIV) tissue (D) from L. infantum-infected wild-type (WT) 
and TLR-2
-/-
 knock-out mice (TLR2-/-). Results were analyzed by real-time PCR and data are mean values  
SEM, representative of two independent experiments and expressed as the number of copies per 1000 copies 
of housekeeping gene HPRT. * (p<0.05) and ‡ (p<0.05) indicate statistically significant differences when 
comparing samples from control (day 0) vs. infected animals and days 7 vs. 28 pi, respectively. 
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2.3.4.   TGF-  
 
At day 7 pi, SP cells from TLR-2
-/- 
mice showed higher TGF- levels in relation to their WT 
counterparts (p<0.001) (Figure 31A). However, infected WT mice showed fairly higher levels of  
(A)                                                                             (B) 
 
 
 
 
 
(C)                                                                                (D) 
 
Figure 31. Ex vixo mRNA expression of  TGF-  by isolated mononuclear spleen (SP) cells (A), total SP 
tissue (B), isolated lymph node cells (LN) (C) and liver (LIV) tissue (D) from L. infantum-infected wild-type 
(WT) and TLR-2
-/-
 knock-out mice (TLR2-/-). Results were analyzed by real-time PCR and data are mean 
values  SEM representative of two independent experiments and expressed as the number of copies per 
1000 copies of housekeeping gene HPRT. * (p<0.05), ‡ (p<0.05) and (p<0.05) indicate statistically 
significant differences when comparing samples from control (day 0) vs. infected animals, days 7 vs. 28 pi 
and TLR-2
-/-
 vs. WT mice, respectively. 
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TGF- with a significant increase during late infection (pday 28 vs. day 0<0.001; pday 28 vs. day 7 =0.006). 
With late infection, TLR-2
-/- 
mice showed decreased TGF-  levels in SP tissue (p day 28 vs. day 
0=0.022) (Figure 31C) as well as, in LN cells (p day 28 vs. day 7=0.033) (Figure 31B). In liver, the same 
pattern was seen in TLR-2
-/- 
mice with decreased TGF-  levels observed at day 28 pi (p day 28 vs. day 
7=0.006) and in relation to WT mice (p<0.001) (Figure 31D). 
Initially, spleen cells of TLR-2
-/- 
mice expressed higher TGF-  levels than WT mice but later 
during infection, a strong reduction in the ability to express this cytokine was observed in spleen 
tissue, LN and liver suggesting a minor contributing role for TGF- to susceptibility of TLR-2
-/- 
mice to L. infantum.   
Surprisingly, WT showed a strong TGF-  response to late infection that does not seem to 
contribute to increased parasite multiplication since these mice are effectively more resistant to L. 
infantum.  This gives indication that although in the spleen, WT are able to develop a pro-
inflammatory response with expression of IFN- this occurs together with an anti-inflammatory 
response with detection of IL-10 and TGF- So, the Th1 response observed was not efficient and 
may have been hampered by clear evidences of immunosuppression in spleen of WT mice. 
However, these immunosuppressive cytokines do not seem to be involved in Treg-mediated 
suppression since they did not accumulate in WT mice. Despite this, these mice end up developing 
chronic infection and are not able to clear the parasite. On the other hand, TLR-2
-/- 
mice were not 
able to develop a Th1 response and IL-10 seems to be the only contributing factor to 
immunosuppression in the spleen. However, the expression of IL-10 did not correlate with high 
Treg levels also detected in these mice suggesting both Treg and IL-10 of non-Treg origin may 
both be contributing to increased susceptibility of TLR-2
-/-
 mice to L. infantum.      
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2.4.   Histopathology 
 
Initial control and eventual resolution of hepatic infection by visceralizing Leishmania spp. in 
normal mice (eg. C57Bl/6) are accomplished with well-formed mature tissue granulomas. In the 
liver, these immunologically active, inflammatory structures are assembled, upon antigen-specific 
response, around a core of fused, parasitized resident macrophages (Kupffer cells). The granuloma 
formation is normally associated to an influx of various effector cell populations (granulocytes, 
CD4
+
 and CD8
+
 T cells) that are known to target Leishmania-infected macrophages.  Under 
optimal conditions, these functional structures limit infection, kill and remove the microbial target 
and then repair any accompanying tissue injury.  
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Figure 32. Liver tissue response to L. infantum in wild-type (WT) and TLR-2
-/-
 knock-out mice (TLR2-/-) 
and the effect on the extent of granuloma formation.  Inflammation in the liver was scored semi-
quantitatively by estimating the total number of infiltrating cells per square millimeter per granuloma. 
Results were expressed as the mean number of infiltrating cells x mm
-2
 of granuloma for each infected mice 
group + SEM.  (p<0.05), indicate statistically significant differences when comparing TLR-2
-/-
 vs. WT mice, 
respectively. 
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The overall antimicrobial efficacy of the granulomatous response appears to be variable, however, 
and depends upon host determinants, the pathogen and the criteria used to define efficacy. 
Although microbial eradication is the ideal outcome in infections which trigger granuloma 
assembly, it is not clear how often this objective is actually ever achieved. Thus, despite even an 
initially intense granulomatous response, a number of pathogens, including L. donovani, establish a 
well recognized state of chronic intracellular parasitism,  
Significant differences between mice genotypes were observed in terms of hepatic inflammatory 
reaction at both time points of infection. TLR-2
-/-
 mice showed granulomas with significantly larger 
infiltrates than WT mice (pday 7= 0.034; p day 28 =0.001) (Figure 32). Images of hepatic infiltration 
and granulomas are showed in Figure 33. 
                   WT                                                           TLR2-/-         
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Figure 33. Liver histological response to L. infantum infection, 7 and 28 days after intravenous infection of L. 
infantum TLR-2
-/-
 knock-out mice (TLR2-/-) (A) and wild-type (WT) C57BL/6 mice (B). Granuloma 
formation (arrows) was evaluated by examining fixed liver tissue sections stained with hematoxylin and eosin 
using light microscopy (magnification 200X) 
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Infection with Leishmania protozoan parasite is a major human health issue worldwide, causing 
morbidity and mortality that, particularly in developing countries contributes to political, social and 
economic instability. There are currently no vaccines against any form of human leishmaniasis 
available to prevent this devastating infection. One of the underlying reasons for the lack of a 
successful vaccine is intrinsically linked to the complexity, as well as the incredible diversity of 
immune mechanisms involved in the pathogenesis caused by Leishmania spp. Surviving a given 
infection such as leishmaniasis requires the generation of a controlled immune response. 
Understanding these cell-mediated immunological mechanisms for controlling infection is essential 
for the development of effective prophylactic and therapeutic vaccines. 
L. infantum is the causative agent of zoonotic visceral leishmaniasis (ZVL). It has been clearly 
established that L. infantum/L. chagasi-human interactions evolve under different forms: 
asymptomatic or subclinical infection, with few or reduced symptoms to typical symptomatic 
visceral leishmaniasis (VL) (Wilson et al., 1995). VL is characterized by marked parasitism in the 
spleen and bone marrow, fever, cachexia, hepatosplenomegaly and suppressed immune cell 
responses. Pathogenesis results from active parasite replication within macrophages and 
widespread dissemination to other organs and tissues of the mononuclear phagocytic system. Acute 
VL disease is associated with an ineffective parasite-specific T cell-mediated immune response 
since CD4
+
 T cells, that are essential for acquired resistance to the invading parasite, can also 
contribute to the pathogenesis of leishmaniasis (Carvalho et al., 1994). Although, PBMCs of 
human VL patients respond to leishmanial antigen with the production of pro-inflammatory 
cytokines such as IL-2, IFN-  and IL-12, these cells are unable to proliferate in vitro in response to 
antigen stimulation (Ghalib et al., 1995). In human and murine cutaneous leishmaniasis, non-
healing response is normally associated with a Th2 type immune response with early and sustained 
production of IL-4. Elevated IL-4 levels have been observed in VL (Sundar et al., 1997; Nylen et 
al., 2007) however no association with the active disease has so far been described.  High levels of 
IL-10 and TGF-  associated to general immunosuppression have been extensively described in 
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human and murine forms of ZVL (Ghalib et al., 1993; Karp et al., 1993; Rodrigues et al., 1998; 
Wilson et al., 1998; Gomes-Pereira et al., 2004; Caldas et al., 2005; Nylen et al., 2007). So, 
unfavourable VL disease outcome does not seem to be related to Th2 dominance nor a defective 
Th1 immune response per se. Other immunosuppressive or immune-evasion mechanisms may 
contribute to pathogenesis of VL.  
Recently, there has been an explosion of interest in regulatory T cells (Treg), a particular subset of 
inhibitory immune cells involved in down regulating excessive immune effector response. Special 
focus has been given to the role that these cells may play during Leishmania infections and the 
control they may or may not exert on effective protection against these pathogens. CD4
+
CD25
+
 
regulatory T cells were the first Treg to be shown to play a critical role in Leishmania persistence 
during infection (Belkaid et al., 2002). Whilst acting as a double-edged sword by exhibiting 
immunosuppressive properties and controlling the extent of immune-mediated pathology normally 
associated to Leishmania infections, Treg also invariably lead to incomplete parasite clearance and 
long-term pathogen persistence. Although the majority of the studies focus on Treg and cutaneous 
leishmaniasis (Belkaid et al., 2002; Ji et al., 2004; Karimini et al., 2005; Campanelli et al., 2006; 
Salhi et al., 2008; Bourreau et al., 2009), there are only three Treg studies in the murine L. 
donovani model and in human visceral leishmaniasis (Stager et al., 2006; Nylen et al., 2007; Saha 
et al., 2007).  
To our knowledge, no studies up to this present work have been directed towards the participation 
of Treg during infection with L. infantum. Chronic L. infantum infections show neither evidences 
of a polarized Th cytokine response nor efficient parasite control. Regarding the immune response 
developed to infections with L. infantum and the underlying mechanisms elicited by this species in 
particular, no clear-cut response has until now been observed. Therefore, it is important to address 
the role for regulatory T cells in the control of immune response during ZVL. The purpose of this 
study is to evaluate whether Treg cells expand within sites of infection with visceralizing 
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Leishmania infantum in susceptible BALB/c mice and whether these cells are able to modulate 
effector immune response induced by this parasite, and contribute to maintain the balance between 
host immunity and pathology, resulting in chronic or persistent infection. 
Several molecules characteristic of Treg were analyzed during L. infantum infection of BALB/c 
mice. An early expansion of CD4
+
CD25
+ 
T cells also expressing GITR was observed after just one 
week of infection coinciding with increases in parasite burden in spleen. GITR is constitutively 
expressed at high levels on murine and human Treg cells. However, GITR must be used in 
combination with other Treg markers since it is not specific to Treg-like cells. It is also found in 
basal amounts on conventional CD4
+
 T cells (McHugh et al., 2002; Shimizu et al., 2002). Activated 
T cells can also up regulate GITR expression (Shevach et al., 2006) which acts as a co-stimulatory 
molecule that upon triggering with GITR ligands, usually expressed on APCs, can control 
proliferation of effector responder T cells making them refractory to Treg suppression. But on Treg 
cells, stimulation via GITR works as a negative regulator of Treg function by directly blocking 
suppression. 
Significant foxp3 expression within the CD25
+
 cell fraction coincided with CD4
+
CD25
+
GITR
+
T 
cell accumulation, after one week and also later on after one month of L. infantum infection when 
high levels of parasitization were detected in the spleen, suggests the involvement of regulatory 
foxp3 expressing - T cells in parasite expansion. The transcription factor FOXP3 appears to be 
critically important for Treg cell development (Fontenot et al., 2003; Hori et al., 2003; Khattri et 
al., 2003) and maintenance of their suppressive function (Williams and Rudenksy, 2007). Mice and 
human deficient for this transcription factor suffer from severe lymphoproliferative autoimmune 
disease (the IPEX syndrome in man and the scurfy phenotype in mice) and/or inflammatory 
disorder. Ectopic expression of FOXP3 in naïve T cells is sufficient to convert them into 
phenotypically and functionally Treg-like cells in mice. Retroviral transcription of FOXP3 
suppresses cytokine gene transcription, confers in vivo and in vitro suppressive activity and 
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upregulates Treg-associated molecules including CD25 and GITR (Hori et al., 2003). FOXP3 is a 
repressor of IL-2, IL-4 and IFN-  transcription through direct physical interactions with 
transcription factors, such as nuclear factor- B (NF- B) and nuclear factor of activated T cells 
(NF-AT) (Bettelli et al., 2005), blocking their ability to induce the endogenous expression of their 
target genes, thus inhibiting the production of pro-inflammatory cytokines and effector functions of 
primary T helper cells.  
One mechanism by which microorganisms might manipulate regulatory T cell function is by 
creating an environment that favours the retention of regulatory T cells. Integrin E 7 (also known 
as CD103), is expressed at the surface of 25% of nTreg in lymphoid tissues (McHugh et al., 2002) 
and defines a subset of nTreg cells with enhanced suppressive properties and specific migratory 
patterns (Huehn et al., 2004). CD103 expression has been shown to favour natural Treg retention at 
dermal sites of L. major infection (Suffia et al., 2005). In fact, Treg that are known to respond to 
parasite antigen are restricted to sites of Leishmania infection (Suffia et al., 2006). Results in the 
present study confirm the presence and expansion of foxp3 expressing - CD4
+
CD25
+
CD103
+ 
T 
cells within sites of L. infantum visceralizing infection, as is the case of the spleen and lymph 
nodes. This is particularly more evident after one month of parasite infection with L. infantum. In 
the model of L. major infection, CC-chemokine receptor 5 (CCR5) expression on Treg was also 
shown to be required for their migration to the infected sites (Yurchenko et al., 2006a). 
Interestingly, exposure of T cells to parasite-infected DC enhances CD103 expression and infection 
of APC with L. major and favours the production of ligands for CCR5 by APC (Sebastiani et al., 
2001), suggesting that the pathogen itself manipulates its environment to favour Treg recruitment 
and retention so as to promote their own survival within the host.  
Treg expansion followed by transient contraction could be related to host-parasite interactions. 
Higher parasite loads and increases in the amount of antigens present may affect the dynamic 
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equilibrium between effector and Treg cells. It has been shown that suppressive Treg activity can 
be selectively modulated (e.g. via toll-like receptors, discussed later in this section) during acute 
and chronic infections. In fact, during acute infection, bacterial antigens may rapidly induce 
effector function, boosting host adaptive immunity while attenuating suppressive Treg activity (Liu 
et al., 2006). In this study, Treg did not continue to expand at two weeks pi and may have 
temporarily lost suppressive activity since foxp3 expression levels and CD25, GITR and CD103 
were also found to be reduced. 
In mice, most naïve CD4
+
 T cells express high levels of CD45RB, whereas CD4
+ 
T cells that have 
previously encountered antigen have lower levels of CD45RB (Lee et al., 1990). Functional 
analysis of CD45RB
high 
and CD45RB
low
 CD4
+
 T cells has shown that important interactions occur 
between these subsets in vivo, where regulatory cells seem to be enriched in the CD4
+
CD45RB
low
 
population (Morrissey et al., 1993; Powrie et al., 1993; Hara et al., 2001). Immune suppression 
exerted by the CD45RB
low
 subset was shown to be dependent on IL-10 and TGF- , but 
independent of IL-4 (Powrie et al., 1996; Assessman et al., 1999). Further subdivision of the 
CD45RB
low
 subset revealed that the regulatory T cells were enriched within the CD25
+
 population 
(Read et al., 2000). In the present study, CD4
+
CD25
+
 T cells with CD45RB
low
 phenotype failed to 
reveal important variations during infection. Gomes-Pereira, (2004a) observed only slight 
variations in the CD4
+ 
memory subsets CD62L
low
/CD45RB
low
 of splenic lymphocytes in mice of 
both ―cure‖ and ―non-cure‖ phenotype infected with L. infantum. However in the liver, the scenario 
was quite different, an imbalance between ―protective‖ CD45RBhigh and ―pathogenic‖ CD45RBlow 
CD4
+
 hepatic T cell subsets in ―non-cure‖ animals was observed. This imbalance may have 
favoured Treg-mediated immunosuppression and the evolution of a non-healing infection. 
Together, these results give indication that perhaps CD45RB may not be a suitable marker for Treg 
subsets that expand in the spleen of BALB/c mice infected with L. infantum. However, this does 
not exclude the possibility that cells with this phenotype may be involved in suppressing effector 
immune responses against L. infantum in other infection models. Functional studies with purified 
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CD4
+
CD25
+
CD45RB
low
 T cells from both spleen and liver were not carried out in this study 
although it would provide further insight on the role of this particular subset during L. infantum in 
vivo infection.  
CD4
+
CD25
- 
effector T cell levels showed important decreases at the same time points of 
CD4
+
CD25
+ 
regulatory T cells expansion. Although IFN-  was secreted by effector cells, they were 
unable to respond adequately to specific stimulation throughout the entire experimental period of 
infection. There seems to be an inadequate Th1 response by effector cells to L. infantum infection 
that may perhaps be related to Treg cells and their immunosuppressive properties. Effector cells 
were only able to respond with IL-4 production after around two months of infection, and only 
when stimulated with antigen-presenting cells, coinciding with reduction in foxp3 expression in 
Treg cells. Also, late IL-4 production failed to influence susceptibility of BALB/c to L. infantum 
since infection was characterized by a lack of major increases in parasite burden during the 
experimental period. However, Treg-mediated suppression of the Th2 response in BALB/c mice 
has in fact been seen during L. major infection (Aseffa et al., 2002; Xu et al., 2003). Together these 
results therefore suggest that Th1 and Th2 effector responses may be controlled by Treg expansion 
during L. infantum infection. 
Regarding possible mechanisms of Treg suppression, CD4
+
CD25
+
 T cells were evaluated in 
relation to cytokine in vitro production upon Leishmania antigen stimulation. These cells were able 
to consistently produce TGF-  when specifically stimulated at day 7 and from day 28 of L. 
infantum infection onwards. It has also been suggested that TGF-  participates in parasite growth 
regulation, initially favouring its multiplication and preventing an inflammatory response (Gomes-
Pereira et al., 2004). In vivo, CD25
+
 Treg activity has been implicated to be dependent on TGF-  
(Levings et al., 2002; Nakamura et al., 2004). It have been shown that these cells are Leishmania-
specific (Suffia et al., 2006) and are involved in the control of effector immune response induced 
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during human mucocutaneous leishmaniasis (Campanelli et al., 2006). In this study, TGF-  
producing-CD4
+
CD25
+
 T cells were seen to exhibit migratory phenotype expressing high levels of 
CD103 and were antigen-specific to L. infantum upon early and after one month of infection when 
parasite burden reached high levels in the spleen. CD103 expression is known to be positively 
regulated by TGF-  (Robinson et al., 2001), which is highly expressed at the vicinity of mucosal 
tissues and at sites of inflammation. Follow-up studies of the evolution of parasite burden, after the 
experimental observational period in this study, showed steadily increasing numbers of parasites. 
The presence of TGF-  producing-CD4
+
CD25
+
 T cells during L. infantum infection may contribute 
to immunosuppression (IL-4 inhibition and weak IFN-  production) and parasite persistence while 
also allowing a better control of parasite-mediated-immunopathology.  
IL-10 has been implicated as an immunosuppressive factor in both human and experimental 
leishmaniasis. It has pleiotropic, primarily deactivating effects on target cells. Elevated production 
of IL-10 is frequently found in human VL (Caldas et al., 2005) and anti-IL-10 treatment seems to 
revert antigen-specific unresponsiveness of PBMC in VL patients (Carvalho et al., 1994; Ghalib et 
al 1995). Based on experimental models, IL-10-deficient or anti-IL10 receptor treated mice display 
enhanced resistance and leishmanicidal activity against L. donovani (Murphy et al., 2001; Murray 
et al., 2005). Experimental models of cutaneous leishmaniasis have shown that IL-10 produced by 
nTreg is responsible for their suppressive activity in vivo and contributes to persistent L. major 
infection (Belkaid et al., 2002; Suffia et al., 2005). However, the extensive data generated fail to 
support a major role for nTreg in human VL. In this study, CD4
+
CD25
+
 T cells from L. infantum-
infected BALB/c mice were capable of secreting some IL-10 but non-specifically and earlier 
during infection implicating a minor role for CD4
+
CD25
+
 IL-10 producing Treg during visceral L. 
infantum infection. 
Several other different types of T regulatory cells have been described in the literature and shown 
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to exhibit regulatory activities (Shevach, 2006). Recent results implicate IL-10 producing-CD25
-
FOXP3
-
 T cells in the pathogenesis of human visceral leishmaniasis and not naturally occurring 
CD4
+
CD25
+
FOXP3
high
 T cells as the major source of IL-10 in the splenic aspirates (Nylén et al., 
2007). CD4
+
CD25
-
FOXP3
-
  cells were also shown to be the source of IL-10-mediated immune 
suppression in chronic cutaneous L. major infections (Anderson et al., 2007; Nagase et al., 2007) 
and in visceral L. donovani infection (Stäger et al., 2006). In the present study, the effector 
CD4
+
CD25
-
 T cell compartment unexpectedly showed to be an important source of IL-10 since 
they were in fact capable of specifically producing larger amounts of this cytokine, early and 
throughout the experimental period, except during two to four weeks of infection where specific 
inhibition was observed. This particular IL-10-secreting CD4
+
 T cell subset seems to be distinct 
from nTreg since they did not express appreciable levels of foxp3 gene and maintained residual 
IFN-  production. Antigen-induced IL-10-producing CD4
+
 T cells arising from CD4
+
CD25
-
FOXP3
-
 are currently referred to as Tr1 cells, adaptive Treg or inducible Treg that are involved in 
the down-regulation of immune responses through their ability of producing high concentrations of 
IL-10 and suppressing naïve and memory Th1 or 2 responses (Mills and McGuirck, 2004). In this 
study, IL-10 producing-CD4
+
CD25
-
FOXP3
-
 T cells may well belong to the Tr1 regulatory subset 
that are being induced in vivo by Leishmania parasites, and that may be contributing to the 
evolution of non-healing phenotype in L. infantum infected-BALB/c mice. 
Taken together, the information here presented identifies T cell subsets with phenotypic and 
functional characteristics of regulatory T cells during L. infantum infection of susceptible BALB/c 
mice. CD4
+
CD25
+
CD103
+
and GITR
+ 
T cells readily expand, present high levels of foxp3 gene 
expression and are antigen-specific. This suggests a predisposition for Treg retention within sites of 
L. infantum infection, consequently influencing local immune response. Th1 and Th2 effector 
immune responses seem inadequate perhaps related to Treg expansion during infection. foxp3 
expressing-CD4
+
CD25
+
 T cells are capable of specifically producing TGF- . IL-10 producing-
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CD4
+
CD25
-
FOXP3
-
 T cells were also identified as an additional source of IL-10 and may represent 
a Tr1 regulatory type subset that is being induced upon encounter with infected APC or parasitic 
antigens. Together, these immunosuppressive T cells may be preventing parasite-mediated 
immunopathology therefore prolonging parasite persistence.  
During the early stages of infection, the host innate immune system must rapidly detect and 
respond to protozoan parasite infection, and this is achieved through innate immune receptors. 
Toll-like receptors (TLR) have now emerged as a major receptor family that have a vital role in 
triggering innate immunity against initial infection, as well as orchestrating the development of 
acquired immune response, which is necessary for protection against re-infection.  
Leishmania derived-molecules can be sensed by TLR molecules (Becker et al., 2003; de Veer et 
al., 2003; Schleicher et al., 2007) through several different immune cells. In fact, new evidence has 
demonstrated Treg can also sense pathogens directly through TLR and, consequently modify their 
behaviour. Does this bring an advantage to either the host or the parasite itself? It is now well 
known that Treg play a central role in the suppression of immune responses during infections to 
prevent tissue damage and in the prevention of autoimmune responses harmful to the host. 
However, during acute infection Treg might hinder effector immune response directed towards the 
elimination of the pathogenic challenge. So, Treg-mediated suppression needs to be tightly 
controlled or in other words the regulators need to be regulated. Since Treg express TLR and TLR 
sense pathogens, it is only natural to hypothesize that TLR may in fact modulate Treg-mediated 
suppression to the host‘s benefit. And this is what has proven to happen.  
In mice and humans, 13 TLRs have now been identified that recognize distinct conserved 
pathogen- associated molecular patterns (PAMPs) (Akira et al., 2003; Pasare et al., 2004). Several 
TLR agonists derived from protozoans have also been identified in recent years (Gazzinelli et al., 
2004). Glycosylphosphatidylinositol (GPI)-linked molecules or anchors that are composed of a 
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glycan core and a lipid component, function as anchors to the surface of eukarytotic cells, and are 
abundantly expressed by protozoan parasites. Specificity is conferred through variations in the 
carbohydrate branches and in the lipid inositol portion. Protozoan GPI anchors, such as of 
Trypanossoma cruzi (Campos et al., 2001), Plasmodium falciparum (Krishnegowda et al., 2005) 
and Toxoplasma gondii (Debierre-Grockiego et al., 2003), have been shown to activate both cells 
from both lymphoid and myeloid lineages and initiate host immune responses and inflammation. 
Leishmania spp. has GPI-linked molecules that can trigger TLR activation. Infectious metacyclic 
promastigotes have a repertoire of GPI-linked molecules on their surface. At this particular stage of 
development, the main GPI-linked molecules are lipophophosglycans (LPG), which contain long 
carbohydrate branches with repeating phosphoglycan units (McConville et al., 1995). Recent 
studies revealed that TLR-2 contributes to the recognition of L. major and to the subsequent 
immune response. LPG has been shown to stimulate mouse macrophages and human NK cells 
through TLR-2, enhancing IFN- , IL-12, TNF-  production and nuclear translocation of NF- B 
(Becker et al., 2003; de Veer et al., 2003). Furthermore, the use of RNA interference to knock out 
the expression of various TLRs revealed that activation of macrophages by L. donovani is also, at 
least in part, dependent on TLR-2 (Flandin et al., 2006).  
Generally speaking, pathogen recognition by TLRs triggers a rapid activation of innate immunity 
by inducing the production of pro-inflammatory cytokines. Once activated by microbial PAMPs, 
TLRs interact with adaptor proteins. TLR molecules have a cytoplasmic domain that is 
homologous to the IL-1 receptor, and is known as the TIR (Toll/interleukin-1 receptor) domain (O‘ 
Neil et al., 2003). The best-studied TIR-domain-containing adaptor protein is myeloid 
differentiation gene 88 (MyD88) and is common to signalling pathways of IL-1R, IL-18R, and 
TLRs to IL-1R-associated protein kinase. Several studies using MyD88-deficient mice in parasitic 
infection models have provided valuable indication on the role of TLR signalling in resistance. 
Resistant mice lacking MyD88 have been shown to be highly susceptible to infection with L. major 
(Muraille et al., 2003). This susceptibility is characterized by large non-healing lesions, marked 
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parasitism and the development of a polarized Th2 immune response, as opposed to the normal IL-
12-dependent Th-1 protective immune response that develops in the wild-type C57BL/6 mice. 
Susceptibility of these MyD88
-/-
 mice has been thought to be a consequence of impaired TLR 
signalling. Also in vivo maturation of dendritic cells induced by L. donovani seemed to be partially 
dependent on MyD88 signalling pathway (de Trez et al., 2004). 
The first comparative study showed that TLR expression was related to functional states of 
different subtypes of T cells. Both Treg and effector T cells expressed TLR-1, 2 and 6. However, 
the Treg subset expressed significantly more TLR-4, 5, 7 and 8 than effector T cells, and increased 
suppressor function upon LPS activation (Caramalho et al., 2003). In fact, TLR-5 triggering of 
human Treg cells induced high levels of FOXP3 expression and enhanced Treg suppressive 
capacity (Crellin et al., 2005). But with respect to TLR-2 and TLR-5, effector cells also expressed 
significant amounts of these TLRs and when stimulated with their respective ligands showed 
increased proliferation and cytokine production (Komai-Koma et al., 2004; Crellin et al., 2005). 
TLR-2 expressed on the surface of activated and memory human T cells can serve as a co-
stimulatory receptor for antigen-specific T cell development and help to maintain T cell memory 
(Komai-Koma et al., 2004) and increase immune response against pathogens. In this study, TLR-2 
expression was in fact detected by real-time PCR in isolated CD4
+
CD25
+
 T cell fractions from L. 
infantum-infected BALB/c mice. Interestingly, the highest level of TLR-2 expression was observed 
at the same time point (day 14) when Treg transiently decreased in number and vice versa when 
Treg expanded. This suggests possible TLR-2 regulation of Treg kinetics during L.infantum 
infection. However, replicate measurements of TLR-2 expression from higher number of isolated 
CD4
+
CD25
+
 T cells should be performed to confirm statistical significance.  
In fact, another study documented a crucial role for TLR-2 in regulating Treg expansion and 
suppression by acting directly on Treg themselves (Sutmuller et al., 2006). TLR-2 triggering on 
Treg cells combined with IL-2 treatment and TCR ligation resulted in the proliferation of the 
Discussion                                                                                                                                              . 
 128 
otherwise anergic Treg cells both in vitro and in vivo. But the suppressive phenotype of Treg cells 
was in fact temporarily abrogated, thereby enabling the enhancement of the immune response in 
vitro against Candida albicans and in an acute in vivo infection model (Sutmuller et al., 2006). So, 
following removal of the TLR-2 trigger, the in vitro-expanded Treg cells fully regained their 
phenotype and suppressive capabilities. This was confirmed by a report from Liu, (2006) where 
FOXP3 expression was found to have decreased following TLR-2 stimulation of Treg, thus 
providing a further insight into the mechanism by which TLR-2 controls Treg-cell function. So it is 
important to stress that different TLR ligands may have the different abilities in regulating Treg 
cell activity, depending on the TLR signalling pathway in question. This ultimately may reflect on 
the modulation and type of immune response actually induced.  
So there is evidence to a role for TLR-2 in regulating Treg immunosuppressive function whilst also 
being implicated in Leishmania-specific immune responses elicited in other cell types. In order to 
elucidate on immunosuppressive Treg function induced by L. infantum parasites and the underlying 
mechanisms involved in the direct host-parasite interactions and immune regulation, the second 
part of this study focuses on the role of TLR-2 on Treg kinetics during L. infantum experimental 
murine infection by investigating the influence of TLR-2 on Treg kinetics, immune response, 
parasite-associated pathology and the outcome of L. infantum infection. To achieve this, TLR-2 
deficient mice and their wild type littermate control mice were infected with virulent L. infantum 
parasites and comparative analysis done to see whether or not the presence or absence of TLR-2 
produces any differential effect on the host parameters related to Treg dynamics and protective 
immunity. 
L. infantum parasites showed higher rates of multiplication in both spleen and liver of TLR-2
-/-
 
knock-out mice when compared to wild-type on the C57Bl/6 background, giving evidence of non-
healing infection in the former. The liver was the organ that displayed higher parasitization levels 
regardless of type of mice or observational time point. Susceptible BALB/c mice infected with L. 
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donovani reveal initial internalization of parasites by liver Kupffer cells, and then influx of 
granulocytes (neutrophils and eosinophils) and CD4
+
 cells, followed by CD8
+
 cells (Wilson et al., 
1996; McElrath et al., 2005). Parasite multiplication occurs up to four weeks after which there are 
reductions in parasite numbers and CD4
+
 cells (Wilson et al., 1995). Progression of the 
granulomatous response should result ultimately in acquired anti-leishmanial immunity (McElrath 
et al., 2005). However, the overall antimicrobial efficacy of the granulomatous response appears to 
be variable and depends upon host determinants, the pathogen and the criteria used to define 
efficacy (Murray et al., 2001). Although microbial eradication is the ideal outcome in infections 
which trigger granuloma assembly, it is not clear how often this objective is actually ever achieved. 
Thus, despite even an initially intense granulomatous response, a number of pathogens, including 
L. donovani, establish a well recognized state of chronic intracellular parasitism (Murray et al., 
2001).   
In this study, TLR-2
-/-
 mice infected with L. infantum developed higher liver parasitism with 
significant expansion after one month of infection. However, this was accompanied by a more 
intense granulomatous response in comparison to WT with increased number of infiltrating cells 
per area of tissue. High liver parasitism despite intense granulomatous response questions the 
efficacy of anti-leishmanial activity in the liver of these mice. Normal granuloma structure but no 
function may have given rise to ineffective granuloma during L. infantum infection. The presence 
of infiltrating immune cells does not seem to directly correlate with efficient parasite control.   
Two possible underlying mechanisms should be considered: defective recognition of parasite 
ligands and initiation of innate immunity through TLR-2 signalling by influxing macrophages and 
other immune cells that are unable to activate basic microbicidal mechanisms despite the assembly 
of a structurally intact-appearing granuloma. In fact, the term, `ineffective granuloma' (Murray & 
Nathan 1999), has been applied to the setting in which macrophages within the granuloma remain 
heavily parasitized despite satisfactory kinetics of assembly and apparently intact cellular 
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composition and structure. In regard to this study in particular, a plausible cause for having 
observed higher numbers of infiltrating cells in liver granulomas in TLR-2
-/-
 mice could be the fact 
that TLR are known to be highly expressed on several cells involved in innate immunity; the other 
possible mechanism is when the pathogen itself stimulates a suppressive host response which 
deactivates primary granuloma-inducing mechanisms. In this study, the presence of high levels of 
immunosuppressive Treg was in fact confirmed in TLR-2
-/-
 mice giving indication that the absence 
of TLR-2 favours late Treg expansion that ultimately may have influenced effector immune 
response in the liver. To note that Treg expansion was evaluated in the spleen since this organ is 
considered as the source of L. infantum-specific T cells involved in the infection control (Gomes-
Pereira et al., 2004a).   
Until date, very little work has been done on the role of TLR in host response to infection with 
protozoan parasites. No studies have looked at the contribution of TLR-2 to acquired immune 
responses to Leishmania infection, let alone to what occurs in terms of parasitism and immune 
response in TLR-2-deficient mice. However, seminal studies have given strong evidences for a 
crucial role of the surface glycolipid LPG in activating immune signalling via TLR-2 (de Veer et 
al., 2003; Becker et al., 2003). LPG was considered as an important activator of pro-inflammatory 
cytokine synthesis in macrophages derived from WT and not MyD88-null mice, giving evidence 
that Toll pathway and a functional MyD88 adaptor protein is required for activation of cytokine 
synthesis and resistance to this pathogen. Also L. major LPG is recognized by human NK cells 
which are activated to produce IFN- , IL-12, TNF-  and NF- B through TLR-2, thus increasing 
the effective destruction of the parasite. Studies performed with other members of the 
Trypanosomatidae family as is the case of T. cruzi showed that GPI anchors derived from these 
parasites induced TLR-2 expression and seemed to be essential for the release  of IL-12, TNF-  
and NO  (Campos et al., 2001). However, when studying gene deficient knock-out models and their 
effect on host resistance to parasite infection, the phenotype observed in terms of parasitism and 
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immune response varies depending on the parasite and the TLR signalling pathway affected. L. 
major infected - MyD88
-/-
 mice as mentioned already show a Th2 phenotype and increased 
susceptibility (de Veer et al., 2003; Muraille et al., 2003). This is also the case for T. brucei 
(Drennan et al., 2005) and T. cruzi (Campos et al., 2004) where decreased or impaired production 
of pro-inflammatory cytokines were observed, respectively,  increasing susceptibility to infection. 
Similar results were seen with T. gondii where MyD88
-/-
 mice die within 10 days of infection 
(Scanga et al., 2002). However, in malaria, MyD88
-/-
 mice infected with P. berghei resulted in 
impaired cytokine production but in fact showed less pathology and better outcome (Adachi et al., 
2001). Therefore, although signalling through MyD88 in innate immune cells has a protective role 
in most cases of protozoan infection by activating a Th1-associated immune response, in other 
situations decreased pro-inflammatory responses resulting from a lack of MyD88 signalling might 
be beneficial to the host. 
The role of TLR-2 signalling in host resistance and pathogenesis of parasitic infections is still 
unclear. For example, lack of expression of TLR-2, did not affect the susceptibility of mice to 
infection with T. cruzi. No major phenotype is observed in terms of parasitism or immune 
responses when either TLR-2-deficient mice are infected with T. brucei (Drennan et al., 2005), T. 
gondii (Chen et al., 2002; Mun et al., 2003) or P. berghei (Adachi et al., 2001). Therefore, these 
studies seem to indicate that the lack of a specific functional TLR might not be sufficient to result 
in the dramatic enhancement of host susceptibility to infection that is seen with MyD88 deficiency. 
However, in the case of TLR-2-deficient mice infected with L. infantum there was a visible effect 
on outcome of infection. To further dissect this in terms of cell-mediated immunity, regulatory T 
cells and overall effector response were evaluated.  
L. infantum-infected TLR-2
-/-
 mice initially showed reduced numbers and no visible expansion of 
Treg that are FOXP3
+
GITR
+ 
when comparing with WT mice, implying that the absence of TLR-2 
does not seem to favour immediate up-regulation of Treg as expected. In fact, Netea (2004) also 
Discussion                                                                                                                                              . 
 132 
observed a 50% decrease of the total Treg population (CD4
+
CD25
+
) in TLR-2
-/-
 mice infected with 
Candida albicans when compared to their wild-type littermates. However, the absence of TLR-2-
mediated signalling resulted in increased resistance to disseminated candidiasis. Whereas 
production of TNF-  and IL-1 is normal, IL-10 synthesis is severely impaired in TLR-2
-/-
 mice. 
Decreased production of IL-10 was associated with increased release of IFN- , to a reduction in the 
generation of Treg cells, and improved candidacidal function of macrophages. This implies that C. 
albicans evades host defence through TLR2-mediated signals.  
Low Treg numbers in TLR-2
-/-
 mice infected with L. infantum did not seem to be associated with 
better effector immune response during initial stages of infection in the spleen since relatively to 
WT mice there were no significant differences in parasite load, CD3
+
CD4
+
CD25
-
FOXP3
- 
effector 
T cell numbers and in total IFN-  production. In fact, IL-4 was found to be strongly induced in 
spleen tissue of TLR-2
-/-
 mice. During L. major infection, CD4
+
CD25
+
 T cells were been shown to 
regulate early IL-4 mRNA by inhibiting the magnitude and the subsequent development of a Th2 
response (Aseffa et al., 2002). So, initially low Treg numbers in L. infantum-infected TLR-2-/- 
mice may allow for induction of higher levels of IL-4 in spleen tissue. However, IFN-  response in 
LN cells of TLR-2
-/-
 mice was significantly reduced in relation to WT and did not seem to be 
adequately induced despite low Treg numbers.  
As already mentioned before, another potential marker for Treg cell subpopulation is the integrin 
( E 7, CD103) that is expressed on approximately 25% of mouse Treg cells, and that controls the 
adherence of conventional T cells to epithelium in the gut by binding to E-cadherin. The subset of 
CD25
+
CD103
+
 T cells appears to be expressed on Treg cells that circulate preferentially to 
inflammatory sites and to exert more potent suppressive effects in vitro (Huehn et al., 2004). Treg 
phenotype positive for CD103, used in this study gave a strong indication of cell migration to and 
retention within sites of infection in TLR-2
-/-
 mice, since it showed to be significantly induced and 
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enhanced when compared to WT. In fact, in the first part of this work, CD4
+
CD25
+
CD103
+
 Treg 
were also shown to be significantly increased in numbers in infected susceptible BALB/c mice. 
Furthermore CD103 expression has also been shown to favour natural Treg retention at dermal 
sites of L. major infection (Suffia et al., 2005). Higher levels of CD4
+
CD25
+
FOXP3
+
CD103
+
 Treg 
cells were observed during both early and late infection in TLR-2
-/-
 mice, indicating increased Treg 
retention in addition to late induction of Treg with memory phenotype (CD45RB
low
) in infected 
spleens. Alloantigen-specific regulatory T cells contained within the CD45RB
low
 CD4
+
 T cell 
population have been shown to be responsible for the maintenance of tolerance to donor 
alloantigens in vivo and require IL-10 for functional activity (Hara et al., 2001). In contrast to the 
first part of the work where CD45RB did not reveal important variations during L. infantum 
infection of susceptible BALB/c mice, when looking at TLR-2
-/- 
mice on a C57BL/6 resistant 
background, this specific memory marker showed to be more strongly associated to Treg markers.  
So high retention of memory Treg associated to significantly higher parasite loads in both spleen 
and liver during later stages of infection of TLR-2
-/-
 mice and lower IFN-  levels detected in total 
spleen tissue may also play a role in Leishmania pathogenesis in TLR-2
-/-
 mice. IL-4 did not seem 
to be the cytokine particularly involved in the outcome of late L. infantum infection in the spleen. 
In fact, IL-4 was found to be significantly reduced in relation to WT during late infection. 
However, in the liver late IL-4 expression was detected in these mice that could have contributed to 
higher liver parasitism. Other Th2 signature cytokines, which were not under study in this current 
work, should also be considered so as to provide more information on cytokines that may be more 
directly involved in susceptibility to Leishmania (e.g. IL-5, IL-13). Also the presence of late 
immunosuppressive Treg cells in infected TLR-2
-/-
 mice did not greatly influence differences that 
were expected in T cell effector populations. Effector T cell response was significantly induced 
with late infection regardless of mice type. Late effector response was elicited despite upregulation 
of the expression of immunosuppressive Treg in the absence of TLR-2. So, TLR-2 signalling in 
WT may be important in providing negative Treg regulation and more protective immunity, giving 
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rise to better control against L. infantum infection.  
Regarding FOXP3
+
 populations within the CD25 negative subset, again in TLR-2
-/-
 mice, the 
numbers are not increased in relation to WT. However, in WT mice this FOXP3
+
 population and 
the CD103
+
Foxp
+
 subset, within the CD25 negative population, do still decrease with infection as 
expected, the latter being more reduced than in TLR-2
-/-
 mice. So again in WT mice, as observed 
previously in the CD25
+
 Treg subsets, FOXP3
+
 committed Treg populations also seemed to be 
more tightly controlled, thus favouring protective immunity against the parasite.  
In retrospective, the most important differences observed between TLR-2
-/-
 and WT mice infected 
with L. infantum are associated to levels of Treg retention with memory phenotype during late 
infection of the spleen. Although total Treg numbers seemed practically unaltered during infection, 
Treg showed increased migration to and retention at sites of infection, suggesting that the induction 
of immunosuppressive Treg function would favour Leishmania multiplication and parasite 
persistence in TLR-2 knock-out mice. In WT mice, thus in the presence of TLR-2 receptor and 
upon eventual recognition of parasitic ligands, abrogation of Treg function would be expected and 
accompanied by breakdown of immune tolerance, and enhanced immune response against 
infection. In this study, during initial infection, the levels of parasite ligands were probably not 
sufficient enough to exert an appreciable regulatory effect on Treg despite the presence of TLR-2 
receptor. However, after one month of infection, significant reductions in infected WT mice of total 
GITR
+
 Treg and CD103
+
 Treg and in comparison to knock-out mice for CD45RB
low
 Treg did in 
fact occur that could have favoured better immunity and parasite control.  
So, antigen recognition by TLR-2 should render Treg less responsive to the presence of parasite 
ligands and a possible infection, thus allowing for an adequate immune response. In fact, it has 
been reported that TLR agonists can directly or indirectly inhibit Treg cell response (Pasare & 
Medzhitov et al., 2003, Peng et al., 2005). TLR-induced IL-6 production by DC indirectly blocks 
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the suppressive function of CD4
+
CD25
+
 Treg cells. Sutmuller (2006) showed that although the 
TLR-2 ligand PAM3Cys directly induced proliferation of CD4
+
CD25
+
 T cells during Candida 
albicans murine infection, there was temporary loss of Treg suppressive activity, which was 
restored after removal of the TLR agonist. Similar findings were reported by Liu (2006) using a 
synthetic bacterial lipoprotein (BLP) PAM3Cys-SK4, also a TLR-2 agonist that was able to induce 
the expansion of both CD4
+
CD25
+
 Treg and CD4
+
CD25
-
 T effector cells but also rendered the 
effectors more resistant to suppression by Treg cells and transiently suppressed Treg function. They 
suggested that the down-regulation of FOXP3 expression would be the putative mechanism for the 
abrogation of Treg suppressive function. In contrast to the previous studies, Zanin-Zhorov et al., 
2006, used the endogenous TLR-2 ligand heat-shock protein 60 (hsp60) and showed that hsp60-
activated Treg actually enhanced their suppressive capacity via both cell-contact dependent 
mechanism and IL-10 and TGF-  production. This discrepancy between several different studies 
could be possibly explained by the nature of the TLR-2 ligands used, the concentrations and the 
ways endogenous TLR-2 ligands interact with TLR-1/2 receptor dimer. Thus the effect of TLR-2 
signalling on CD4
+
CD25
+
 Treg still remains somewhat controversial and most likely varies 
depending on the Treg subset in question, the nature of TLR-2 ligand and the type of pathogen 
under study. 
For example, during acute C. albicans infection, Treg numbers (CD4
+
CD25
+
) in the blood 
circulation of TLR-2
-/-
 mice are significantly reduced compared to their WT littermate controls 
(Netea et al., 2004). However, the TLR-2
-/-
 mice were more resistant to disseminated Candida 
infection, and this was mainly associated to enhanced candidacidal macrophage activity and also to 
impaired IL-10 release by total spleen cells. These authors also showed that TLR-2 agonists 
(peptidoglycan) induced in vitro survival of Treg. So, in this model of acute infection TLR-2-
derived signals seem to favour Treg survival, increase IL-10 production and thus contribute to 
fungal pathogenesis. In our model of infection with L. infantum, TLR-2
-/-
 mice were in fact more 
susceptible and this was associated to increased Treg retention, apparently unefficient liver 
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granuloma formation and ultimately enhanced parasite persistence.  
Anti-inflammatory response was also evaluated in this study. IL-10 was mainly observed during 
late infection, regardless of mouse phenotype. So, the presence or absence of TLR-2 did not seem 
to influence IL-10 expression, and it did not seem to correlate with CD103
+
 Treg detected late 
during infection in TLR-2
-/- 
mice. Other immune cells should be considered as potential sources of 
IL-10 that is being expressed. In fact, in the first part of this work the CD4
+
CD25
-
 effector T cell 
fraction isolated from infected susceptible mice were demonstrated in vitro to be an important 
source of IL-10. Since effector CD3
+
CD4
+
CD25
-
FOXP3
-
 T cells were also found to be expressed at 
significantly higher levels also later during infection it is possible that they may give rise to IL-10 
that is being induced, thus contributing to anti-inflammatory milieu and perpetuation of chronic 
infection. Also a recent study in an experimental model of visceral leishmaniasis showed that NK 
cells were recruited to the spleen and into hepatic granulomas, where they inhibited host protective 
immunity against L. donovani in an interleukin-10 (IL-10)-dependent manner (Maroof et al., 2008). 
Initial IL-10 response seems to be organ dependent since while it is detected early upon infection in 
spleen of WT mice it is significantly reduced in the liver. This could indicate that anti-
inflammatory response in the liver is less evident in WT than in TLR-2
-/- 
mice. Another factor that 
may be inducing better effector response and lower parasite load in WT mice.  
To the present date, no studies have evaluated the phenotype and the type of Th responses that is 
induced in TLR-2
-/- 
knock-out mice when infected with L. infantum. As mentioned above, de Veer 
(2003) and Muraille (2003) observed Th2 response and increased susceptibility to L. major but in 
MyD88
-/-
 mice. Other authors have shown that TLR-2 promotes Th2 responses and increases the 
production of IL-10 (Agrawal et al., 2003). However, these studies evaluated how signalling via 
distinct TLR-2 agonists conditions DCs to elicit distinct Th responses. Activation of DCs via TLR-
2 ligand PAM-Cys skewed toward Th2 responses via induction of extracellular MAP kinase 
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signalling and c-Fos. It would be expected that during an infection with L. infantum, increased 
concentrations of TLR-2 ligands (e.g. LPG) would limit Treg suppressive activity and promote the 
onset of immune response in WT mice. In fact, CD4
+
CD25
+
CD103
+
 and CD45RB
low
 Treg were 
found to be reduced in WT mice. Th1 response mediated by IFN-  expression in WT was found to 
be higher during early infection in LN and in the spleen during late infection. However, Th2 
response (IL-4) varied greatly according to the cells/organ in question. No evident differences in 
IL-10 expression were observed between mice although less TGF-  was initially detected in spleen 
cells of WT when compared to TLR-2
-/-
 mice.  
GPI anchors from T. cruzi parasites were found to be potent activators of TLR-2 and TLR-2 
activation seems to be essential for initiating host innate response with induction of IL-12, TNF-  
and NO. TLR-2
-/-
 mice were able to mount a robust pro-inflammatory cytokine response 
(producing IFN- ), during the acute phase of infection with T. cruzi parasites (Campos et al., 2004). 
However, deletion of the functional TLR-2 gene had no major impact on parasitemia nor on 
mortality. In contrast, the MyD88
-/-
 mice had a diminished cytokine response and reactive nitrogen 
intermediates (RNI) production upon acute infection with T. cruzi and were more susceptible to 
infection, with high levels of parasitemia and accelerated mortality (Campos et al., 2004). These 
authors suggest that it is possible that TLR-2 may be playing an immunoregulatory role in wild 
type mice. Upon TLR-2 activation via GPI anchors, macrophages become refractory, cease to 
produce pro-inflammatory cytokines, leading to induced tolerance. The lack of TLR-2 could be 
preventing this tolerance state and induce more robust immune response. Alternatively, the lack of 
functional TLR-2 could also prevent stimulation of CD4
+
CD25
+
 T cells with immunoregulatory 
function, culminating in enhanced production of IFN-  during in vivo infection with T. cruzi.  
Increased susceptibility toward T. brucei observed for MyD88-deficient animals was shown to be 
due to defective TLR signaling. However, screening of several TLR-deficient animals revealed that 
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neither TLR-1, TLR-2, the combination of both TLR-2 and TLR-4, or TLR-9 were required by the 
host to control the first peak of parasitemia following a clonal T. brucei infection (Drennan et al., 
2005). However, TLR-2-, TLR-4- and MyD88-deficient mice with the avirulent cyst-forming 
Fukaya strains of T. gondii showed high levels of IL-4 and IL-10 produced by peritoneal exudate 
cells and died within 8 days of infection (Mun et al., 2003). In this study higher levels of IL-10 
were found in both spleen and liver although no differences were found between TLR-2 deficient 
and WT mice in response to L. infantum.  However, an early expression of IL-4 in total spleen 
tissue, and later in LN was found significantly higher in TLR-2 deficient mice. 
Visceral leishmaniasis has been frequently associated to TGF-  (Wilson et al., 1996; Gomes-
Pereira et al., 2004). In susceptible BALB/c mice, the presence of regulatory TGF-  producing-
CD4
+
CD25
+
 T cells were seen to exhibit migratory phenotype expressing high levels of CD103 and 
were antigen-specific to L. infantum. Other studies have also shown that, in vivo, CD25
+
 Treg 
activity has been implicated to be dependent on TGF-  (Read et al., 2000, Levings et al., 2002; 
Nakamura et al., 2004), and these cells are Leishmania-specific (Suffia et al., 2006) and control 
effector immune response induced during human mucocutaneous leishmaniasis (Campanelli et al., 
2006).  
The expression of immunosuppressive cytokine TGF-  was evaluated in TLR-2 deficient mice 
infected with L. infantum, so as to determine whether there were any differences observed in the 
absence of TLR-2 and any association to increased levels of migrating regulatory cells to sites of 
infection. Initially, spleen cells of TLR-2
-/- 
mice expressed higher TGF-  levels than WT mice but 
later during infection, a reduction in the ability to express this cytokine was shown, particularly 
more evident in liver. This may suggest a minor role for TGF-  in mediating parasite-induced 
immunopathology and susceptibility of TLR-2
-/- 
mice to L. infantum.  
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Surprisingly, WT showed a strong TGF-  response to late infection that does not seem to 
contribute to increased parasite multiplication since these mice are effectively more resistant to L. 
infantum. This occured together with an anti-inflammatory response with detection of IL-10. 
However, Treg activity was not found to be elevated in response to infection in WT mice. Other 
immune cells such as Th3 cells (Weiner et al., 2001) or CD8
+
 regulatory T cells (Cosmi et al., 
2003; Pomié et al., 2008) should also be considered as potential producers of TGF-  and thus 
contribute to the development of chronic infection in WT mice. In conclusion, the migration to 
sites of L. infantum infection of suppressive Treg in TLR-2 deficient mice seem to be IL-10 and 
TGF-  independent, suggesting other mechanisms mediating parasite-induced pathology in these 
mice.  
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FINAL CONCLUSIONS 
 
To summarize the results obtained in this present work, the following conclusions can be made 
regarding: 
1.    Phenotypic characterization of regulatory T cell populations during L. infantum in vivo 
infection 
 
-Identification of T cell subsets with phenotypic and functional characteristics of regulatory T cells 
during L. infantum infection of susceptible BALB/c mice. Inducible CD4
+
CD25
+ 
regulatory
  
T cells 
that are also GITR
+  
and
 
CD103
+  
readily expand upon Leishmania infection, present high foxp3 
gene expression and are antigen-specific, suggesting predisposition for Treg recruitment and 
retention within sites of L. infantum infection, consequently influencing local immune response.  
-Treg expansion is transient perhaps due to selective modulation via host-parasite interaction. 
However, Treg expansion seems to be influence immune response since Th effector cells are 
unable to respond specifically to stimulation. Th1 is inadequate to control infection and Th2 is 
inhibited.  
-foxp3 expressing-CD4
+
CD25
+
 T cells are capable of specifically producing TGF-  IL-10 
producing-CD4
+
CD25
-
FOXP3
-
 T cells were also identified as an additional source of IL-10 and 
may represent a Tr1 regulatory type subset that is being induced upon encounter with infected APC 
or parasitic antigens. 
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2.   Evaluation of the effect of TLR-2 modulation on Treg populations during L. infantum in 
vivo infection 
 
-Defective TLR-2 signalling had a visible effect on outcome of L. infantum infection. Higher rates 
of parasite multiplication were observed in both spleen and liver of TLR-2
-/-
 knock-out mice, 
despite the ability in forming well-defined and structured liver granulomas. These granulomas were 
apparently ineffective in parasite clearance, when compared to wild-type mice. 
-Defective TLR-2 signalling did induce during late infection high retention of memory Treg which 
seemed to be associated to high parasite load and low IFN-  levels. TLR-2 signalling pathway may 
play a role in Treg modulation and consequently in L. infantum pathogenesis. Functional TLR-2 
signalling in WT may be important in providing tight control over FOXP3
+
 committed Treg 
populations, negative Treg regulation and more protective immunity, giving rise to enhanced 
immunity and more effective response against infection.  
-The presence or absence of TLR-2 did not seem to influence IL-10 or TGF-  expression, and it 
did not seem to correlate with CD103
+
 FOXP3
+ 
Treg detected late during infection in TLR-2
-/- 
mice. Detection of high levels of suppressive Treg in L. infantum infected TLR-2 deficient mice is 
not accompanied by associated inductions of immunosuppressive cytokines.        
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